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Objective
This review investigates the effectiveness of ‘home
treatment’ for mental health problems in terms 
of hospitalisation and cost-effectiveness. For the
purposes of this review, ‘home treatment’ is
defined as a service that enables the patient to be
treated outside hospital as far as possible and
remain in their usual place of residence. 
Methods
Systematic literature search
‘Home treatment’ excluded studies focused on 
day, residential and foster care. The review was
based on Cochrane methodology, but non-
randomised studies were included if they com-
pared two services; these were only analysed if 
they provided evidence of the groups’ baseline
clinical comparability.
Review of economic evaluations
Economic evaluations among the studies found
were reviewed against established criteria.
Identification of service components
A three-round Delphi exercise ascertained the
degree of consensus among expert psychiatrists
concerning the important components of
community-based services that enable them 
to treat patients outside hospital. The identified
components were used to construct the follow-
up questionnaire.
Follow-up of authors
As a supplement to the information available 
in the papers, authors of all the studies were
followed up for data on service components,
sustainability of programmes and service
utilisation.
Data analysis
The outcome measure was mean days in hospital
per patient per month over the follow-up period.
• Comparative analysis – compared experimental
to control services. It analysed all studies with
available data, divided into ‘inpatient-control’
and ‘community-control’ studies, and tested 
for associations between service components
and difference in hospital days.
• Experimental services analysis – analysed 
only experimental service data and tested 
for associations between service components
and hospital days.
Results
Systematic literature search
A total of 91 studies were found, conducted over 
a 30-year period. The majority (87) focused on
people with psychotic disorders.
Review of economic evaluations
Only 22 studies included economic evaluations.
They provided little conclusive evidence about
cost-effectiveness because of problems with the
heterogeneity of services, sample size, outcome
measures and quality of analysis.
Delphi exercise
In all, 16 items were rated as ‘essential’, falling 
into six categories: home environment; skill-mix;
psychiatrist involvement; service management;
caseload size; and health/social care integration.
There was consensus that caseloads under 25 and
flexible working hours over 7 days were important,
but little support for caseloads under 15 or for 
24-hour services, and consensus that home visiting
was essential, but not on teams being ‘explicitly
dedicated’ to home treatment.
Response to follow-up
A total of 60% of authors responded, supplying
data on service components and hospital days in
most cases. Other service utilisation data were far
less readily available.
Service characterisation and classification
The services were homogeneous in terms of ‘home
treatment function’ but fairly heterogeneous in
terms of other components. There was some
evidence for a group of services that were multi-
disciplinary, had psychiatrists as integrated team
members, had smaller caseloads, visited patients at
home regularly and took responsibility for both
health and social care. This was not a cohesive
group, however.
Executive summaryExecutive summary
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Sustainability of services
The sustainability of home treatment services 
was modest: less than half the services whose
authors responded were still identifiable. Services
were more likely to be operational if the study 
had found them to reduce hospitalisation
significantly.
Meta-analysis
Meta-analysis with heterogeneous studies is proble-
matic. The evidence base for the effectiveness of
services identifiable as ‘home treatment’ was not
strong. Within the ‘inpatient-control’ study group,
the mean reduction in hospitalisation was 5 days
per patient per month (for 1-year studies only). 
No statistical significance could be measured for
this result. For ‘community-control’ studies, the
reduction in hospitalisation was negligible. More-
over, the heterogeneity of control services, the
wide range of outcome measures and the limited
availability of data might have confounded 
the analysis.
Regularly visiting at home and dual responsibility
for health and social care were associated with
reduced hospitalisation. Evidence for other
components was inconclusive. Few conclusions
could be drawn from the analysis of service
utilisation data.
Location
Studies were predominately from the USA and 
UK, more of them being from the USA. North
American studies found a reduction in hospital-
isation of 1 day per patient per month more than
European studies. North American and European
services differed on some service components, 
but this was unlikely to account for this finding,
particularly as no difference was found in their
experimental service results.
Conclusions
State of research
There is a clear need for further studies,
particularly in the UK. The benefit of home
treatment over admission in terms of days in
hospital was clear, but over other community-
based alternatives was inconclusive.
Non-randomised studies
Difficulties in systematically searching for non-
randomised studies may have contributed to 
the smaller number of such studies found (35,
compared with 56 randomised controlled trials).
This imbalance was compounded by a relatively
poor response rate from non-randomised
controlled trial authors. Including them in the
analysis had little effect.
Limitations of this review
A broad area was reviewed in order to avoid 
the problem of analysing by service label. While
reviews of narrower areas may risk implying a
homogeneity of the services that is unwarranted,
the current strategy has the drawback that the
studies cover a range of heterogeneous services.
The poor definition of control services, however, 
is ubiquitous in this field, however reviewed 
areas are defined.
Inclusion of mean data for which no standard
deviations were available was problematic in 
that it prevented measuring the significance of 
the main findings. The lack of availability of 
this data, however, is an important finding,
demonstrating the difficulty in seeking 
certainty in this area.
Only days in hospital and cost-effectiveness were
analysed here. The range and lack of uniformity 
of measures used in this field made meta-analysis
of other outcomes impossible. It should be 
noted, however, that the findings pertain to 
these aspects alone.
The Delphi exercise reported here was limited 
in being conducted only with psychiatrists, 
rather than a multidisciplinary panel. Its findings
were used as a framework for the follow-up and 
analysis. Their possible bias should be borne 
in mind when considering them as findings 
in themselves.
Implications for clinicians
The evidence base for home treatment compared
with other community-based services is not 
strong, although it does show that home treat-
ment reduces days spent in hospital compared 
with inpatient treatment. There is evidence that
visiting patients at home regularly and taking
responsibility for both health and social care 
each reduce days in hospital.
Implications for consumers
Services that visit patients at home regularly 
and those that take responsibility for both health
and social care are likely to reduce time spent in
hospital. Psychiatrists surveyed in this review also
considered support for carers to be essential. 
The evidence from this review, however, was 
that few services currently have protocols for
meeting carers’ needs.Health Technology Assessment 2001; Vol. 5: No. 15
v
Recommendations for research 
and commissioners
A centrally coordinated research strategy, with
attention to study design, is recommended. Studies
should include economic evaluations that report
health and social service utilisation. Service com-
ponents should be collected and reported for both
experimental and control services. Studies should
be designed with adequate power and longer
durations of follow-up and use comparable 
outcome measures to facilitate meta-analysis.
Research protocols should be adhered to through-
out the studies. It may be advisable that inde-
pendent researchers conduct studies in future. 
It is no longer recommended that home treat-
ment be tested against inpatient care, or that 
small, localised studies replicate existing, more 
highly powered studies.Health Technology Assessment 2001; Vol. 5: No. 15
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Background
Despite the increasing shift in favour of community-
based mental healthcare over the last 30 years,
inpatient treatment remains the major cost within
integrated services. This limits developments in 
the provision of community mental health services.
At the same time, a wide variety of models of com-
munity service are now in operation. The need to
develop a reliable working classification of these
services in order to research their effectiveness 
has become increasingly evident – both because of
the range of labels employed and because certain
labels are considered to denote better and more
fund-worthy services, despite often lacking clarity 
of definition.
The example of ‘Case Management’ illustrates the
vexed question of service classification in com-
munity mental healthcare. Case Management has
been described as involving, as a bottom-line, “a
relationship between a client and a case manager
that is designed to enhance continuity and co-
ordination of care”,
1 but there exists a “Babel-like
confusion”
2 about the multiplicity of its forms and
varieties. Work has been done on defining Assertive
Community Treatment (ACT),
3,4 but there is less
clarity about other forms of Case Management, 
and the impressive array of synonyms for or near-
approximations to ACT (Program for Assertive
Community Treatment (PACT), Training in Com-
munity Living (TCL), Assertive Case Management,
Assertive Outreach, Aggressive Outreach) under-
mines attempts to clarify it as a model. Moreover, if
‘brokerage’ Case Management (the brokering of
services to the client, not necessarily by a clinician)
and ACT have been described as “opposite ends 
of a continuum”,
1 then the range of service models
falling between the two is less clearly delineated.
Scott and Dixon
1 see the distinction as particularly
blurred with ‘Intensive Case Management’ (ICM), 
a term often used interchangeably with ACT but
distinguished from it by them on the grounds that it
often lacks one or more ACT programme elements.
ACT is sometimes described as team-based where
Case Management involves individual caseloads,
5
but this distinction is not maintained consistently.
Cochrane Systematic Reviews provide a means of
evaluating randomised controlled trials (RCTs) and
conducting systematic meta-analyses, where data 
are available. Cochrane Systematic Reviews have
been conducted in four areas encompassed by our
term ‘home treatment’: ACT,
6 Case Management,
5
Community Mental Health Teams (CMHTs)
7 and
Crisis Intervention.
8 Reviewers, however, report on 
a wide range of outcome measures and scales used,
impeding pooling of results, and point out the
“striking … extent to which inadequately validated
instruments [are] used to measure outcome”.
5,6
Meta-analyses are also hampered by lack of data 
in an appropriate form (reported with means and
standard deviations). In the area of services (rather
than interventions) research, these problems are
exacerbated by the lack of clear definition of the
services under review.
Marshall and Lockwood
6 based their definition 
of ACT on the label used by the study authors, 
and excluded studies of ACT as an alternative 
to hospitalisation or ‘hospital diversion’. They
found it to be “a clinically effective approach”.
Marshall and colleagues
5 defined Case Manage-
ment as any form of ‘care’ or ‘case management’
or ‘Care Programme Approach’ (CPA) excluding
ACT, and concluded that Case Management is “an
intervention of questionable value”. The authors
admit the limitations of their inclusion criteria 
in terms of service definition, realising that “it is
not possible to be certain that the trialists were
applying their labels correctly. It may even be 
that the interventions in successful trials are 
more likely to be retrospectively labelled ‘ACT’.”
This might be argued to render unsound their
conclusion that ‘ACT’ should be implemented 
and ‘Case Management’ abandoned.
Tyrer and colleagues
7 reviewed studies of CMHT
care, excluding studies of services labelled either
ACT or Case Management. They found that
CMHT care was not inferior to standard non-
team care in any important respect and suggested
that it may be superior in reducing hospital
admission. Finally, Crisis Intervention might be
considered not to fall entirely within the area 
of ‘home treatment’ but, in practice, Joy and
colleagues
8 in their review found that all the
included studies were of “a form of home care 
for acutely ill people, which included elements 
of crisis intervention”. They concluded that 
Chapter 1
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To attempt a characterisation of service models at
the level of components (bottom-up) rather than
label (top-down), we conducted a Delphi exercise,
utilising expert psychiatrists’ opinions. We did not
seek a definition of ‘home treatment’ from this
exercise; instead, we asked leading psychiatrists
what they considered to be the most important
components of community-based mental health
services that enabled them to treat a patient out-
side hospital. The components generated through
this exercise were then used to characterise the
services in our review through a follow-up survey 
to authors. Key components were tested for associ-
ation with the outcome days in hospital. The year
of study publication and the location of the study
were also tested for association with days in hosp-
ital, to identify wider trends. To answer questions
about the sustainability of the service programmes
studied, the follow-up survey included questions
about the components of the service today.
In this review, days in hospital during the follow-
up period is used as the outcome measure, as a
proxy for clinical outcome. It is recognised that
this is problematic
14 as it is a measure of the
services people receive rather than those they
need, and has been shown to be sensitive to 
local practice and policy. It does not specifically
measure change in health status. Despite this, it
remains the only robust proxy measure for clinical
status within a system. Moreover, meta-analyses 
in other areas necessarily use similarly crude
measures. We chose hospital days as the outcome
that was most likely to be obtainable from the
studies. Bearing in mind that previous reviews 
have found a wide range of outcome measures 
and scales to be used,
5,6 we chose to analyse only
hospitalisation outcomes and not other clinical 
or social outcomes or user and carer satisfaction.
It is a premise of the analytical strategy that to
analyse studies with inpatient-control services
alongside studies with community-based control
services would give misleading results, given that
the outcome measure was days in hospital. It is
acknowledged that control patients in hospital
would not necessarily remain there for the entire
study period, while patients in the community 
(in experimental or control conditions) might 
be admitted to hospital; this is, indeed, the basis 
on which days in hospital is used as an outcome
measure. Nevertheless, the studies using inpatient
treatment as the control service are analysed
separately to avoid distortion of results.
Where possible, the analysis is not divided any
further on the basis of the control service. This
enables us to analyse the maximum number of
services together. The control services are often
even more poorly defined than the experimental
services. Since the premise of the review is that
experimental services should not simply be
analysed by their label, it was important not to 
base our analysis on even less well-defined labels
for the control services. We anticipated that
incomplete information on the control service
characteristics would exacerbate the problem,
since ‘standard care’ control services in some
studies might comprise a model labelled, for
instance, ‘Case Management’ in other studies.
To reflect these problems with the range and 
lack of clarity of control services, we present two
analytical strategies. The first (the ‘comparative
analysis’) is a meta-analysis of those studies for
which we obtained data on hospital days, and
proceeds along conventional lines, taking the
difference between experimental and control
services as its outcome measure. Here, our
research question necessarily reflects the diversity
of control services, acknowledging that in many
studies it is unclear what the experimental service
is being compared with, unless it is inpatient
treatment. Where individual service components
are tested for association with outcome, studies 
are only included where we have information
about both experimental and control service
components, in order to calculate the difference
between them (for example, in caseload size). 
It is hypothesised that evidence in favour of
experimental services may be due to some 
degree to the issues discussed earlier that 
limit generalisability, such as the impact of 
the charisma of study authors and their
commitment to that service. The size of this 
effect is not ascertainable through this
conventional meta-analysis.
The alternative, less conventional, analysis (the
‘Experimental Services Analysis’) uses only data
from the experimental services. This analysis is 
not a randomised comparison. It has the dis-
advantage that its findings will therefore be
affected by differences in the severity of the 
illness of patients in different studies and by 
local policies on hospitalisation. The analysis
presupposes a certain quality of data based on 
the fact that the studies from which the data 
are taken are randomised trials. For this reason,
non-randomised studies were not used in 
this analysis.
The Experimental Services Analysis has the
advantage, however, that the associations betweenIntroduction
4
service components and days in hospital can be
tested using a larger number of studies: all the
studies can be included, regardless of what control
service was used (including inpatient treatment).
The diversity of the control services is thus no
longer a problem, as the experimental services 
are compared only with each other. For this
analysis, we needed information only on service
components for the experimental service, which
was likely to be available more often than for the
control service. It was also hoped that the possible
impact of the charisma and commitment of
experimental service leaders would be minimised
by analysing experimental services only against
each other.
Definitions
For the purposes of this review, ‘home treatment’
or ‘home-based service’ is defined as a service that
enables the patient to be treated out of hospital 
as far as possible and to stay in their usual place 
of residence.
The term ‘Community Mental Health Team’ is 
used in this review and the follow-up questionnaire
(see page 37) as a generic term. This is in contra-
distinction to the definition used by Tyrer in his
review,
7 which is a narrower concept, excluding
ACT and Case Management.
Aims
The aims of the review are:
• to ascertain the effectiveness of home treatment
over usual services in terms of reducing hospital
days and in terms of cost-effectiveness
•t o identify key components of home 
treatment services
•t o measure the effects of different components
of home treatment services on days in hospital
•t o ascertain the sustainability of home treatment
services and of these key components
•t o identify and evaluate the published studies in
this area which include an economic evaluation
•t o measure the impact of methodological quality
(in particular, randomisation) on the results 
of studies.
Research questions
• Are ‘home treatment’ services more effective
than inpatient treatment in terms of reducing
hospital days and costs?
• Are ‘home treatment’ services more effective, 
in terms of reducing hospital days and costs,
than other community-based services with 
which they are compared?
Our initial brief was to evaluate the effectiveness 
of home treatment ‘compared to admission’ for
mental health problems. This gives rise to the first
research question above. (‘Inpatient treatment’
here means an initial period of inpatient treat-
ment, followed by discharge as appropriate.) 
In view of the development of community care
over the last 30 years, however, it was necessary 
to include studies comparing home treatment to
services other than inpatient treatment. Because 
of the multiplicity of control services discussed
earlier, this gives rise to the second question above.
The difficulties with answering this question, and
interpreting its findings, are discussed below.
Further, more specific questions were generated
using a Delphi exercise (see chapter 4):
• Are services with smaller caseloads superior 
to services with larger caseloads in terms of
reducing hospital days and in terms of cost-
effectiveness (positive correlation between
caseload size and hospital days)?
• Are services with a higher contact frequency
superior to services with a lower contact fre-
quency in terms of reducing hospital days and in
terms of cost-effectiveness (negative correlation
between contact frequency and hospital days)?
• Are services with a higher proportion of 
contacts made in the patient’s home (or home
environment) superior to services with a smaller
proportion of such contacts in terms of reducing
hospital days and in terms of cost-effectiveness
(negative correlation between the percentage 
of home contacts and hospital days)?
• Are services with longer hours of operation
superior to services with shorter hours of
operation in terms of reducing hospital days 
and in terms of cost-effectiveness (negative
correlation between hours of operation 
and hospital days)?Health Technology Assessment 2001; Vol. 5: No. 15
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Introduction
In searching the literature for this review, we 
aimed to be both systematic and wide-ranging. 
We adopted the search methodology of the
Cochrane Systematic Reviews and searched the
substantial database of trials compiled by the
Cochrane Schizophrenia Group (CSG), as well 
as other important databases. Four Cochrane
Reviews – of ACT,
6 Case Management,
5 CMHTs
7
and Crisis Intervention
8 – cover areas that fall
within our definition of ‘home treatment’ as a
service that enables the patient to be treated out 
of hospital as far as possible and to stay in their
usual place of residence. We incorporated the
search strategies of these four Cochrane Reviews
into ours in order to include all their findings. 
We also searched their reference lists to ensure
that this had been successful. Our search strategy,
however, also aimed to be over-inclusive, in view 
of the fact that the previous reviews had been 
very tightly focused and that the area is 
inherently broad and unclear.
Methods
Criteria for selecting studies for 
this review
Types of participants
The majority of the study participants were
required to be within the age range 18–65 years
(maximum range 16–75 years) and to suffer 
from a ‘mental health problem’. Substance abuse
as a sole diagnosis was not included, but studies
were eligible if they included people with a dual
diagnosis of a mental health problem with
substance abuse.
Types of services
A service was considered to be ‘home treatment’ 
or ‘home-based’ if it aimed to treat the patient
outside hospital as far as possible and enabled
them to stay in their usual place of residence.
Studies of day care, foster care and community
residential services were excluded.
Types of studies
Two categories of study were included. Studies
were included as RCTs if they met Cochrane
quality standards for RCTs.
15 Studies were included
in the review as ‘non-randomised studies’ if they
compared two services. Their inclusion in the
analysis, however, was dependent upon further
methodological criteria (see page 7).
Outcome measure
The outcome measure for this review was days in
hospital over the follow-up period. Other outcomes
were not analysed due to the reported range of
outcome measures commonly used and the finding
that a large proportion of instruments used in
studies have been inadequately validated.
5,6
Search strategy for identification 
of studies
Electronic searching
Searches were conducted in two stages. In the first
stage, the CSG terms for psychotic illness were
used (see appendix 3).
The following term was used to identify ‘home
treatment’ studies:
[OUTREACH or HOSTEL or AFTERCARE or
RESIDENTIAL or HOUSING or TRANSITIONAL
or POSTHOSPITAL or ((COMMUNIT* near4
(TEAM* or CENTER* or CENTRE* or TREAT*) 
or ((CASE or CARE) near MANAGEMENT) or 
CPA or (CARE near1 PROGRAMME near1
APPROACH) or (ASSERTIVE near1 COMMUNITY
near1 TREATMENT) or PACT or TCL or
(TRAINING near (COMMUNITY near1 LIVING))
or (MADISON near4 MODEL) or (INTENSIV* 
or MOBILE or OUTREACH or COMMUN* or
HOME) near3 (CARE* or INTERVEN* or TREAT*
or THERAP* or MANAGEMENT* or MODEL* 
or PROGRAMM* or TEAM* or SERVICE* or
BASE*) or (HOSPITAL* near3 (DIVERSION or
ALTERNATIVE*) or ((DAY or DROP-IN) near3
(HOSPITAL or CARE or TREATMENT or CENTRE
or CENTER or UNIT)) or (AMBULATORY and
(TREATMENT or CARE)) or (PARTIAL near1
HOSPITALI?ATION) or (CRISIS or EARLY) near1
INTERVENTION) or FOSTER or GUARDIANSHIP
or ‘DAILY LIVING PROGRAMME’].
The following databases were searched using the
CSG’s terms for RCTs combined with their term for
psychotic illness and the term for home treatment:
Chapter 2
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CINAHL (1982–10.99)
The CSG Register (–9.99)
EMBASE (1980–10.99)
MEDLINE (1966–12.99)
PsycLIT (1887–9.99).
Terms specific to each database were added to the
generic term for home treatment. For full details,
see appendix 3.
In the second stage, the search was performed again
using the following term for mental health prob-
lems: [(MENTAL* or PSYCH*) near (DISORDER*
or ILL*)]. This less sophisticated search term was
designed to pick up any studies of mental health
problems other than psychotic illness, which might
have been missed by the original search.
Reference searching
Reference lists of all included RCTs and identified
reviews (including the four Cochrane Reviews in
this area, both the ‘included’ and ‘excluded’
studies lists) were searched for eligible studies
missed by the electronic search.
Non-randomised studies
Systematically searching for studies that are not
RCTs is known to be problematic.
16 As yet, no
solution has been found, but a Cochrane Group 
for Non-randomised Studies has recently been estab-
lished. An attempt was made to drop the CSG terms
for RCTs, but this yielded thousands of items and
was abandoned. Our search for non-randomised
studies was therefore not ‘systematic’, unlike the
search for RCTs. However, the electronic searches
produced numerous items that were not RCTs,
including reviews and editorials as well as studies,
and the search was supplemented with searches of
the reference lists of the included RCTs and reviews.
Selection of studies
Electronic searches were conducted at two time-
points: July and November 1999. For the original
search, the search terms above were combined 
with the CSG’s terms for severe mental illness; 
in the second search, these terms were replaced 
by the terms for mental health problems or
psychiatric disorder. This ensured that no studies
of non-psychotic populations had been missed in
the original search and had the additional benefit
of finding more recent publications (Figure 1).
The search for studies from the identified
publications was performed by two reviewers 
(JC and CW). One reviewer (JC) examined the
abstracts of all publications detected by the search
Electronic search
2526 items
Discard duplicates and
non-mental health items
Search four Cochrane
review lists
Screen for items that
meet inclusion criteria
Search other review reference 
lists and study reference lists
55 items
551 items
445 items 51 items
244 items 307 items discarded
Sort into studies
91 studies
FIGURE 1 Systematic literature search
Dashed lines indicate filtering stagesHealth Technology Assessment 2001; Vol. 5: No. 15
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and eliminated irrelevant ones (such as publications
on non-mental health topics and child and geriatric
mental health) and duplicates. Both reviewers exam-
ined the abstracts of the remaining publications and
eliminated studies of day care, residential care and
foster care, as well as other studies that were not of
home treatment (as defined on page 5). The results
were pooled and copies obtained of all papers
pertinent to the studies.
Methodological criteria
The studies were initially grouped into the 
two categories – ‘RCTs’ and ‘non-RCTs’ (non-
randomised studies) – on the basis of the author’s
description of the study. Their methodology was
later assessed against Cochrane methodological
criteria, and apparent RCTs with flawed random-
isation were moved into the ‘non-RCTs’ category.
To be included as an RCT, studies had to be
adequately randomised and use an intention-to-
treat analysis.
15 Alternate assignment was not
acceptable as a form of randomisation. Non-
randomised studies were included in the review if
they compared two services. They were only
included in the analysis, however, if they were
prospective studies and either matched cases and
controls or provided evidence that the two groups
were similar on baseline clinical variables (such as
diagnostic profile, years in hospital, or admissions).
Data extraction and missing data
Both researchers extracting data were non-clinical.
It was hoped that this would minimise bias.
Hospital days and service utilisation
Data were extracted from the papers by JH and
supplemented through a process of follow-up to
the study authors (see chapter 5). Studies were
categorised as either ‘data provided by author’,
‘data extracted from paper’, ‘no usable data’
(where hospitalisation was presented in a form
other than mean hospital days per patient) or 
‘no relevant information in the study’ (where
hospitalisation was not collected).
Study characteristics
Details of the studies – duration of the study,
attrition, number randomised, number followed
up, diagnostic profile of participants – were
extracted from the papers by JC.
Results
The initial searches produced 2526 items, which
was reduced to 445 after elimination of duplicates
and non-mental health items. A further 55 items
were added which had not been found in our
search, but had been included in the four
Cochrane Reviews, either in their ‘included’ or
their ‘excluded studies’ lists. The examination 
of reference lists in the studies and other 
reviews produced a further 51 items.
Elimination of irrelevant material produced 
244 items, relating to 91 studies. Once their
methodology had been assessed, they were found
to comprise 56 (uncompromised) RCTs and 
35 non-RCTs (compromised RCTs or non-
randomised studies) (Figure 1). All included 
studies are listed in appendix 1. Studies excluded
from the review are listed in appendix 4. The
percentages given below are for those studies 
for which we have the relevant data.
Study characteristics and patient
populations: all studies
Characteristics and patient groups of each study
are listed in appendix 2.
Of all the studies, 18 were ‘inpatient-control’
studies, that is, where the control service was an
initial period of inpatient treatment followed by
discharge as appropriate. The remaining studies
were ‘community-control’ studies. The patient
populations studied comprised either entirely
psychotic patients or had a predominance of
psychotic patients in the majority of the studies, but
there were seven studies (four RCTs and three non-
randomised studies) with predominantly or solely
neurotic patients. Six of the studies were of dual
diagnosis patients (mental illness and substance
misuse), and ten studies were of homeless mentally
ill patients. One study was of jail recidivists. A total
of 19 studies focused on ‘high service users’ (also
defined as ‘heavy users of services’ or as having
‘high admissions’, ‘significant treatment history’ 
or ‘unusually high readmissions’) and three were
on patients who were ‘difficult to treat’. Only 
six studies had excluded patients with a history 
of violence and five excluded them if they were
misusing substances, despite major concerns
expressed about exclusions (Table 1).
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Study characteristics and patient
populations: RCTs
Nine of the RCTs were inpatient-control studies.
Ten of the community-control studies selected
patients at the point of discharge from hospital;
the rest selected them from other (community)
sources or from a combination of these and hosp-
ital discharge. One study was cluster-randomised.
The studies’ dates of first publication ranged from
1973 to 1999, with a median of 1995.Systematic literature search
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The mean duration of follow-up across the 
RCTs was 17.7 months, with a range from three 
to 48 months. The majority were 12-month
(30.9%), 18-month (18.2%) or 2-year (18.2%)
studies. The size of the study population varied
too, with the total number randomised ranging
from 24 patients to 873. In all, 44% of the studies
had fewer than 100 participants in total and 
12% had fewer than 50.
Four of the RCTs focused predominately on 
dual diagnosis with substance misuse, and eight 
on homeless mentally ill patients. Thirteen focused
on ‘high service users’ and three on patients who
were ‘difficult to treat’. Four studies excluded
patients with a history of violence and two if 
they were misusing substances.
Study characteristics and patient
populations: non-randomised studies
We found 35 studies that compared a home
treatment service to a control service, but were 
not randomised or had flawed randomisation. 
Ten had flawed randomisation, 17 were pro-
spective non-randomised (observational) studies
and five were retrospective studies. In three 
studies the design was not clear.
We extracted information on the comparability 
of the experimental and control patients for 
all 27 prospective non-randomised studies. We
included the flawed-randomisation RCTs in this
process, as the inadequacy of the randomisation
might have resulted in non-comparable groups.
Seven studies had matched controls and 17 gave
evidence that the groups were similar on clinical
measures at baseline. These 24 studies were elig-
ible for inclusion in the analysis (data analysis). 
In two studies the groups were not similar at
baseline and in four there was no evidence 
for their comparability. However, all the non-
randomised studies are included in the descrip-
tive results, as in these descriptions we aim to
provide a detailed overview of the full range 
of studies. (Both non-randomised and flawed-
randomisation studies will be referred to
henceforth as ‘non-randomised studies’.)
Nine of the studies were inpatient-control 
studies. Of the remaining 26 (community-control)
studies, seven had selected the patients at the 
point of discharge and the rest had selected 
them by other means. The year of first publi-
cation ranged from 1964 to 1999, with a median 
of 1992.
The majority of the studies again included pre-
dominantly psychotic patients (91% of studies),
with only three considering predominantly or 
only neurotic patients. Only two studies were 
of dual diagnosis patients (with mental illness 
and substance misuse) and two of homeless
patients. Six studies focused on ‘high service 
users’, and none focused specifically on ‘difficult 
to treat’ patients. Only two studies excluded 
violent patients and three excluded patients
abusing substances.
The mean duration of follow-up in these non-
RCTs was 21.8 months. The largest group was 
of 2-year studies (12 studies: 36%), with six (18%)
1-year and four (12%) 18-month studies. The 
size of the total population selected ranged from 
30 to 1416, but 11 studies (37%) had fewer than 
100 participants in total, and three studies (10%)
had fewer than 50.
TABLE 1  Study characteristics
Characteristics Total RCTs Non-RCTs p-value
n = 91 n = 56 n = 35
Inpatient-control (%) 18 (20) 9 (16) 9 (26) 0.26
Community-control (%) 73 (80) 47 (84) 26 (74)
Median year of 1st publication 1994 1995 1992 0.051
Majority psychotic patients (%) 84 (92) 52 (93) 32 (91) 1.00
Studies of dual diagnosis (%) 6 (7) 4 (7) 2 (6) 1.00
Studies of homeless mentally ill (%) 10 (11) 8 (14) 2 (6) 0.31
Mean follow-up (months) (SD) 19.2 (12.8) 17.7 (10.6) 21.8 (15.6) 0.23
Mean number randomised (SD) 179.4 (200.5) 173.6 (168.2) 189.6 (249.8) 0.64
Mean number followed up (SD) 154.0 (194.3) 147.1 (153.2) 167.0 (256.6) 0.80
SD, standard deviationHealth Technology Assessment 2001; Vol. 5: No. 15
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Differences between randomised and
non-randomised studies
The difference in date of publication between RCTs
and non-randomised studies approached signifi-
cance (p = 0.051). Non-randomised studies were
earlier than RCTs, first publishing data in 1992
compared to 1995. A few early studies with flawed
randomisation (Pasamanick – Ohio
18; Weinman –
Philadelphia
19) had affected this result: prior to
their relocation to the non-randomised studies
group, the median year of publication had been
almost the same for the two groups. The RCTs were
not significantly larger studies (the difference in
numbers of participants was not significant), or
longer, and the predominant diagnostic profile 
was not significantly different. Despite being 
earlier studies, the non-randomised studies were 
not more likely to be inpatient-control studies.
Comparing studies where the control service was
inpatient treatment to the rest, there was a highly
significant difference in the date of publication 
(an 8-year difference overall). This difference
continued to be highly significant when only the
RCTs were analysed, and just reached significance
when only the non-randomised studies were
analysed (Table 2).
Studies with three treatment
conditions
A total of 21 studies (13 RCTs and eight non-
randomised studies) allocated participants to 
three treatment arms; for instance, intensive 
versus standard Case Management versus ‘usual
services’ (Curtis – New York
20) or ‘consumer ACT’
versus ‘non-consumer ACT’ versus ‘standard care’
(Herinckx – Oregon
21). Only nine of these (seven
RCTs and two non-randomised studies) had data
on mean days in hospital (appendix 5).
Names given to services
Experimental services (Table 3)
Experimental services in half the studies were named
as varieties of ICM, ACT or TCL. A total of 63% of
the RCTs studied ICM compared with 34% of the
non-randomised studies, and the difference was
significant. Case Management (‘standard’, ‘broker-
age’ or ‘strengths’) and home-based care or home
care made up a further 13% and 10% respectively,
and CMHT care was studied in 6%. The ‘other’
category comprised a range of services, including:
community psychiatric nurse (CPN) care; ‘outreach’;
‘close supervision’; ‘intensive community follow-up’;
‘treatment network team’; ‘nursing social support
programme’; general practitioner (GP) psychiatric
clinics; ‘community service’; ‘enablers’; and
‘guardianship networks’. Services that described
themselves as working on the principles of ICM, ACT
or TCL themselves had a variety of names: ‘assertive
outreach Case Management’, ‘assertive outreach’
and ‘continuous treatment’, among others.
Control services (Table 4)
Control services were drawn from a wide variety of
services, notably inpatient services (19%) and non-
intensive forms of Case Management (20%), such
TABLE 2  Inpatient-control services by year
Median year of first  Total
data publication
RCTs Non-RCTs
Inpatient-control 1986 1982 1986
(Type I)
Community-control 1995 1993 1994
(Type II)
p-value 0.001 0.046 0.001
TABLE 3  Labelling of experimental services
*
Labels Total RCTs Non-RCTs
n = 91 n = 56 n = 35
ICM/ACT/TCL 47 (52) 35 (63) 12 (34)
(%)
CM (%) 12 (13) 6 (11) 6 (17)
Home(-based) 9 (10) 3 (5) 6 (17)
care (%)
CMHT (%) 5 (6) 4 (7) 1 (3)
Other (%) 18 (20) 8 (14) 10 (29)
* p = 0.037
CM, Case Management
TABLE 4  Labelling of control services
Labels Total RCTs Non-RCTs p-
n = 91 n = 56 n = 35 value
Inpatients (%) 17 (19) 8 (14) 9 (26)
Outpatients/ 17 (19) 11 (20) 6 (17) 0.73
CMHC (%)
CM (standard/ 18 (20) 13 (23) 5 (14)
brokerage/
strengths) (%)
ACT (%) 2 (2) 1 (2) 1 (3)
Standard care  21 (23) 13 (23) 8 (23)
(%)
No service 3 (3) 0 (0) 3 (9)
Other (%) 13 (14) 10 (18) 3 (9)
CMHC, community mental health centreSystematic literature search
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as ‘standard’ or ‘traditional’, ‘strengths’ and
‘brokerage’. The ‘other’ services included
psychoeducation (one study), CPN service 
(one), generic teams (one) and psychosocial
occupational therapy or rehabilitation (two). 
The largest category was ‘standard care’ (23),
which was rarely clearly defined in the papers.
Further clarity on the standard care control
services was sought through follow-up.
Service models used as controls in some studies
were used as experimental services in others 
for a variety of reasons. Some studies compared
two forms of ACT or Case Management in which
one feature differed. In other cases, the date of the
study influenced the choice of service studied, as 
services that were once treated as experimental 
or innovative (such as Case Management) later
became ‘standard’ and were used as the control 
for studies of ICM.
Reviews
Of the 56 RCTs in this review, 33 (58.9%) had to
date been included in one of the four Cochrane
Systematic Reviews falling within this area (ACT,
Case Management, CMHT and Crisis Inter-
vention
5–8). Of the remaining 23, ten were pub-
lished more recently than the Cochrane Reviews.
Eight of the remaining 13 studies had been
excluded from the Cochrane Reviews as not
meeting their inclusion criteria.
Outcome variables
Hospitalisation
In all, 34 studies reported information on
hospitalisation in a form not usable in our analysis,
that is, not in the form of mean hospital days per
patient. Typical measures collected were number 
of admissions, duration of admissions (for patients
who were admitted at all) and proportion of all
patients who were hospitalised at any point during
the follow-up period (appendix 5).
Of 26 studies presenting data on hospitalisation
that we could not include in our analysis, nine
found a significant difference in favour of the
experimental service and none found a significant
difference in favour of the control service. In 
the remainder, the findings were not significant 
or the significance was not clearly stated. Out 
of the RCTs for which there was hospitalisation
data that we could not use, only one study found
significant results in favour of the experimental
service, one found a significant difference in
favour of the control service, and one found a
significant difference only within groups. Out of
the non-randomised studies, six found a significant
difference in favour of the experimental service
and none found a significant difference in favour
of the control service. It must be noted that 
this is a very crude expression of the results, 
since the hospital measures were all different.
Other outcomes
The studies reported on a wide range of clinical
and social outcomes. Most had clinical measures 
of psychopathology and symptomatology and
measures of social functioning. Many reported 
on ‘satisfaction with treatment’, some on ‘needs 
for care’, family and carer satisfaction and/or
‘burden’ and social support. Studies specifically 
of homelessness in combination with mental 
illness necessarily included measures of homeless-
ness or residential autonomy, while studies of
patients with co-morbid substance misuse 
included substance misuse measures.
To analyse these outcomes in detail is beyond the
scope of this review. As discussed above, reviewers
who have done so have found that a wide range 
of different scales are used, many of them in-
adequately validated (see page 1). This severely
limits the comparability and generalisability of 
the study findings.
Attrition rates
Although we extracted data on the number of
participants followed up, focusing on the number
for whom data on hospital days were obtained, 
this information was extremely difficult to 
ascertain from the published information. 
The figures reported for numbers followed 
up should thus be treated with caution.
Discussion
Scope of research
We found 91 studies: a large number compared 
to many areas of service research. Nevertheless,
given the breadth of inclusion criteria for this
review, and its 30-year time span, even this many
studies might seem relatively small. This highlights
the fact that service research is presently lagging
behind therapeutic intervention research in
mental health.
Studies of all designs were more likely to study
varieties of ACT and ICM than other service
models, but RCTs were significantly more likely
than non-randomised studies to test these models.
Very few looked at special patient groups such 
as homeless people or people with co-morbid
substance misuse. The studies also variedHealth Technology Assessment 2001; Vol. 5: No. 15
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tremendously in size. We did not examine 
each study for evidence of a power calculation
because they have only recently come into 
regular use. Given what is now known about the
spread of hospitalisation for severely mentally ill
patients (positively skewed as a result of the nature
of the illness), it is likely that many of the studies
were not sufficiently powered to allow for this. 
The issue of powering is returned to in the 
review of economic evaluations (page 23,
‘Statistical power’).
Location
The vast majority of the studies (76 out of 91) 
were conducted in the USA (55 studies) and the
UK (21). It is possible that the low number of
other studies found may reflect search strategy
bias, as databases may favour English-language
studies. Nevertheless, several non-English studies
(not all of them having English abstracts) were
found by the search but did not meet the inclusion
criteria for this review (see appendix 4).
22–26
Methodology
In this review, we have distinguished between 
RCTs and non-randomised studies in order to
analyse the RCTs alone, and have relegated RCTs
with compromised randomisation to the ‘non-
randomised studies’ group. This was justified in
view of the methodological rigour that RCTs offer.
The distinction between uncompromised and
compromised RCTs (RCTs with flawed random-
isation) may, however, be unreliable. Our policy
was in line with that of the Cochrane Centre: a
study was included if it gave details of random-
isation that showed it to have been adequate or 
if it did not give details, and relegated if it gave
details that showed it to have been compromised.
This runs the risk that where authors did not give
details about the randomisation, their studies may
have been included as ‘uncompromised RCTs’,
although their randomisation was in fact flawed.
Unfortunately, the level of under-reporting of
randomisation details is so high that it would be
impossible to exclude studies where the authors
failed to detail the randomisation. Anecdotal
evidence concerning two of the studies included 
as uncompromised RCTs, however, suggests that
this is indeed problematic. In one study, there
seems to have been well-intentioned but misguided
contravention of the randomised allocation by
clinicians to ‘protect’ known patients who they
considered too ill for the experimental service to
contain. In another, much earlier study, referrers
withdrew some patients from the study on the 
basis of the allocation, without telling research 
staff their names, and then presented them 
again in an attempt to achieve the preferred
treatment. Similar problems surrounded the 
issue of attrition, which was very poorly 
reported overall.
We found fewer non-randomised studies than
RCTs. This may be due to the difficulty of con-
ducting a ‘systematic’ search for such studies,
which distorted the search strategy between the
two groups. The fact that the non-randomised
studies were earlier on average than the RCTs,
however, needs to be treated with caution. The
relegation of some RCTs with flawed random-
isation (such as Pasamanick – Ohio
18 and Wein-
man – Philadelphia
19) to the non-randomised
studies group had a great impact on this finding
because these were very early studies. Without
them, it would seem that researchers are no more
likely to choose RCTs over non-randomised studies
today than they were 20 or 30 years ago. The fact
that the RCTs with compromised randomisation
were usually earlier studies suggests that the
methodology of RCTs may have been improving
with time.
Over three times as many of the non-randomised
studies (excluding flawed RCTs) were prospective
studies as were retrospective ones. In three cases,
however, the study design was not clearly stated in
the paper. This may imply that these three studies
were retrospective, as authors may be more likely
to report the study design of prospective studies.
Most of the prospective studies (24 out of 27,
including the flawed RCTs) either had matched
controls or presented evidence that the two 
groups were clinically similar at baseline. Never-
theless, this leaves 11 studies that would not be
eligible for analysis because of being retrospective,
having dissimilar patient groups or not reporting
evidence of their comparability.
Inpatient-control studies
Inpatient-control studies were significantly earlier
than community-control studies, regardless of the
study design, as we had expected. There were,
however, some recent inpatient-control studies.
Despite the progressive shift from inpatient to
community treatment and the huge influence 
of pioneering inpatient-control studies (Marx –
Madison
27 and Stein – Madison
11), there is 
clearly still a belief among researchers that 
it is important to test home treatment in 
comparison to inpatient care.Health Technology Assessment 2001; Vol. 5: No. 15
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Introduction
This review aims to assess the state of the evidence
concerning the effectiveness of home treatment 
in terms of hospital days and cost-effectiveness.
Our analysis of the outcome days in hospital is 
presented in chapter 6. Our assessment of the 
state of economic evidence, however, takes two
forms. In chapters 5 and 6 (see page 37, ‘Methods’;
page 38, ‘Service utilisation data’; page 59, ‘Cost
analysis’; page 61, ‘Comparative analysis: service
utilisation data and costs’; page 63, ‘Costs’; and
page 66, ‘Experimental services analysis: service
utilisation and costs’), we detail an intensive follow-
up of study authors for service utilisation data
usable in a meta-analysis of costs. Here, however,
we report on a review of the specific economic
evaluations undertaken by the home treatment
studies found, evaluating their methodologies 
and summarising their findings.
The three main types of economic evaluation 
used in health and social care evaluation are all
represented in the studies discussed below. The
three types are described briefly in Box 1.
Methods
All economic evaluations reviewed were taken from
the results of the general search strategy (page 7,
‘Results’). A study was considered to be appro-
priate for inclusion in the economic review if
reference was made to service outcomes as well 
as costs. Studies were not included if they did 
not explicitly consider other outcomes alongside
costs within the paper or in a companion paper
because such cost analyses do not constitute eco-
nomic evaluations.
28 Studies that reported on the
outcomes from different interventions but only
focused on the costing of inpatient admissions
were also excluded from the review in this section.
We did not subject each paper to a systematic
quality review, although in drawing up this
discussion we did employ the widely used
Drummond and colleagues’ ‘checklist’
28 for
assessing the quality of economic evaluations 
(Box 2), as well as examining the appropriateness
of the statistical methods used. Here, we offer a
Chapter 3
Review of economic evaluations
BOX 1  Types of economic evaluation
Cost-effectiveness analysis (CEA) addresses two types
of question:
• if two treatment options are of equal cost, 
which provides the greatest level of health-
related benefits?
• if two options are found to be equally beneficial,
which is less costly?
Typically, resource costs are combined with clinical
outcomes measured in ‘natural’ units of effectiveness
to produce cost-effectiveness ratios (such as cost per
successfully treated case). Most mental healthcare
CEAs concurrently use a range of instruments mea-
suring symptomatology, functioning, general quality
of life and patient satisfaction. They also consider the
cost implications of specific service arrangements or
treatments. Multiple outcome evaluations that do not
assume a single primary outcome are sometimes
called cost–consequences analyses.
Cost–utility analysis (CUA) differs from CEA in its
approach to outcome measurement, with health gain
(in terms of life years gained) weighted by the ‘utility’
that relevant groups attach to the health states in
which an improved life expectancy will be lived. The
most common form of utility-based measure used in
CUA is the quality-adjusted life-year (QALY).
29,30 CUA
allows comparisons to be made across a wide range of
healthcare programmes that target different patient
and population groups. In a mental health context,
however, concerns have been expressed that what is
gained in terms of broad programme comparability
may be lost due to the insensitivity of current QALY
measures to changes in mental health-related well-
being.
31
Cost–benefit analysis (CBA) addresses questions 
of allocative efficiency (do benefits exceed costs?),
which ultimately requires the measurement of 
welfare changes in monetised units in order to enable
direct comparisons between costs and benefits. All
consequences linked to specific interventions are
ideally taken into account in appraising efficiency. 
In mental health, these consequences include the
direct resource implications of the service, broader
resource implications felt by other agencies and
(more difficult to quantify) gains in patient welfare
and consequences for families and other informal
care-givers.
(Efficiency is defined as improved balance between
costs and outcomes.)Review of economic evaluations
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general descriptive overview of the evaluations 
and their conclusions, comment on the quality 
of studies and point out any factors that may 
affect the reliability of published conclusions. 
As elsewhere in this report, we distinguish
inpatient-control studies (where the control 
service was an initial period of inpatient treat-
ment) from community-control studies (where 
the control service was community-based). 
We divide our discussion into UK and North
American evidence because health systems 
differ so greatly between the two.
Results
Overview of evidence on the efficiency
of home treatment
From the pool of studies identified through the
search process, 22 met the above criteria (11 from
the USA, two from Canada and nine from the UK).
Tables 5 and 6 summarise the UK and North
American studies respectively.
The studies span a 20-year period, although the
majority were published during the last ten years.
Not surprisingly, the most common form of eco-
nomic evaluation reported was CEA (including
cost–consequences analysis) (19 studies), with two
describing their evaluations as a CBA, and one a
CUA. All but four of the included studies were
based on RCTs of experimental services.
All the studies were concerned with assessing 
new services for adults with mental health
problems, although there was some variation 
in more specific inclusion criteria. One North
American paper was primarily concerned with
evaluating services for people with a dual 
diagnosis of mental health problems and sub-
stance misuse, whilst a key inclusion criterion 
for three others was homelessness in addition to
mental health problems. A smaller number of
studies in both North America and the UK also
covered severe neurotic illness. Two studies from
the UK focused on community psychiatric nursing
for people with neuroses and affective disorders.
In the descriptions of studies in Tables 5 and 6,
both the article giving the economic evaluation
and the study to which it belongs are referenced.
United Kingdom (Table 5)
Of the nine UK studies meeting the review criteria,
six were community-control studies. Two of these
were evaluations of CPN services for neurotic
illness. Mangen and colleagues (1983)
37 (Paykel –
London) evaluated treatment delivered by CPNs
against outpatient psychiatrist treatment, whilst 
the control intervention in Gournay and Brooking
(1995)
33 (Gournay – Middlesex) was GP care.
Neither study delivers convincing evidence that
CPNs are more cost-effective than the control
service, although Mangen and colleagues report
significantly lower psychiatric treatment costs for
patients in the experimental arm. Gournay and
Brooking report a net benefit linked to the 
delivery of CPN care (after allowing for increased
work attendance when estimating costs). However,
they do not report appropriate statistical tests. 
The CUA reported by Gournay and Brooking
concludes that CPNs would be more efficiently
deployed within patient groups with ‘more serious’
disorders. This conclusion should, however, be
treated with caution, as it is based on a tentative
comparison of cost–utility ratios drawn from
another paper
41 (not included in this review, 
see appendix 4).
The four remaining community-control studies
focused predominately on psychotic patients. They
were concerned with evaluating the efficiency of
Case Management or care programming arrange-
ments, although given the existing confusion 
over the meaning of such terms, and the fact that
local service initiatives are likely to develop inde-
pendently of one another, comparisons between
studies is difficult. Each of the studies essentially
addresses different questions, as reflected in their
use of different control services.
BOX 2  Checklist for reviewing economic evaluations
(Drummond et al., 1997)
28
1. Was a well-defined question posed in an
answerable form?
2. Was a comprehensive description of competing
alternatives given?
3. Was there evidence that the programme’s
effectiveness had been established?
4. Were all the relevant costs and consequences for
each competing alternative identified?
5. Were costs and consequences measured accurately
in appropriate physical units?
6. Were costs and consequences valued credibly?
7. Was an incremental analysis of costs and
consequences performed?
8. Were costs and consequences adjusted for
differential timing?
9. Was allowance made for uncertainty in the
estimates of costs and consequences?
10. Did the presentation and discussion of study
results include all issues?Health Technology Assessment 2001; Vol. 5: No. 15
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TABLE 5  Summary of economic evaluations of community home-based care for mental health problems: UK
Study   Type of  Design Sample   Inclusion criteria Comparison Conclusions
name study size and 
follow-up 
period
Gater –  CEA RCT  n = 89 Diagnosis of schizo- Multidisciplinary Evidence of better client
Manchester
32 (cluster) 24 months phrenia; registered  community-based outcomes in experi-
with GPs; age 16–65; team with primary mental group and higher
onset of symptoms  care links versus patient satisfaction.
more than 3 years  standard hospital- Mean social costs higher
before start of study; based psychiatric for experimental group,
on medication or  service although no significance
symptomatic for  tests reported
2 years prior to study
Gournay –  CUA RCT n = 177 Patients with non- CPN care in a Net costs of the CPN
Middlesex
33 6 months psychotic problems  primary care setting care versus GP option
attending GPs’  versus usual care was negative (i.e. a net
surgeries delivered by GPs benefit). Based on the 
comparison with another 
study, the cost per 
additional QALY gained 
in this patient group 
using CPN care was 
more than that estimated 
for ‘more serious’ forms 
of mental illness
Merson –  CEA RCT n = 100 Psychiatric emerg- Community Early Early intervention service
London
34 3 months encies; age 16–65; Intervention Scheme shown to be no less
psychotic disorder; versus hospital-based effective than hospital
local resident; not  acute care alternative with lower
requiring mandatory  mean costs. However, no
inpatient services; not  evidence of statistically
currently in contact  significant differences in
with psychiatric services mean costs is presented
Muijen –  CEA RCT n = 181 Schizophrenia or DLP versus standard At 20 months the DLP
London 1
35 45 months severe affective  inpatient treatment was found to be more
disorder; age 17–64; cost-effective, but this
not pregnant advantage disappeared 
after 45 months
Muijen –  CEA RCT n = 82 Two hospital Community support CPN support team found
London 2
36 12 months admissions during the  team versus generic to be more cost-effective
previous 2 years; CPN care at 6 months, but this was
schizophrenia or  not sustained for the full
affective psychosis  12-month follow-up
lasting more than  period
2 years; age 18–64
Paykel –  CEA RCT n = 71 Discharged from Treatment from  No significant differences
London
37 18 months hospital/day hospital  CPN versus standard in mean total costs or
or current outpatients  outpatient treatment clinical outcomes
with 6 months attend- from a psychiatrist. between interventions.
ance; age 18–69; (ICD)  Primarily patients However, psychiatric
neurosis; unipolar with  chronic treatment  costs 
affective psychosis; neurotic mental significantly lower at 
personality disorder health problems 18 months, suggesting 
that it may be the more 
cost-effective option
DLP, Daily Living Programme; ICD, International Classification of Diseases
continuedReview of economic evaluations
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McCrone and colleagues (1994)
36 (Muijen –
London 2) evaluated the cost-effectiveness of 
a local service development in south London
involving the reorganisation of standard CPN
services into a Case Management system. Com-
pared with the standard CPN service, the new
service arrangement was found to be no more 
cost-effective at 12 months, although over a 
shorter 6-month follow-up there was evidence 
that the Case Management approach was more
efficient. McCrone and colleagues (1998)
38
(PRiSM – London) compared service utilisation
and costs between two mental healthcare sectors 
in south London. One sector delivered ‘standard’
services provided by a generic mental health 
team involving a Case Management system of 
care and liaison with inpatient services. The 
other sector consisted of an acute/emergency
psychiatric team and a team providing ‘psychiatric
assertive continuing care’. The study reports 
no significant differences in overall mean costs 
of service use (differences based on those
reporting service use only). Based on the con-
clusions from a series of companion papers, there
was no consistent evidence favouring either sector
in terms of patient outcome.
42–46
Tyrer and colleagues (1998)
39 (Tyrer – London 2)
evaluated the cost-effectiveness of a system of 
Case Management utilising community multi-
disciplinary teams versus outpatient care. No cost
or outcome differences were found between the
groups. The UK700 study’s economic evaluation 
is one of the largest multisite economic studies of
its type (UK700 Group, 2000
40). It tested whether
ICM was more cost-effective than standard Case
Management. No evidence was found to support
this hypothesis.
The other three UK studies, all inpatient-control
studies, evaluated different services for acute
mental health problems. Merson and colleagues
TABLE 5 contd  Summary of economic evaluations of community home-based care for mental health problems: UK
Study   Type of  Design Sample   Inclusion criteria Comparison Conclusions
name study size and 
follow-up 
period
PRiSM –  CEA Pro- n = 123 Any individual with a Inter-sectoral No significant difference
London
38 spective 24 months psychotic disorder comparison of in overall service costs
non-RCT living in the two study  intensive community- between intensive and
catchment areas based mental health  standard care sectors
service versus  (however, mean com-
‘standard’ service parisons based on 
service users only). Based 
on the results from com-
panion papers, evidence
on service outcomes is
varied with no consistent
evidence that either
intensive or standard 
sector services were
more effective along
various outcome scales
Tyrer – CEA RCT n = 155 Psychotic disorder or Multidisciplinary No differences in cost or
London 2
39 12 months severe non-psychotic  CMHTs versus outcome after 1 year
mood disorder; age  hospital-based care
16–65; at least one 
psychiatric hospital 
admission within 
past 3 years
UK700
40 CEA RCT n = 708 Psychotic illness for ICM versus  ICM not found to be
24 months at least 2 years; age  standard CM significantly more cost-
18–65; admitted to  effective than standard
hospital at least twice  CM
and once during 
past yearHealth Technology Assessment 2001; Vol. 5: No. 15
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(1996)
34 (Merson – London) compared the cost-
effectiveness of an early intervention scheme to
acute inpatient care and found no difference in
costs or outcomes. Knapp and colleagues (Muijen –
London 1) found the DLP to be more cost-effective
than hospital-based care after 20 months,
47 but not
after 45 months.
35 Gater and colleagues (1997)
32
(Gater – Manchester) looked at the costs and
outcomes of multidisciplinary CMHTs with local
primary care links against a standard service pro-
vided from the district general hospital psychiatric
unit. Client outcomes were in general better in the
experimental group than in the control group, and
there was evidence of greater patient satisfaction
with the experimental service. Net social costs per
client (aggregated across all impacts) were higher
for the experimental service. No formal statistical
testing revealed whether this difference was
statistically significant.
Quality of evidence from UK studies
Resource use
It is important in mental health service evaluation
to take a comprehensive approach to the identifi-
cation of resource use and costs. Patients are likely
to utilise a wide ‘package’ of services delivered 
by health and social care agencies and possibly
other providers (such as criminal justice system
agencies). This is especially pertinent when
evaluating Case Management arrangements, 
given case managers’ remit to engage with other
agencies in the interests of client health and
general well-being. Failure to account for the 
costs of improved community service access 
could give a misleading indication.
Each of the UK studies generally took such a
comprehensive approach. Each covered relevant
health and social care contacts. Knapp and
colleagues
35 (Muijen – London 1), McCrone 
and colleagues
38 (PRiSM – London), McCrone 
and colleagues
36 (Muijen – London 2) and the
UK700 Group
40 (UK700) also allow for the cost 
of changes in specialised accommodation use. 
This would probably not have been a relevant
consideration for Gournay and Brooking
33
(Gournay – Middlesex) or Mangen and
colleagues
37 (Paykel – London), given their 
focus on patients with neurotic illness. Each 
of the studies that evaluated services specifically 
for psychotic illness included criminal justice
system costs with varying degrees of detail 
(such as the value of police and court time).
Cost valuation
Each study appeared to have employed
appropriate unit costing sources to value patients’
resource utilisation; that is, each attempted to
assess the marginal opportunity cost of resource
use taking a long-run perspective.
Patient and carer costs
Two other sources of resource use that are 
often overlooked are patient costs and the impact
of interventions on informal or family carers.
Gournay and Brooking
33 (Gournay – Middlesex)
included costs incurred by patients and relatives,
covering the value of work loss from treatment
attendance and travel expenses. Mangen and
colleagues
37 (Paykel – London) considered 
patient travel costs incurred in seeking treatment.
Gater and colleagues
32 (Gater – Manchester) 
made estimates of client costs of service attend-
ance (in terms of time and money) and costs
falling on informal carers. McCrone and
colleagues
38 (PRiSM – London) cost the time
devoted to informal care in their study sample
using the cost of a paid home-help to proxy the
value of time given up by informal care-givers. 
No other studies in the group of UK evaluations
included either patient-related costs or the value 
of any effects of service arrangements on 
informal carer welfare.
Duration of follow-up
In three of the nine UK studies (Gater –
Manchester
32; Muijen – London 1
35; UK700
40), 
the follow-up period over which costs and out-
comes were assessed exceeded 12 months. Only
one (UK700) discounted future costs using the
prevailing discount rate employed by the UK
Treasury for public sector programmes (6%). 
This was also varied in a sensitivity analysis, which
did not alter the main conclusions. The UK700
study was the only evaluation that exposed its 
cost-effectiveness estimates to a series of sensitivity
tests. These included variation in assumptions
regarding the value of unit costs, the level of
capital overheads as a proportion of staff costs 
and the ratio of staff contact to non-contact time.
As with the discount rate, these sensitivity analyses
did not affect the study’s conclusions.
Sample size and power
Given that classical statistical inference plays a
central role in clinical and economic evaluations,
the most worrying aspect of existing evidence 
(for economic evaluations as for effectiveness
evaluations) relates to the number of individuals
recruited for study. We would also stress that in
Tables 1 and 2 the sample size figures relate to 
the point at which patients were randomised, 
and do not account for sample attrition over the
period of evaluation. Sample size at follow-up isReview of economic evaluations
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obviously important for statistical power.
48,49
The typical finding in mental health evaluations 
of heavily right-skewed cost distributions (a small
number of patients incurring disproportionate
costs) and large standard deviations adds to the
difficulty of achieving a fully-powered study.
Powering issues have only relatively recently come
to the fore in health economic evaluations, and so
it is perhaps not surprising that only one of the
nine UK studies (UK700) conducted a prospective
power calculation. This yielded a sample in excess
of 700 participants split between two arms in the
trial. In this case, a subjective judgement was 
made regarding the level of powering (80%), 
the significance levels to apply to tests of mean
differences in cost between intensive and standard
Case Management participants, and what was
considered to be an adequate difference in mean
costs (£45 in this instance, although any chosen
difference is likely to be arbitrary). We shall refer
to the UK700 evaluation as offering a standard
because it was the only economic evaluation in 
this field to conduct a prospective power
calculation for cost comparisons.
In recognition of the problems experienced with
sample attrition in the DLP evaluation (Muijen –
London 1), Knapp and colleagues
35 carried out a
retrospective power calculation and concluded that
the insignificance of the differences between the
experimental and control patients may have been
due to lack of statistical power. With the exception
of the UK700 evaluation, therefore, insufficient
sample size (at recruitment and after attrition)
casts doubt on the reliability of those studies 
that find significant results.
Analysis
The UK700 evaluation employed bootstrapping
methods to test for differences in mean costs
between groups and also to generate 95% con-
fidence intervals (95% CIs) for cost-effectiveness 
ratios. None of the other UK evaluations could 
be considered entirely satisfactory when judged 
by current guidelines on how to report economic
data.
50 For example, four studies failed to report
mean costs and standard deviations, one compared
mean costs using t tests which are potentially
unreliable on non-normally distributed cost data,
and two reported comparisons of logarithmically
transformed costs. The log-transformation of 
raw cost data was a popular approach for a while 
as a means to normalise skewed distributions, but 
it does not enable comparisons to be made of
arithmetic mean costs, which are the relevant 
unit of account in economic evaluations.
North America (Table 6)
Of the 13 economic evaluations identified from
North American studies, nine were community-
control studies and four were inpatient-control
studies. The same broad caveats apply here as for
the UK studies, limiting the conclusions that can
be drawn.
Two of the inpatient-control studies evaluated 
ACT programmes. Weisbrod and colleagues
(1980)
62 (Stein – Madison) report an economic
evaluation of the then newly developed ACT 
model in Madison. Despite being the earliest,
pioneering study of ACT, this is one of the few
attempts at conducting a full CBA. In a recent 
cost-effectiveness evaluation, Rosenheck and Neale
(1998)
61 (Rosenheck – Connecticut) evaluate ten
IPCCs, which were developed partly on the basis 
of advice received from experts based at the
Wisconsin ACT programme. The third inpatient-
control study, Fenton – Montreal (Fenton and
colleagues, 1982
56) evaluated the cost-effectiveness
of ‘home-based’ care. In another, much earlier,
Canadian evaluation, Coates and colleagues
(1976)
53 (Coates – Vancouver) studied costs and
outcomes of home treatment, hospital-based 
care and a combination of the two for different
combinations of home care and hospitalisation.
They show, for example, that a combination 
of high expenditures on home care with brief
hospitalisation produces significant improvement
in outcomes for the additional costs involved. 
All four inpatient-control economic evalu-
ations delivered evidence that favoured the
experimental services.
With one exception, all the community-control
evaluations were concerned with the cost-
effectiveness of variants of the ACT model against
the ‘usual’ treatment, including what is described
in some papers as ‘standard Case Management’.
Two (Wolff – New Jersey
63; Lehman – Baltimore
59)
were specifically concerned with evaluating whether
ACT was an efficient means of coordinating care
for homeless people with severe mental health
problems. The evidence from these studies is gen-
erally favourable towards the implementation of
ACT when supporting this specific client group.
In the remaining community-control studies of
ACT, there is no consistent message that these
services offer a more efficient alternative to what 
is usually provided. Bond and colleagues (1988)
51
(Bond – Indiana 1) and Clark and colleagues
(1998)
54 (Drake – New Hampshire) both report
results that favour neither ACT nor its alternative.
In the cost-effectiveness evaluation conducted Health Technology Assessment 2001; Vol. 5: No. 15
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TABLE 6  Summary of economic evaluations of community home-based care for mental health problems: North America
Study  Type of  Design Sample   Inclusion criteria Comparison Conclusions
name study size and 
follow-up 
period
Bond –  CBA/CO RCT n = 167 DSM III diagnosis of Assertive CM versus Evidence on cost-
Indiana 1
51 6 months psychotic disorder; usual care at each effectiveness of assertive
age 17 years plus; dis- of the three sites CM was inconclusive
charged from state 
hospital. Patients also 
had to meet at least 
one of three risk 
factors for re-
hospitalisation
Chandler –  CEA RCT n = 439 Selection criteria  ISA (based on PACT) ISA more effective than
California 1
52 36 months not explicit. Patients  versus usual mental usual care but also 
severely disabled but  healthcare including more costly
did not have high   limited CM and
level of service use vocational and 
rehabilitative services
Coates –  CEA Non- n = 212 Meeting existing Home-based care Cost-effectiveness results
Vancouver
53 randomised 12 months criteria for hospital versus inpatient care vary according to the
study admission; age 16–69; versus a combination combination of home
not in jail or under  of the two care and hospital-based
Magistrate’s Warrant treatment received by 
clients. Authors note that 
significant improvements 
in outcome can be 
gained at low additional 
expense from a high-
resourced home-based 
treatment with brief 
hospitalisation
Drake –  CEA RCT n = 223 Schizophrenia; schizo- ACT versus  No evidence of any cost-
New  36 months affective disorder; standard CM effectiveness advantage
Hampshire
54 bipolar disorder; of ACT over 3 years –
concurrent substance  although there was
misuse disorder; age  evidence of increasing
18–60; no medical co- ACT efficiency with time
morbidities preventing
study participation
Essock –  CEA RCT n = 262 Diagnosis of major ACT versus Cost-effectiveness of
New York
55 18 months depression, bipolar  standard CM ACT varies according 
disorder, schizophrenia  to hospitalisation risk – 
or schizo-affective  with ACT demonstrating 
disorder; two or  a cost-effectiveness
more psychiatric  advantage amongst
admissions in past  patients who were in
2 years; homeless at  hospital at point of
some time in past  randomisation
year or requiring 
extensive assistance 
with personal 
care needs
CO, cost–offset analysis; DSM III, Diagnostic and statistical manual of mental disorders, version III; ISA, Integrated Service Agency 
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TABLE 6 contd  Summary of economic evaluations of community home-based care for mental health problems: North America
Study   Type of  Design Sample   Inclusion criteria Comparison Conclusions
name study size and 
follow-up 
period
Fenton –  CEA RCT n = 155 Age 18 years plus; Home-based versus Home-based care
Montreal
56 24 months in contact with family hospital-based care significantly less costly 
than hospital alternative 
and performed no  
worse along a series  
of outcome measures
Jerrell –  CEA RCT n = 122 DSM III diagnosis  PACT versus  No significant outcomes
S. Carolina  24 months with co-occurring  clinical CM versus  advantage for PACT
2
57 substance use dis- brokerage CM other than role function-
order. All clients  ing. PACT was found
recruited on discharge  to be no more costly
from acute or sub- than the control services
acute care (at least 
two previous episodes 
in past year) or from 
lengthy residential stay 
or repeated emerg-
ency visits.At least 
two other criteria also 
had to be met from a 
list of clinical and 
social indicators
Jerrell –  CEA RCT n = 132 DSM III diagnosis  Behavioural skills Behavioural skills model
S. Carolina  18 months with co-occurring  model versus ICM was found to be the
1
58 substance misuse   versus ‘12-steps’ most cost-effective
(i.e. dual diagnosis). approach (this supplementary inter-
Patients were   standard intervention vention. ICM was more
required to have  available – AA and cost-effective than the
undergone psychiatric  NA).All three were ‘12 steps’ approach
treatment one or  considered to be
more times prior to   supplementary forms
referral. Patients also   for care to other
had to meet at least  mental health
one of two additional  services
clinical/social criteria  
for participation
Lehman –  CEA RCT n = 152 Severe and persistent ACT versus usual No significant difference
Baltimore
59 12 months mental illness; home- community-based in mean total costs
lessness (streets  care for homeless between interventions.
and shelters) people with severe  However,ACT led to
mental illness  significantly more days 
(inpatient acute care  of stable housing. Some
and crisis-orientated  evidence that incre-
care, CM, outreach, mental cost-effectiveness
advocacy, medical  depends on racial
care, primary care –  characteristics (neutral
all specifically for  for black patients)
the homeless)
DSM III, Diagnostic and statistical manual of mental disorders, version III;AA,Alcoholics Anonymous; NA, Narcotics Anonymous
continuedHealth Technology Assessment 2001; Vol. 5: No. 15
21
by Chandler and colleagues (1996)
52 (Chandler –
California 1), the ISA model (based on the ACT
model) was generally more effective than limited
Case Management and vocational and rehabili-
tative services, but also significantly more costly.
Essock and colleagues (1998)
55 (Essock – New
York) found that the cost-effectiveness of ACT
depends on the type of patient, specifically those
with a higher risk of hospitalisation. Jerrell
(1995)
57 (Jerrell – S. Carolina 2) offers some
evidence of the relative cost-effectiveness of 
ACT given its superior performance in terms of
improved role functioning compared with an
‘intensive broker’ model of care. It was found to 
be no more effective along other outcome scales,
although no more costly than the broker model.
One remaining community-control study, Jerrell
(1996)
58 (Jerrell – S. Carolina 1), compared three
approaches for dealing with the substance misuse
problems of dual diagnosis patients. The authors
evaluated the cost-effectiveness of Case Manage-
ment compared to a behavioural skills approach 
as a supplementary intervention to standard
TABLE 6 contd  Summary of economic evaluations of community home-based care for mental health problems: North America
Study   Type of  Design Sample   Inclusion criteria Comparison Conclusions
name study size and 
follow-up 
period
McGurrin –  CEA Quasi- n =183 Serious and ICM versus  Lower mean total 
Philadelphia
60 experimental 36 months persistent mental  standard   costs for ICM clients 
illness; eligible  community-based  (although no significance 
for CM care tests reported). Better 
functioning reported 
for experimental group 
(no significance tests 
reported)
Rosenheck –  CEA RCT n = 873 Currently  IPCC versus stand- Evidence generally
Connecticut
61 24 months hospitalised on VA ard care (inpatient suggests that IPCC is a
psychiatric research care, psycho- cost-effective alternative,
unit; primary  pharmacological after dropping two sites
psychiatric diagnosis; treatment, that failed to implement
high rates of pre- rehabilitation) the appropriate care
vious hospitalisation model fully
Stein –  CBA RCT n = 130 Non-chronically TCL programme Community-based
Madison
62 12 months institutionalised  (PACT) versus treatment more costly 
population; standard hospital in direct resource terms,
age 18–62 intervention  but overall the additional
with aftercare benefits of this approach 
exceeded the additional 
costs. Significantly lower 
recorded symptoms in 
experimental group along 
four out of 13 clinical 
scales. No other signifi-
cant differences found
Wolff –  CEA RCT n = 85 Currently homeless ACT with lay ACT (with or without lay
New Jersey
63 18 months or at risk of home- workers versus  persons) was no more
lessness; DSM-III-R  ACT alone versus costly than brokered CM
axis I; no recent  brokered CM and was more effective
convictions for rape, along certain outcome
homicide or serious  scales, including patient
assault; willing to  satisfaction and reduced
engage in treatment psychiatric symptoms
VA,Veterans Affairs;IPCC, Intensive Psychiatric Community Care; DSM III, Diagnostic and statistical manual of mental disorders,
version IIIReview of economic evaluations
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community mental health services and compared
to the standard ‘12-step’ approach associated 
with Alcoholics Anonymous and Narcotics Anony-
mous. The behavioural skills intervention was
found to be the most cost-effective of the three. 
In a non-randomised study, McGurrin and Worley
(1993)
60 (McGurrin – Philadelphia) evaluated 
ICM against ‘standard’ services. The results imply
limited improvements in client outcome but an
overall reduced cost of care arising from the 
ICM model (although no significance testing 
is reported).
Quality of evidence from North American studies
Resource use
The comprehensiveness of the costings within 
each of the North American evaluations was
variable. Most studies attempted to cover at the
very least the cost of mental health services
received by patients. The most comprehensive
studies in a costing sense, covering mental health
service use, medical service contacts, criminal
justice system costs and welfare payments received
by patients (although, excluding administrative
resources, these are strictly economic transfers)
were Stein – Madison (Weisbrod and colleagues,
1980
62), Bond – Indiana 1 (Bond and colleagues,
1988
51), Drake – New Hampshire (Clark and
colleagues, 1998
54), Essock – New York (Essock 
and colleagues, 1998
55) and Rosenheck – Con-
necticut (Rosenheck and colleagues, 1998
61).
Weisbrod and colleagues
62 and Clark and col-
leagues
54 were the only evaluators who attempted
to estimate informal carer costs. This mirrors the
neglect of these costs in the UK studies.
Cost valuation
With the North American evaluations, unlike 
the UK ones, it was difficult to assess in many
instances the extent to which resource use was
valued using unit cost information that con-
formed to standard notions of opportunity 
costing. In a number of studies, no explicit
references are made to the concept of long-run
marginal opportunity costing. However, these
studies detail the sources of information used
when costing resource use, including, for example,
provider and Medicaid financial records. However,
without knowledge of the nature of the data con-
tained within these systems it is difficult to appraise
fully the appropriateness of the costing methods.
Most were probably based on charges (prices) 
data, which may not always be very close to the
costs of delivering services. Some studies do 
give a more explicit indication that the unit 
costs employed were formulated on the basis of
economic principles. In the eight evaluations
where the discounting of costs would have been
relevant – that is, where the follow-up period ex-
ceeded 12 months – only one evaluation reported
that mean cost estimates over the period of the
study had been adjusted for timing.
Patient and carer costs
Weisbrod and colleagues
62 (Stein – Madison)
estimated carer costs according to the value 
of any work-related absence, whilst Clark and
colleagues
54 (Drake – New Hampshire) valued 
time given up in caring for family members 
with a mental illness (derived from informal carer
interviews) using wage data in addition to family
expenditures. None of the North American
evaluations considered the patient costs 
associated with attending services.
Sample sizes and power
With the exception of Rosenheck and Neale,
61 all
the North American evaluations were conducted
on sample sizes at the point of randomisation that
were considerably smaller than the UK700
40 trial,
which suggested that at least 600 participants 
were needed. As with the UK evidence, we would
therefore have to call into question conclusions
that may be based on potentially spurious 
statistical inference.
Analysis
The great majority of papers included statistical
details that gave some indication of within-sample
variation around mean cost estimates. However,
given the general finding of skewed cost distri-
butions, many studies may have applied inappro-
priate statistical tests (such as t tests and ordinary
least squares linear regression). In some instances,
the exact methods employed to analyse cost data
within a multivariate context were not spelt out,
making it difficult to judge their appropriateness.
The most sophisticated and robust analyses of 
cost and outcome data were reported in studies
that invoked specific statistical methodologies to
test for significant differences in sample cost-
effectiveness ratios (Drake – New Hampshire;
Essock – New York; Lehman – Baltimore; and
Rosenheck – Connecticut).
Discussion: future pathways in 
the economic evaluation of 
home treatment
This review highlights a number of issues to be
addressed when taking forward evaluative work in
this area, some relating to the design of economic
evaluations in order to improve their usefulness toHealth Technology Assessment 2001; Vol. 5: No. 15
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policy-makers, and some concerning the
appropriate analysis of economic data generated
within trials and observational studies.
Statistical power
Most of the economic studies reviewed lacked 
a prospective power calculation. It is obviously
desirable for sample sizes to be sufficient to detect
any clinically meaningful differences in costs. 
The powering and significance levels employed 
in the UK700
40 study are a reflection of what has
now become conventional in statistical analyses 
of trial data. However, careful consideration may
be needed in deciding upon a meaningful cost
difference. Guidance on this latter point would
enable greater comparability between studies in
specific areas if prospective power calculations
become more commonplace.
The UK700 study based its power calculations 
and subsequent sample size on a single previous
economic evaluation.
64 This highlights an addi-
tional problem for the implementation of reliable
power calculations – the need for reliable prior
information on the likely sample cost variance.
Sturm and colleagues
49 conducted an exploratory
analysis of sample sizes that would be required 
in order to detect substantial cost differences,
reflecting on a number of high-profile US studies.
They argue that sample sizes well in excess of 
those reported in large studies such as the 
UK700 evaluation would be needed in order 
to detect even large cost differences: an
uncomfortable conclusion for mental 
health economic evaluations.
On these grounds, and assuming that classical statis-
tical testing procedures are an acceptable guide 
to decision-making (see page 26), then there is an
argument for directing scarce research resources
away from small-scale evaluations towards those
investigations that can convincingly demonstrate
adequate statistical power. Unfortunately, even
costly large-scale multicentre trials may fall short 
of what is required to avoid inadequate testing 
of cost and effect differences.
49
Adequacy of cost-effectiveness analysis
The majority of the economic evaluations reviewed
were CEAs. When comparing the efficiency of 
two home treatment services, CEA and CUA can
offer unambiguous assessments of which inter-
vention is the more efficient in cases where one
‘dominates’ the other (where one intervention
costs less and is also more effective). However, it is
perfectly plausible for one intervention or service
model to be both more costly and more beneficial
than the other in terms of measured patient
outcomes. This was an issue, for example, in 
the evaluation of the ISA by Chandler and
colleagues (1996)
52 (Chandler – California 1).
CEA/CUA in such instances could promote
inconsistencies in policy decision-making.
65
Where an intervention is found to be both more
costly and more effective, CEA/CUA cannot offer
any guidance on whether the intervention should
be delivered on efficiency grounds. This can only
happen if there is some agreed explicit monetary
price or value attached to measured units of
mental health gain that can be directly compared
with cost. Moreover, the presentation of cost-
effectiveness information of this kind can lead to 
a set of implicit prices being adopted by decision-
makers. Economists would traditionally advocate
using money values for mental health and quality
of life improvements in programme evaluations
that reflect – in aggregate – how much patients 
are willing to pay for the changes identified. 
This embodies a system of value judgements that
may not be palatable to all. For example, while
willingness to pay embodies individuals’ strength 
of preferences over improved levels of health and
functioning, it is also inextricably linked to ability
to pay. As such, while policy-making guided by this
criterion may encourage efficiency in resource
allocations, there is likely to be some trade-off with
what is deemed to be an equitable distribution of
health and social care-related benefits.
Further research should be directed towards 
the development of an instrument that can be
broadly applied to measure improvements in
mental health-related quality of life. The appli-
cation of techniques such as conjoint analysis
66–68
could in principle be used to generate a system 
of generic prices or valuations, uniquely appli-
cable to changes in health status identified 
within this instrument.
Treatment protocol adherence
In contrast to the wider group of studies in 
this review, almost all of the economic studies
reviewed were fairly explicit as to what constituted
the experimental and control services. There 
was usually some reference to the nature of 
inputs, treatment processes and caseload sizes 
(a vital issue in Case Management evaluations)
relating to services, and the settings within which
services were delivered. Some had protocol
guidelines to try to ensure that the service followed
a consistent approach. Knapp and colleagues
35
(Muijen – London 1) suggest that departures from
the DLP protocol may have explained the loss of Review of economic evaluations
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cost-effectiveness in the longer term. However,
hardly any of the other studies appeared to 
pay close attention to the extent to which the
experimental services under evaluation remained
consistent to the protocols during the 
evaluation period.
Treatment protocol adherence can have 
potentially important implications for the
conclusions reached within an economic
evaluation. In their evaluation of a model of 
IPCC, Rosenheck and Neale
61 randomised 
patients within each of ten different sites. Within
the group of general medical sites that were
included in the study, IPCC was found to be
significantly more costly than treatment as usual.
However, when two of the sites were excluded 
from the analysis on the basis that they did not
follow the treatment protocol, no significant
differences were detected in treatment group 
costs. Future evaluative work in this field should
play closer attention to treatment processes 
and the sensitivity of results to service 
protocol adherence.
Valuing changes in inpatient 
resource use
An important part of any economic evaluation 
is to identify the broad implications of new 
services for resource use within other public,
private and voluntary sector institutions.
Residential care and inpatient bed days usually
account for substantial proportions of total care
package costs for people with mental problems.
69
The impact on hospital admissions and subsequent
length of stay is an important outcome in evalu-
ating community services for people with severe
mental health problems.
The appropriate valuation of reductions in
inpatient days is problematic. Most evaluations 
to date have used unit costs estimates that build 
in an allowance for fixed cost elements (staffing
and capital-related costs) when looking at the
economic value of an avoided inpatient day. 
These standard unit costs based on long-run
marginal opportunity costing principles are 
useful in terms of evaluating the resource and 
cost implications of expanding services. However, 
it is dangerous to assume that the reduction of
inpatient bed days will lead to subsequent reduc-
tions in the staffing required and to re-allocation
of capital resources. Long-run marginal unit costs
are therefore likely to overestimate true resource
savings (at least in the immediate term) and will
fail to address the true economic implications of
reducing inpatient days.
Reducing hospital days is likely to reduce
‘congestion’ within the capacity-constrained
inpatient system. Preventing admissions per se
and shortening hospital stays (through early
discharge into community aftercare) may free 
up bed space for patients in serious need of
hospital admission who might otherwise have 
faced delay. It may be that in the long run 
effective home treatment services will lead to 
the requirement of fewer psychiatric inpatient 
beds and associated staffing and capital resources,
and it would seem appropriate to value these
impacts using long-run marginal unit cost estim-
ates. This needs to be closely examined in future
evaluations. Further research is also required into
the appropriate valuation of reduced congestion
within the inpatient care system.
The welfare of informal carers
When evaluating community-based care for 
people with severe mental health problems, it
would seem that any exclusion of the effects of 
new service initiatives on their informal carers
would be a major oversight. There are probably
two main reasons why economic evaluations of
home treatment have excluded their impact on
informal carers. First, there are difficulties in
identifying and measuring the implications of
home treatment and alternative systems of treat-
ment on carers. For example, more intensive 
case management and linkage with care services
may enable a carer to work outside the home or
increase the time they have to pursue recreational
activities. Measuring these changes requires both
interviews with carers and the deployment of a
diary-based system of time-keeping.
The valuation of time savings is just as problematic.
The most straightforward approach would be to
apply a wage rate for those employed in the labour
market on the basis that, at the margin, this is 
an adequate reflection of the value that people
place on a unit of time sacrificed when attending
work. However, there are reasons for arguing 
that wage rates may over-estimate the value of 
carer time. Where wage data are unavailable,
perhaps because a carer is not in formal employ-
ment, then alternative methods will be needed 
to estimate their ‘shadow wage’. This may ultim-
ately require the deployment of established 
survey methods to determine carers’ willingness 
to pay for the benefits afforded them by home
treatment services.
Patient groups
Reporting outcomes across a wide patient group
can mask important differences between subgroupsHealth Technology Assessment 2001; Vol. 5: No. 15
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of patients in terms of the services’ cost-
effectiveness. Only three of the economic evalu-
ations performed subgroup analyses to detect
whether cost-effectiveness varied across patient
groups. Essock and colleagues
55 found that 
ACT was more cost-effective for patients who 
were specifically at high risk of re-hospitalisation.
ACT was found to be no more cost-effective than
standard care practices for other patient groups.
Lehman and colleagues
59 found some evidence
that the efficiency of ACT depended on patients’
ethnic groups. By contrast, no cost-effectiveness
differences according to ethnicity were found 
by the UK700 study.
40
Notwithstanding the question of adequate
statistical power, we would encourage subgroup
analyses in order to identify whether home treat-
ment services are more cost-effective for certain
patients, and therefore to assist the efficient and
equitable targeting of resources. For example, 
it would be interesting to see whether the con-
clusions reached by Essock and colleagues
55
on the impact of hospitalisation risk and illness
severity hold up in other evaluative contexts.
Adequacy of follow-up periods
The mean follow-up period in the North 
American economic evaluations was 20.7 months
(range 6–36) and for the UK it was 18 months
(range 3–45). The extent to which these follow-up
periods are adequate for testing for any sustainable
efficiency gains is debatable. Extensive follow-up
periods are problematic because they can add 
to the costs of conducting research and lead to
lengthy periods before results can be disseminated.
They can also introduce sample size problems
through attrition. This was, for example, thought
to be a threat to the reliability of the findings in
Muijen – London 1,
35 which had a follow-up 
period of 45 months, the longest of any of the
evaluations reviewed. Nevertheless, the chronic
nature of most severe mental health problems 
that are likely to be dealt with by home treatment 
services necessitates longer-term perspectives.
Analytical issues
Given that clinical and economic evaluations rely
on the sampling of patients drawn from relevant
populations, it is important that for both cost and
outcome data evaluators pay particular attention 
to reporting the uncertainty surrounding sample
statistics as measures of true population values. 
In economic evaluation, we would typically want 
to see the reporting of standard errors, standard
deviations, or 95% CIs around mean cost estimates.
More importantly, researchers should make clear
the statistical precision of mean differences in 
costs and outcomes between groups.
The analysis of economic data in clinical trials
poses a number of statistical challenges.
50 It is 
now widely recognised that the distribution of 
cost data is often non-normal, but this is not 
always taken on board in practice. Future evalu-
ative work on home treatment must ensure that
appropriate statistical methods are adopted, such
as the non-parametric bootstrapping used in the
UK700 economic evaluation of ICM. It is inter-
esting to note, however, that the use of this 
method did not produce different results in 
this study from standard t tests. This may imply 
that the more conventional approaches to
hypothesis testing are robust to deviations from
their distributional assumptions, an issue that
warrants further investigation.
Whilst it is usual to analyse economic data gener-
ated from clinical trials using bivariate methods 
of comparison on the grounds that randomisation
should avoid confounding group differences,
multivariate analyses can also yield important
insights. Multivariate methods designed specific-
ally for the analysis of longitudinal (or panel) 
data yielded by clinical and economic evaluations
are now beginning to be more widely used. These
include, for example, random and fixed effects
methods of analysis,
70,71 as used in the Drake – 
New Hampshire
54 study in its evaluation of an 
ACT programme. The interaction of a time
variable with a treatment group variable enabled
the authors to show that, controlling for other
factors, the efficiency of ACT (measured according
to cost-effectiveness ratios estimated for each 
patient) increased as the study progressed.
It was evident from the more recently published
papers examined in this review that the estim-
ation of incremental cost-effectiveness ratios 
using confidence intervals is becoming a more
accepted practice (Essock – New York; Drake –
New Hampshire; Rosenheck – Connecticut;
Lehman – Baltimore; UK700). The traditional
approach to confidence interval estimation relies
upon the division of sample mean incremental
effects by mean incremental costs. Criticisms of 
this approach point to the fact that economic 
data generated in clinical trials is open to 
sampling error and that this should be reflected 
in cost-effectiveness ratio estimation. Various
methods have been recommended for dealing 
with this issue.
72–74 Polsky and colleagues (1997)
75
used a Monte Carlo simulation exercise to 
derive evidence, suggesting that the reliability Review of economic evaluations
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of confidence intervals around incremental 
cost-effectiveness ratios generated by different
methods may be sensitive to assumptions con-
cerning the distribution of costs and effects data
and the extent of correlation between costs and
effects. This suggests that the methods used in
future evaluations of home treatment should pay
closer attention to distributional issues and the
correlation between cost and outcomes when
deciding on the most statistically reliable
methodology to adopt.
These recent statistical advances have offered
increasing levels of sophistication in the analysis 
of data generated in mental healthcare evaluations.
The whole application of economic evaluation
based on statistical inference, however, has been
called into question. Claxton
65 argues that the
choice of one treatment over another cannot
ultimately be informed by a test of whether to
accept the null hypothesis (no difference in mean
net benefit). If the null hypothesis is accepted,
decision-makers are given no guidance on which
option to choose. Adopting this approach rather
than simply choosing the service with the highest
mean net benefit can be shown to impose un-
necessary costs on patients in terms of lower
aggregate health gains. As we know, standard
statistics are likely to place heavy demands on 
the design of economic evaluations, particularly
given the substantial numbers of patients required
in order to detect significant differences in 
group costs. The decision-making approach
adopted by Claxton may offer some way out 
of this problem. In order to inform the future
direction of evaluative work in the mental health
field, we would encourage further debate on 
this issue.Health Technology Assessment 2001; Vol. 5: No. 15
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Introduction
A three-round Delphi exercise, utilising expert
opinion, was designed to identify the components
of home-based services considered most import-
ant. The Delphi exercise is well established 
as a method of ascertaining expert opinion 
in a systematic way that allows free and equal
expression of opinion through the anonymity 
of the procedure. An initial open question
generates a range of ideas, submitted by each
participant anonymously, and these ideas are 
then fed back to the whole group, who rate 
them for their importance. The group then re-
rates the items in the light of information about
the whole group’s response.
76 Delphi exercises
have been used to identify essential components 
of care for schizophrenia and components of
ICM.
77,78 It should be noted that Delphi exercises
are particularly useful at measuring consensus,
rather than the range of opinion, and at 
avoiding the bias produced by often 
polemical, face-to-face debates.
Components rated as ‘essential’ or ‘very 
important’ were grouped into categories by 
three researchers (CW, TB, JC) according to
clinical judgement, and these categories used 
to devise a ‘service characterisation questionnaire’
(appendix 6) to be sent to authors of the studies 
in the review. The components were also used to
identify secondary research questions for the
review (see page 4, ‘Research questions’).
Methods
A three-round ‘conventional Delphi’ method was
used. It took place between November 1999 and
January 2000. The panel of experts was drawn 
from consultant psychiatrists in the UK who 
were known to have an interest and expertise in
community-based care. In all, 13 experts were
invited to take part, and 12 agreed. They were
asked to list between eight and ten components 
in response to the question:
“In a community-based service that enables people 
with mental health problems to be treated outside
hospital, what are the most important components
that achieve this?”
They were instructed to exclude ‘correct
medication’, ‘integration of the service in the local
healthcare network’ and ‘availability of accessible
inpatient beds’ as not being specific components
of the service. The exercise was administered 
by a non-clinical researcher (JC).
Round 1
The 12 participants produced 98 items. One 
item was excluded because it concerned medi-
cation, leaving a total of 97 components. Items 
that were beyond the control of a service (such 
as ‘supportive families’) were retained on the
grounds of their importance to the panel.
Round 2
The participants were asked to rate each of the 
97 components on the scale of 1–5 (1 = essential, 
2 = very important, 3 = important, 4 = less import-
ant, 5 = unimportant) and to use the full range of
scores as far as possible. A total of 11 participants
did so; the twelfth did not return the form in time
and so did not complete the rest of the exercise.
The participants were given the opportunity to add
components at this stage, but none did so. Median
scores were calculated for each component.
Round 3
The 11 participants were fed back their own
ratings from Round 2 along with the group’s
median rating for each item. They were asked 
to re-rate each component in the light of this
information, and to comment where their new
rating differed from the median by more than 
two points.
Definitions
‘Consensus’ was defined as 80% of the partic-
ipants being within one point of the median 
score. ‘Strong consensus’ was defined as 100% of
participants being within one point of the median.
This is intended only as a rule of thumb. The
phrase “[83]% consensus” is used as shorthand
Chapter 4
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below for ‘[83]% of the participants being within
one point of the median rating’.
Results
Consensus
Of 97 components, 89 (92%) achieved consensus,
with 49% achieving strong consensus. Of 16
‘essential’ components, 11 reached strong con-
sensus (100% of participants giving a rating within
one point of the median), four reached consensus
with 91% of ratings within one point of the median,
and one had 82% of ratings within one point of 
the median (Table 7). Of the 40 components rated
as ‘very important’, all but two reached consensus,
and 23 reached strong consensus (Table 8). Of 
34 components rated ‘important’, all but three
reached consensus, with 14 reaching strong con-
sensus. Two of the four components rated ‘less
important’ failed to achieve consensus; no com-
ponents were rated ‘unimportant’ (Table 9).
Components rated ‘essential’ and 
‘very important’
Examination of components that were very 
close in meaning revealed a high level of internal
consistency, with, for example, ‘Regular home
visiting’ and ‘Intensive as necessary in vivo
treatments’ scoring the same, and ‘Skilled staff,
well trained’ scoring the same as ‘Skilled staff’.
Such pairings, where the rating and consensus
were identical, are expressed henceforth with 
the near duplicate in brackets.
Components rated ‘essential’ and ‘very important’
were grouped into categories by researchers
according to clinical judgement (Table 10). 
This produced the following six categories 
for items judged ‘essential’:
• home environment
• skill-mix
•p sychiatrist involvement
• service management
• caseload size
• health/social care integration.
The ‘very important’ items were grouped into 
13 categories, of which six matched the ‘essential’
component categories and the remaining 
seven were:
• hours
• cross-agency working
• crisis care
•h ousing/accommodation
•i npatient issues
• carer issues
• day care.
Home environment
‘Home visiting’ (and ‘The capacity for frequent
home visits’) and ‘Assessment and treatment in the
home environment’ were both rated essential, with
100% and 91% consensus respectively; and
‘Regular home visits’ and ‘Intensive as necessary 
in vivo treatments’ were rated very important, with
100% consensus. There was also 91% consensus
TABLE 7  Components of care judged ‘essential’
Components Median rating % within 1 point of median
Home visiting 1 100
Capacity for frequent home visits 1 100
Assessment and treatment in the ‘home’ environment 1 91
Multidisciplinary team 1 91
Skilled staff, well trained 1 100
Skilled staff 1 100
Community mental health nurses 1 100
Psychiatrist as a member of the multidisciplinary team 1 100
Senior medical staff in community 1 100
Sufficient medical support 1 100
Experienced community-oriented psychiatrists 1 100
Flexibility of contact frequency 1 91
Well-organised and -managed team 1 100
Strong leadership 1 91
Reasonable caseloads 1 82
Attention to social as well as clinical needs 1 100Health Technology Assessment 2001; Vol. 5: No. 15
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TABLE 8  Components of care judged ‘very important’
Components Median rating % within 1 point of median
A team dedicated to intensive home treatment 2 73
*
Regular home visits 2 100
Intensive as necessary in vivo treatments 2 100
Home-based care including home-based assessment from a psychiatrist 2 91
Team with broad range and special expertise 2 100
Expert community staff with evidence-based training to prevent  2 100
relapse of known SMI patients
Visiting possible up to four times weekly 2 100
Regular multidisciplinary review 2 91
Comprehensive systematic physical, social, psychological assessment 2 91
Good gatekeeping and prioritisation 2 100
Flexible titration of ‘case management’ time according to need 2 82
An environment which tolerates risk-taking 2 100
Willingness to take reasonable risks 2 100
Reasonable case loads (less than 1:25) 2 100
Good liaison with social services, e.g. integration in teams 2 100
Integration of social and healthcare in multidisciplinary team 2 91
Good health and social services liaison 2 100
Financial management of clients (benefits) 2 82
Help with obtaining benefits 2 82
Care plan to address social, housing, benefits, etc. needs 2 91
Flexible working hours (6 am – 9 pm; not 24 hours) 2 82
7-day service – extended hours 2 91
Access to out-of-hours mental health workers 2 100
Rapid response services 2 100
Good links to primary care 2 100
Knowledge of local support systems 2 100
Coherent and integrated service framework (e.g. good  2 100
integration with inpatient services, generic CMHTs)
Crisis element of team/team approach 2 82
Crisis services 2 82
Crisis availability 2 100
Community crisis response and treatment services 2 73
*
Housing (supported and unsupported) 2 100
Range of adequate/supported accommodation 2 100
Range of supported accommodation 2 100
High staffed (24-hour) residential accommodation 2 100
Access to crisis accommodation for those who lack  2 91
appropriate housing
Team’s use of inpatient beds to focus on early discharge  2 82
(if you want one admitted you need to take one out!)
Attention to needs of informal carers 2 91
Support for carers 2 100
Sufficient support services (day care) 2 100
* Participants failed to reach consensus on this item
SMI, severe mental illnessIdentifying service components (Delphi exercise)
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TABLE 9  Components of care rated less than ‘very important’
Components Median rating % within 1 point of median
Skill-sharing across disciplines 3 91
Supportive families 3 91
Secure housing tenure 3 100
Early referral to services (short duration of untreated illness) 3 100
Readily accessed day care 3 91
Effective accident and emergency liaison mental health services 3 100
Good quality residential care 3 100
Effective substance abuse services 3 100
Keyworker with caseload of 1:15 maximum 3 82
Keyworker trained in psychoeducation, cognitive behavioural  3 100
therapy family problem-solving, etc.
RMO with caseload of not more than 100 3 82
Residential alternative to hospital beds 3 91
Available 24 hours to a defined ‘patch’ 3 72
*
Family/carer-focused education/information 3 100
Team large enough to provide same level of direct care  3 100
as in inpatient setting
Multidisciplinary team should include approved social workers 3 73
*
Out of hours capacity for home visits 3 91
Family support (psycho-education etc.) 3 100
Skilled diagnosis and management of personality disorders 3 91
Range of day care 3 100
Support workers 3 100
Effective drug and alcohol services 3 91
Senior psychiatrist involvement in all admissions 3 91
Good primary care liaison 3 82
Close multidisciplinary working, including primary care team members 3 91
Availability of resources outside of hospital to support and deliver  3 100
structured daytime activities
Good clinical case management (e.g. CPA) 3 82
Systematic assessment and regular review of needs 3 91
Access to range of day care services 3 100
Good primary care services 3 73
*
Help with drug and alcohol misuse 3 91
Structured daytime activities 3 100
Compliance enhancement procedures/therapy 3 82
Acute day hospitals 3 91
Definable, multi-axial goals, reviewable at least 3/12 in care plan 4 91
Vocational/employment staff within team 4 73
*
24-hour availability (including weekends) 4 63
*
Psychological services working with patients with borderline  4 82
personality disorder
* Participants failed to reach consensus on this item
RMO, responsible medical officerHealth Technology Assessment 2001; Vol. 5: No. 15
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TABLE 10  Development of the service characterisation questionnaire
Components generated by the Delphi exercise Question(s) in the service characterisation 
questionnaire
Home environment
• Home visiting (1)
•A ssessment and treatment in the home environment (1)
• Regular home visits (2)
• Intensive as necessary in vivo treatment (2)
•H ome-based care including assessment from a psychiatrist (2)
Skill-mix (excluding medical)
•M ultidisciplinary team (1)
• Community mental health nurses (1)
• Skilled staff, well trained (skilled staff) (1)
•T eam with broad range and special expertise (2)
• Expert community staff with evidence-based training 
to prevent relapse of known SMI patients (2)
Psychiatrist involvement
• Psychiatrist as a member of the multidisciplinary team (1)
• Senior medical staff in the community (1)
• Sufficient medical support (1)
• Experienced community-oriented psychiatrists (1)
Service management
• Flexibility of contact frequency (1)
•V isiting possible up to four times weekly (2)
• Regular multidisciplinary review (2)
•W ell-organised and -managed team (1)
• Strong leadership (1)
•C omprehensive systematic physical, social, psychological 
assessment (2)
• Good gatekeeping and prioritisation (2)
• Flexible titration of ‘case management’ time according 
to need (2)
• An environment which tolerates risk-taking (2)
•W illingness to take reasonable risks (2)
Caseload size
•R easonable caseloads (1)
• Reasonable caseloads (less than 1:25) (2)
Health/social care integration
•A ttention to social as well as clinical needs (1)
• Good liaison with social services, e.g. integration in teams (2)
• Integration of social and healthcare in multidisciplinary team (2)
• Good health and social services liaison (2)
• Financial management of clients (benefits) (2)
• Help with obtaining benefits (2)
•C are plan to address social, housing, benefits, etc. needs (2)
(1), rated ‘essential’; (2), rated ‘very important’
OT, occupational therapist
continued
•D id the team have a home treatment function?
•D id team members regularly visit patients at home?
•W hat proportion of patient contacts took place 
at home?
•W ere the following part of the team:
postgraduate qualified psychiatrist
junior doctor
psychiatric nurse
OT
social worker
other (please state)
•D id any of the staff have specific qualifications in
community working?
•W as there in-service training especially geared at
community-based care?
• If there was a psychiatrist on the team, was s/he an
integrated member?
•H ow many hours of psychiatrist time were designated
per week?
•W hat was the maximum contact frequency per patient
per month?
•W hat was the average contact frequency per patient
per month?
•D id the team have multidisciplinary review of patients
at least once weekly?
•H ow many staff (approximately) were in the team?
•W hat was the target number of patients on the
team’s books?
•W hat was the target individual caseload size?
•D id the team take responsibility for healthcare
functions (e.g. medications)?
•D id the team take responsibility for social care
functions (e.g. housing, benefits)?Identifying service components (Delphi exercise)
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that ‘Home-based care including home-based
assessment from a psychiatrist’ was very important.
The idea of ‘A team dedicated to intensive home
treatment’ was rated very important too, but 
failed to reach consensus (73%), with a range 
of ratings from 1 (essential) to 4 (less important).
One participant commented that dedication to
home treatment was not necessary and that in 
his area patients were “not at home but floating
elsewhere”; another commented that the evidence
base for home treatment was not strong.
Skill-mix (excluding medical)
There was 100% consensus that ‘Skilled staff, well
trained’ (‘Skilled staff’), and ‘Community mental
health nurses’ were essential, and that having a
‘Team with broad range and special expertise’ 
and ‘Expert community-based staff with evidence-
based training to prevent relapse of known SMI
patients’ were very important. There was also 
91% consensus that it was essential for the 
service to be a ‘Multidisciplinary team’.
‘Multidisciplinary team should include approved 
social workers’ was rated important but partic-
ipants failed to reach consensus on this item. 
One, who rated it essential, commented that 
social workers “are an essential resource if we 
are to integrate care”. There was 100% consensus
that having ‘Support workers’ was important.
Having ‘Vocational/employment staff within team’
was rated less important, but participants again
TABLE 10 contd  Development of the service characterisation questionnaire
Components generated by the Delphi exercise Question(s) in the service characterisation 
questionnaire
Hours 
• Flexible working hours (6 am – 9 pm; not 24 hours) (2)
• 7-day service – extended hours (2)
• Access to out-of-hours mental health workers (2)
•R a pid response services (2)
Cross-agency working
• Good links to primary care (2)
• Knowledge of local support systems (2)
• Coherent and integrated service framework (e.g. good 
integration with inpatient services, generic CMHTs) (2)
Crisis care
•C risis element of team/team approach (2)
•C risis services (2)
•C risis availability (2)
• Community crisis response and treatment services (2)
Housing/accommodation
• Housing (supported and unsupported) (2)
•R ange of adequate/supported accommodation (2)
•R ange of supported accommodation (2)
•H igh staffed (24-hour) residential accommodation (2)
• Access to crisis accommodation for those who lack 
appropriate housing (2)
Inpatient issues
•T eam’s use of inpatient beds to focus on early discharge 
(if you want one admitted you need to take one out!) (2)
Carer issues
•A ttention to needs of informal carers (2)
• Support for carers (2)
Day care
• Sufficient support services (day care) (2)
(1), rated ‘essential’; (2), rated ‘very important’
•H ow many hours did the team operate on weekdays?
•H ow many days a week did the team operate?
•D id the team have a specific crisis element?
•D id the team have a protocol for meeting the needs 
of carers?Health Technology Assessment 2001; Vol. 5: No. 15
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failed to reach consensus. One commented that
the availability of such staff was essential, but that
they did not necessarily need to be part of a team.
Psychiatrist involvement
There was 100% consensus that having a
‘Psychiatrist as a member of the multidisciplinary
team’, ‘Experienced community-oriented psychia-
trists’, ‘Sufficient medical support’ and ‘Senior
medical staff in the community’ were each 
essential for the service.
Service management
There was 100% consensus that a ‘Well organised
and managed team’ was essential, and that ‘Good
gatekeeping and prioritisation’ and ‘An environ-
ment which tolerates risk-taking’ (or ‘Willingness
to take reasonable risks’) were very important.
There was consensus (91%) that ‘Strong leader-
ship’ was essential and that ‘Regular multi-
disciplinary review’ and ‘Comprehensive systematic
physical, social, [and] psychological assessment’
were very important. There was a weaker consensus
(82%) that ‘Flexible titration of “case manage-
ment” time according to need’ was very important.
One participant commented that Case Manage-
ment had not worked. There was consensus 
that ‘Flexibility of contact frequency’ was essential
(91%) and 100% consensus that ‘Visiting possible
up to four times weekly’ was very important.
Caseload size
There was consensus (82%) that having
‘Reasonable case loads’ was essential, and 100%
consensus that having ‘Reasonable case loads 
(less than 1:25)’ was very important. Having still
smaller caseloads (‘Keyworker with caseload of 
1:15 maximum’) was rated only as important, 
with a consensus of 82% and a range of 2 (very
important) to 5 (unimportant). One participant
said that caseloads of less than 15 were not
important and that his team had always 
“coped on caseloads of over 20”.
Health/social care integration
There was 100% consensus that ‘Attention to 
social as well as clinical needs’ was essential, and
that ‘Good health and social services liaison’ and
‘Good liaison with social services, e.g. integration
in teams’ were very important. However, one
participant not in agreement said that the evi-
dence base for this was not strong. There was 
also consensus that ‘Integration of social and
healthcare in multidisciplinary team’ was very
important (91%). There was consensus that a
‘Care plan to address social, housing, benefits, 
etc. needs’ was very important (91%), and that
‘Financial management of clients (benefits)’, and
‘Help with obtaining benefits’ were very important
(both 82% consensus).
Hours
There was 100% consensus that ‘Rapid response
services’ and ‘Access to out-of-hours mental 
health workers’ were very important. The idea 
of a ‘7-day service – extended hours’ was con-
sidered very important, with 91% consensus, 
but ‘Flexible working hours (6 am – 9 pm; not 
24 hours)’ reached weaker consensus (82%). 
One participant, however, said that there was 
not a strong evidence base for 7-day services, and
‘Available 24 hours to a defined “patch”’ failed 
to reach consensus, with a median rating of 3
(important); one person commented that “the
evidence is that 24-hour services accessed through
a wider provision are fully adequate. Mature
services have very few ‘input time’ problems”.
Cross-agency working
There was 100% consensus that ‘Good links 
to primary care’, ‘Knowledge of local support
systems’, and ‘Coherent and integrated service
framework (e.g. good integration with inpatient
services, generic CMHTs)’ were all very important.
Crisis care
There was 100% consensus that ‘Crisis availability’
was very important. The consensus about having 
a specific crisis focus – ‘Crisis element of team/
team approach’ and ‘Crisis services’ – was 
weaker (both 82%), but they were both rated 
very important. ‘Community crisis response and
treatment services’ was rated very important but
failed to reach consensus (73%), with ratings
ranging from 1 (essential) to 4 (less important).
Housing/accommodation
There was 100% consensus that ‘Housing
(supported and unsupported)’, a ‘Range of
supported accommodation’ (‘Range of adequate/
supported accommodation’) and ‘High staffed 
(24 hour) residential accommodation’ were all
very important. However, one person argued 
that “there are different types of 24-hour staffed
accommodation, some of which are useless”. 
There was also consensus (91%) that ‘Access 
to crisis accommodation for those who lack
appropriate housing’ was very important. One
participant commented that this is “remarkably
expensive and … not cost-effective”.
Inpatient policy
There was consensus (82%) that it was very
important that the ‘Team’s use of inpatient Identifying service components (Delphi exercise)
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beds [should] focus on early discharge (if you 
want one admitted you need to take one out!)’.
However, one participant felt that these were
“secondary issues”. ‘Senior psychiatrist involvement
in all admissions’ was rated important with 91%
consensus, but one person felt that involvement 
in all admissions was unnecessary.
Carers
There was 100% consensus that ‘Support for
carers’ was very important, and consensus that
‘Attention to needs of informal carers’ was very
important. There was strong consensus that
‘Family/carer focused education/information’
(‘Family support (psycho-education etc.)’) was
important. Conversely, ‘Supportive families’ was
thought to be important to the service (this item
reached 91% consensus).
Day care
There was 100% consensus that ‘Sufficient support
services (day care)’ was very important. The item
‘Acute day hospitals’ was rated as important, with
91% consensus, but one person commented that
day hospitals were “not necessary for effective
community treatment” and another that there
were “hardly any available” and that they were
“rarely integrated” into services.
Components rated less than 
‘very important’
Help with drug and alcohol misuse was rated
important with 91% consensus. One person rated
it essential but conceded that it did not necessarily
have to be a part of the team. ‘Early referral to
services (short duration of untreated illness)’ was
rated important with 100% consensus, but one
participant stated that the evidence base for this
was not strong. ‘Effective A & E liaison mental
health services’ was only rated important with
100% consensus, but one participant, who felt 
this rating was too low, said such services were 
“the key point of contact with services, generating
a high proportion of admissions”.
‘Skilled diagnosis and management of personality
disorders’ was rated important with 91% con-
sensus. One participant, rating it more highly,
believed that this “is an underestimated issue 
in the UK”. ‘Psychological services working with
patients with borderline personality disorder’ 
was also rated important, though with less
consensus (82%), and one person argued that 
the evidence base was not strong for this idea.
‘Effective drug and alcohol services’ was rated
important with 91% consensus. One participant
rated it unimportant, commenting that such
services needed to be “part of the provision”
available, though not as part of the team (Table 9).
Use of Delphi-generated components 
in service characterisation
Components rated ‘essential’ or ‘very important’ 
to the service were grouped into categories
according to clinical judgement. They were then
used (by JC, CW and TB) to construct the service
characterisation questionnaire used to follow up
authors of the studies in the review (‘Follow-up 
of authors’, page 37). In choosing which com-
ponents to use as the basis for questions, priority
was given to those that were rated essential and to
those reflecting the original research priorities of
the project. Thus, all the categories of items that
were rated ‘essential’ were represented in the
service characterisation questionnaire, while
categories of items rated ‘very important’ were 
only represented where they matched our brief.
Priority was also given to items that were more
easily identifiable, and ideally quantifiable. 
Table 10 details the ‘essential’ and ‘very 
important’ items and their correspondence 
to the questionnaire.
Discussion
This exercise was limited in being conducted only
with psychiatrists, rather than a multidisciplinary
panel. The panel’s views have been used as a
framework for the follow-up and analysis in this
review. When considering them as findings in
themselves, as we do in this chapter, the possible
bias of the participants should be borne in mind. 
It should be noted that ‘consensus’ and ‘strong
consensus’ were defined in order to provide a rule
of thumb for interpreting the results. Although 
the panel was the usual size for a Delphi, one
participant changing a rating by one point could
potentially have the effect of altering the level of
consensus achieved. The Delphi exercise, however,
is a means of measuring the degree of consensus
rather than the range of opinion on a given sub-
ject, and its anonymity avoids the bias that can 
be produced by face-to-face, often polemical,
discussion between experts.
Despite being asked to list service components, 
the panel produced several items that were not
components and are beyond the control of pro-
fessionals (such as ‘Supportive families’) or of 
the team (such as ‘Day care resources’ or ‘Good
primary care services’). However, this serves to
emphasise the importance of the wider context 
in which mental health services work. WhereHealth Technology Assessment 2001; Vol. 5: No. 15
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groups of components on the same theme were
identified, the broader, less specific components
tended to be rated more highly and with greater
consensus, while the more specific components
were more contentious. This is probably inevitable,
given the calibre of the participants. Nevertheless,
the disagreements over components are important
for the light that they shed on current opinion
about community services for the mentally ill.
Not surprisingly, the panel prioritised home
visiting as an essential component of the service.
However, they did not reach consensus on the 
idea of a service being dedicated to intensive 
home treatment. Similarly, while there was 100%
consensus that general crisis availability was very
important, the consensus was weaker on having
crisis services, and consensus was not reached 
at all on the more specific component ‘Community
crisis response and treatment services’. These
results suggest a more flexible approach to accom-
modating the components considered necessary
for community-based care, and possibly a more
generic team with these components incorporated.
Having a ‘crisis element to the team [or a crisis]
team approach’ did receive consensus, though 
not strong.
There has been considerable debate about the
meaning of ‘24-hour cover’ in services for those
with serious mental illness in the community. 
Here, the panel considered ‘Flexible working
hours (6 am – 9 pm)’ and a ‘7-day service –
extended hours’ to be very important. Actually
being ‘Available 24 hours to a defined patch’ was
rated only ‘important’, and indeed two specific
comments addressed and challenged the need 
for 7-day, 24-hour services.
There was clear agreement about the need for
‘Reasonable caseloads’, also specified as being 
less than 25. Having smaller caseloads than this,
however, was not considered to be as important,
and this finding challenges current practice in
some services.
The panel were in favour of multidisciplinary
teams with a range of expertise and skills,
integrating health and social care, and with good 
links to primary care. The weight given to psychia-
trist involvement, including having ‘Home-based
assessments from a psychiatrist’ has implications
for skill-mix in teams, but may of course reflect 
the fact that this was a panel of psychiatrists. It
would be important to see if other expert mental
health professionals, users and GPs shared this
view. It is also noteworthy that consensus was not
reached on the need for inclusion of ‘Vocational/
employment staff’ in the team, nor was this rated
highly. However, there was 100% consensus that
‘Support workers’ were important to include in 
a team.
As expected, the organisation and management 
of the team received considerable attention, 
and ‘Strong leadership’, ‘Good gatekeeping and
prioritisation’, and a ‘Willingness to take reason-
able risks’ were stated in particular. Good practice
is clearly seen to include ‘Regular multidisciplinary
review’ and ‘Comprehensive physical, social, and
psychological assessments’. ‘Support for carers’
and ‘Attention to the needs of informal carers’
were also both seen as very important, and this 
is in line with the growing awareness of carers’
needs reflected in ‘The National Service
Framework for mental health’.
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Overall, the Delphi exercise was successful in
identifying service components that the partic-
ipants considered important in enabling people
with mental health problems to be treated out-
side hospital. Components considered ‘essential’
and ‘very important’ were utilised to construct 
the service characterisation questionnaire used 
to follow up authors of studies in the systematic
review. The exercise proved, however, to be valu-
able in itself for the level of detail it provided 
on service components and their perceived 
relative importance in the care of mental health
patients in the community. Of particular note 
was the finding that teams specifically dedicated 
to home treatment and crisis intervention were
considered less necessary, as were caseload sizes 
of less than 25, and that having flexible working
hours across 7 days was considered more 
important than a 24-hour service.Health Technology Assessment 2001; Vol. 5: No. 15
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Introduction
We report here a large-scale follow-up to authors 
of the studies in this review, in order to elicit
information on service utilisation, service com-
ponents and sustainability of the services.
The need for a comprehensive service profile is
especially important in mental health research
because of the wide-ranging impact of psychiatric
disorders on individual abilities and needs, and
because many people with mental health problems
are supported by a number of healthcare pro-
fessionals and other service agencies. We sought
such information in order to provide as full a
costing as possible of the services in each study, 
as a supplement to the conclusions that could be
drawn from the specific economic evaluations
reviewed in the ‘Review of economic evaluations’
(chapter 3).
The service components identified through 
the Delphi exercise as important for home-
based services were used to construct a service
characterisation questionnaire (page 34, ‘Use 
of Delphi-generated components in service
characterisation’). This aimed to provide us 
with a way of retrospectively characterising 
both the experimental and the control services 
at the level of service components, rather than
labels. Moreover, this information was sought 
from the authors themselves, rather than 
from the papers, where it was often 
not reported.
The generalisability of study findings is a matter
for concern for several reasons (page 1, ‘Back-
ground’). The generalisability of services research
is particularly undermined by doubts about the
sustainability of the experimental programmes 
and their service components. In order to gain 
a picture of the sustainability of the experimental
services in the studies, we asked the authors
whether those services were still in operation. 
If they were, we asked them to answer each
question about service components in relation 
to the service as it is operating today, as well as
during the period of the study. If they were not, 
we sought information about how long they 
had operated after the end of the study.
Methods
Authors of the identified studies were contacted
where possible and asked to complete a
questionnaire comprising the following:
• General
– whether the service was still identifiable or, 
if not, when it was disbanded
–d istinctive attributes of the experimental
service which made it ‘innovative’ at the time
of the study
– which of these attributes were still being 
used and which had been dropped
– whether or not the control service was 
a CMHT
– characterisation of the control service if it 
was not a CMHT
• Service characterisation questionnaire
(appendix 6, page 114)
– 20 items, each to be answered for the
experimental and control services during 
the study period (if the control service was 
a CMHT) and the experimental service 
today (if applicable)
• Service use data information questionnaire
– whether service use data were collected 
(14 categories of service, chosen on the 
basis of the most frequently used services 
as reported in previous studies), for use 
in the cost analysis.
Country-specific versions of the service use data
information questionnaire were used for the UK,
the USA, Canada and Australia following piloting
of the draft instrument and consultation with
researchers in these countries. Authors from other
countries were given the standard (UK) checklist.
Information from the general questionnaire 
and the service characterisation questionnaire 
was used to characterise services and answer
questions about sustainability of services and
components, and in the data analysis (page 62,
‘Comparative analysis: service components’ 
and page 66, ‘Experimental services analysis:
components’). Information from the service use
data information questionnaire was passed on 
to a cost researcher (JH), who contacted the
authors again for data if they had said that 
Chapter 5
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data were available. For each category of service,
the author was asked to supply the mean and
standard deviation service use for each time-point
when data were reported to have been collected.
For both service characterisation and service
utilisation, data not supplied by authors were
extracted from the papers wherever possible 
(by JC and JH respectively). UK unit costs were
attached to these reported mean monthly service
use measures by JH. Unit costs were taken from
‘Unit costs of health and social care’ (1999),
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except for police cell costs (taken from McCrone
and colleagues
38) and prison costs (obtained from
the Home Office).
Statistical methods
Data were analysed using SPSS (version 8). 
In comparing groups (responders versus non-
responders, RCTs versus non-RCTs, North
American versus UK studies), chi-squared tests
were used for categorical data (proportions) and
Mann–Whitney U exact tests for non-parametric
continuous data (such as percentage of contacts
made at home and caseload size). The associations
between service components were measured using
Spearman rank correlation coefficients to see
whether a high proportion of home contacts, a
smaller caseload, a higher contact frequency or
longer hours of the service were correlated.
Results
Response rate and missing data
The authors of 55 studies (60%) responded to 
the request for further information through the
follow-up questionnaire. More authors of RCTs
responded (43 studies, 77% of RCTs) than did
authors of non-randomised studies (12 studies,
34%). Some of the service characteristics were
supplemented from the papers, but much
information was not ascertainable in this way. 
(Table 11.) Percentages in the tables are for those
studies for which we have the information.
Non-responders
Of the 36 studies whose authors did not respond 
to follow-up, eight could not be traced and one
had died. Studies whose authors could not be
contacted or who did not respond were signifi-
cantly more likely to be non-randomised studies 
(p < 0.001). Studies by responders were published
only 1 year later than those by non-responders.
Responders were more commonly European than
non-responders and less likely to be from ‘other’
countries than Europe or North America. They
tended to have smaller numbers of participants.
However, none of these differences reached
statistical significance (Table 12).
Service utilisation data
The authors of 46 studies completed the service
use data information questionnaire. Authors
reported collecting fairly comprehensive service
use data in their studies (appendix 7, Table 52). 
Of responding authors, 43 noted that their studies
had collected inpatient data, 37 had collected
outpatient data, 28 residential care data, 31 day
care use, 31 employment patterns, 28 emergency
service use, 24 CPN contacts, 27 social worker
contacts, 18 medications, 28 prison stays and 
21 police contacts.
Further follow-up letters were sent to all 
46 authors requesting summary service utilisation
data, corresponding to the data they had reported
having collected. There were 12 replies. Some data
were not available because authors had moved to
other jobs and could not access it, and in some
cases the data had been archived but were not
TABLE 11  Results of the author follow-up
Characteristics RCTs Non-RCTs Total
n = 56 n = 35 n = 91
Author responded (%) 43 (77) 12 (34) 55 (60)
Some supplementary service information  13 (23) 20 (57) 33 (36)
obtained from papers (%)
Control was a CMHT (%) 21 (38) 8 (24) 29 (33)
Some information about control given or extracted (%) 40 (71) 9 (26) 49 (54)
Hospitalisation data provided by author (%) 9 (16) 3 (9) 12 (13)
Hospitalisation data extracted from papers (%) 31 (55) 9 (26) 40 (44)
Hospitalisation data not in usable form (%) 14 (25) 20 (57) 34 (37)
Hospitalisation data not collected (%) 2 (4) 2 (6) 4 (4)Health Technology Assessment 2001; Vol. 5: No. 15
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readily available. Some authors simply did not 
have the time to respond to our detailed request.
From these replies and the published service
utilisation results in the papers (extracted for 
40 studies), costs were calculated based on UK
1998–99 price levels. This was possible for all ser-
vice categories included in appendix 7, Table 52
except two: employment patterns and medications.
Employment patterns had been collected and
reported in many different ways in the studies, 
and it was not possible to convert responses or
reported figures to a common measure. Moreover,
some studies collected employment information
only at baseline and not subsequently. With medi-
cations, we decided not to ask for the details of
medications taken because the task of converting
these into cost measures was well beyond the scope
of this study. For people with serious mental illness,
medications are known to account for only a small
percentage of the total cost (around 5% of total
healthcare costs for people with schizophrenia
81).
The calculated costs are reported in appendix 7,
Tables 53–58. Of the 52 studies for which costs 
were computed, 12 sets of calculations were 
based on data provided by authors, and 40 from
published papers. It is immediately obvious that
there are very different patterns of costs compared
with the patterns of reported data collection in
Table 52. It can also be seen that there are very 
few non-randomised studies for which costs 
could be collected: only three authors of non-
randomised studies returned our questionnaires,
and so most of our data came from papers.
There are marked variations between studies
within service categories. For example, the mean
monthly cost of inpatient services ranged from 
£35 to £2737 for experimental groups, and from
£64 to £4376 for control groups. There were also
substantial differences between studies in relation
to some of the other service categories, such as
outpatient services, residential care, CPN and
social workers. Most costs other than inpatient
costs were very low relative to inpatient service 
use. Inter-study differences in such relative costs
would be quite heavily influenced by the levels of
disability of patients and by the date of the study
because there is more reliance on community
alternatives to inpatient accommodation services
today than was the case one or two decades ago.
Service characterisation
Percentages given below are for those services 
for which we have information from the 
authors, supplemented in some cases from
published articles.
Experimental services
Most of the services were staffed by multi-
disciplinary teams (comprising three or more
disciplines) but 19% were not. Overall, the 
services had a mean of three disciplines repre-
sented, with a range of one to six. Slightly more 
of the services studied in RCTs were multi-
disciplinary (83% compared to 76% of non-
randomised studies). Most of the services had 
a psychiatrist, a psychiatric nurse and a social
worker; fewer had a junior doctor, OT or
psychologist. Just over half had an ‘other’ 
worker on the team, including family liaison
workers, vocational specialists, ‘community
workers’, ‘support workers’ and substance misuse
specialists where appropriate. Of those services
with a psychiatrist on the team, just over half said
he/she was an ‘integrated member of the team’,
and the hours of ‘dedicated psychiatrist time’ 
per week ranged from one to 160 (mean 23.5)
(Table 13).
TABLE 12  Author follow-up: responders versus non-responders
Characteristics Responders Non-responders p-value
n = 55 n = 36
RCT (%) 43 (78) 13 (36) < 0.001
Community-control (%) 46 (84) 26 (72) 0.190
European (%) 18 (33) 7 (19) –
North American (%) 35 (64) 24 (67) 0.121
*
Other (%) 2 (4) 5 (14) –
Median year of 1st data publication 1994 1993 0.06
Mean number of participants (SD) 165.2 (165.1) 200.5 (245.1) 0.275
* Compares responders to non-responders for breakdown by location of studyFollow-up of authors
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Most services had staff with ‘specific qualifications
in community working’ and 89% had ‘in-service
training’. The number of staff in the team ranged
from two to 25, with a mean of eight, and the
‘target number of patients’ ranged from 20 to 
400, with a mean of 91. The mean ‘target indi-
vidual caseload size’ was 15, but ranged from 
two to 40. The experimental service with case-
loads of only two (Godley – Illinois
82) was an
unusual one – ‘community support aides’ – 
which accounts for the unusually small caseload.
Authors of six studies said that the experimental
service had had shared caseloads, so that the
question about caseload size was ‘irrelevant’. The
mean ‘maximum contact frequency’ per patient
per month was 27 contacts (ranging from two to 
120), and the mean ‘average contact frequency’
was nine contacts, ranging from one to 60. 
Contact frequency was higher in the services
studied in RCTs (10 mean contacts compared 
to five) (Table 14).
Almost all of the services had a ‘home treatment
function’, with 95% ‘regular[ly] visit[ing] patients
at home’. (For correlations between service
components, see page 51, ‘Service classification’).
The proportion of all contacts that were made 
in the patient’s home or home environment, how-
ever, ranged from none to 100%, with a mean of
59%. Almost two-thirds of the services operated 
5 days a week, but a third operated 7 days a week.
Over half (56%) operated 8 hours per weekday,
28% operated between 9 and 15 hours, and 16%
operated 24 hours a day. Almost all services took
responsibility for ‘healthcare functions’ and ‘social
care functions’, but only 83% took responsibility
for both. In 72%, the team had a ‘crisis element’
and in 90% it had ‘multidisciplinary review of
patients at least once weekly’. All the services 
tested in non-randomised studies had weekly
multidisciplinary review and took responsibility
for social care, compared with 86% and 92%
respectively in RCT services. Only a third of the
services had a ‘protocol for meeting the needs 
of carers’ (Table 15).
Changes in experimental service components 
over time
To see whether key service components – ‘caseload
size’, ‘average contact frequency’, ‘hours of
TABLE 13  Team structure (experimental services)
Characteristics RCTs Non-RCTs Total
Multidisciplinary teams (%) 39 (83) 16 (76) 55 (81)
Psychiatrist on the team (%) 41 (79) 18 (78) 59 (79)
Junior doctor on the team (%) 12 (28) 4 (22) 16 (26)
Psychiatric nurse on the team (%) 39 (78) 20 (91) 59 (82)
OT on the team (%) 21 (46) 5 (24) 26 (39)
Social worker on the team (%) 38 (76) 13 (62) 51 (72)
Psychologist on the team (%) 13 (33) 4 (17) 17 (27)
Psychiatrist an integrated member of team  26 (74) 6 (67) 32 (73)
(% of services with a psychiatrist)
Mean hours of dedicated psychiatrist time per week (SD) 19.5 (12.9) 50.7
* (63.4) 23.5
* (26.1)
* This finding is affected by the substantial amount (160 hours) of dedicated psychiatrist time in one study (PRiSM – London)
TABLE 14  Training, caseloads and contacts (experimental services)
Characteristics RCTs Non-RCTs Total
Specific qualifications in community working (%) 29 (69) 6 (67) 35 (69)
In-service training (%) 43 (90) 15 (88) 58 (89)
Mean number of staff on team (SD) 7.7 (4.3) 8.0 (6.0) 7.8 (4.8)
Mean target number of patients (SD) 81.5 (78.5) 140.6 (111.5) 90.5 (85.5)
Mean target individual caseload size (SD) 14.9 (9.7) 16.2 (7.8) 15.2 (9.2)
Mean maximum contact frequency per month (SD) 28.2 (27.5) 15.7 (13.9) 27.0 (26.6)
Mean average contact frequency per month (SD) 9.9 (12.1) 5.3 (2.4) 8.7 (10.7)Health Technology Assessment 2001; Vol. 5: No. 15
41
operation’ and ‘proportion of contacts at home’ –
changed over time, we tested them for correlation
with the year of first data publication (Table 16).
Studies for which we had information (from the
authors or papers) represented the full time span
of the review. The association between average
contact frequency and year of first data publication 
almost reached significance, with average contact
frequency falling in progressively later studies.
There were little or no associations between year 
of publication and target individual caseload size,
hours of operation or proportion of contacts at
home. We also tested the following components
against year of data publication: psychiatrist on 
the team; multidisciplinary team; psychiatrist an
integrated team member; home treatment func-
tion; regularly visiting at home; responsibility 
for both health and social care; specific crisis
element; multidisciplinary review; protocol for
meeting carers’ needs. None of the differences 
was significant.
Control services
Of the authors who responded, 44% (24 services)
stated that the control service was a CMHT 
(Table 11). This figure was supplemented where 
the information was in the papers, giving a figure
of 32% of the total sample (27 services) being
CMHTs. Of the authors who responded, three-
quarters gave information about the control
services. Overall, some information was obtainable
on 54% of the control services, either through
follow-up or in the papers.
The median year of publication for studies 
where the control service was a CMHT was very
similar to studies where it was not (1994 and 1995
respectively; not statistically significant).
In the descriptions below, only control services 
that were CMHTs were included. Some authors
gave information about characteristics of control
services that they had said were not CMHTs, but
this data had not been collected systematically so
was excluded.
Of those control services described as CMHTs,
most were multidisciplinary but 14% were not. 
The majority had a psychiatrist on the team and
most had a psychiatric nurse and a social worker,
but fewer had junior doctors and OTs. The
psychiatrist was again an integrated member of 
the team in only about half (55%) of the services
with psychiatrists. The mean hours of designated
psychiatrist time (29 overall) varied between the
two groups, with 22 hours for the services studied
in RCTs compared to 56 for the other services
(Table 17).
About half of the services had staff with specific
qualifications in community working and 12 
had in-service training. The teams had a mean 
TABLE 15  Team operation (experimental services)
Characteristics RCTs Non-RCTs Total
Home treatment function (%) 40 (95) 16 (100) 56 (97)
Regularly visit patients at home (%) 47 (94) 23 (96) 70 (95)
Mean proportion of visits made at home (SD) 58.8 (26.7) 59.0 (29.1) 58.8 (26.9)
Mean days per week (SD) 5.7 (1.0) 5.4 (0.9) 5.6 (1.0)
Mean hours per weekday (SD) 11.5 (5.5) 12.4 (7.0) 11.7 (5.9)
Responsibility for healthcare functions (%) 43 (92) 18 (90) 61 (91)
Responsibility for social care functions (%) 43 (92) 14 (100) 57 (93)
Responsibility for health and social care functions (%) 35 (83) 9 (82) 44 (83)
Crisis element to the team (%) 30 (71) 8 (73) 38 (72)
Multidisciplinary review at least weekly (%) 37 (86) 15 (100) 52 (90)
Protocol for meeting needs of carers (%) 13 (32) 4 (36) 17 (33)
TABLE 16  Correlation with year of publication
Target individual   Average contact  Hours of operation % of contacts 
caseload size frequency at home
Year of 1st data publication –0.186 –0.235 –0.052 –0.145Follow-up of authors
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of nine staff and 221 patients, with a mean
caseload size of 31.8 and a range from 4.5 to 100.
‘Maximum contact frequency’ ranged from one 
to 76 contacts per patient per month (mean 15.6).
‘Average contact frequency’ ranged from one 
to 40 contacts per patient per month (mean 5.7)
(Table 18).
Seventeen (65%) of the services had a specific
‘home treatment function’ (70% of the RCT 
services compared to 50% of the others), and 
17 regularly visited patients at home, with a third
of contacts taking place there. For each of these
variables, more of the results were accounted 
for by the services studied in RCTs than by those
studied in non-randomised studies. Not surpris-
ingly, the services operated a 5-day week on
average and a 9-hour day. Most were responsible
for healthcare and most for social care, with 58%
responsible for both; in each case, the services
studied in RCTs were more likely to have these
roles. The team had a crisis element in 44% of
cases and 46% had weekly multidisciplinary review.
Only four services (16%) had a protocol for
meeting carers’ needs (Table 19).
Changes in control service components over time
We tested the following control service com-
ponents against the year of data publication, 
to see if we could detect developments in these
services: psychiatrist on the team; multidisciplinary
team; psychiatrist an integrated team member;
home treatment function; regularly visiting at
home; responsibility for both health and social
care; specific crisis element; multidisciplinary
review; protocol for meeting carers’ needs. 
Only ‘multidisciplinary review of patients at least
weekly’ approached significance (p = 0.065), but
services with this component were only an average
of one and a half years later than studies without 
it. None of the other differences was significant.
We also tested ‘proportion of contacts at home’,
‘caseload size’, ‘hours of operation’ and ‘average
contact frequency’ for correlation with year of
TABLE 17  Team structure (CMHT control services)
Characteristics RCTs Non-RCTs Total
max. n = 21 max. n = 6 max. n = 27
Multidisciplinary teams (%) 14 (82) 4 (100) 18 (86)
Psychiatrist on the team (%) 16 (80) 4 (66) 20 (77)
Junior doctor on the team (%) 6 (33) 3 (50) 9 (38)
Psychiatric nurse on the team (%) 14 (74) 3 (75) 17 (74)
OT on the team (%) 8 (42) 3 (60) 11 (46)
Social worker on the team (%) 16 (76) 3 (60) 19 (73)
Psychiatrist an integrated member of team  13 (52) 3 (60) 16 (55)
(% of services with a psychiatrist)
Mean hours of dedicated psychiatrist time  21.6 (21.2) 56.3 (45.4) 28.5 (29.2)
per week (SD)
TABLE 18  Training, caseloads and contacts (CMHT control services)
Characteristics RCTs Non-RCTs Total
max. n = 21 max. n = 6 max. n = 27
Specific qualifications in community working (%) 11 (52) 3 (60) 14 (54)
In-service training (%) 9 (43) 3 (43) 12 (43)
Mean number of staff on team (SD) 9.6 (7.6) 8.3 (2.9) 9.3 (6.9)
Mean target number of patients (SD) 225.1 (282.3) 151.0 (–)
* 221.0 (274.7)
Mean target individual caseload size (SD) 27.3 (15.7) 46.0 (39.3) 31.8 (23.7)
Mean maximum contact frequency per month (SD) 17.8 (19.7) 5.7 (5.7) 15.6 (18.4)
Mean average contact frequency per month (SD) 6.7 (9.8) 2.1 (1.3) 5.7 (8.9)
* One case onlyHealth Technology Assessment 2001; Vol. 5: No. 15
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publication. Only ‘proportion of contacts at 
home’ was significantly correlated with the year 
of publication (correlation coefficient 0.286, 
p = 0.01). This suggests that control services in
later studies had higher proportions of contacts
made at home.
Service characterisation by location
The majority of the studies were North American,
mostly from the USA (four were Canadian) 
(Table 20). Of the 25 European studies, 21 were
British, three Scandinavian and one German. 
Of the other studies, four were Australian, one 
was from New Zealand, one was Indian and one
Chinese (appendix 2). There was no significant
difference between European and North American
studies in year of publication of data (p = 0.14).
Figures below (Tables 21–26) are from the follow-
up questionnaires, supplemented from the papers
wherever possible. Data have been presented for
the ‘Other’ services followed up, but due to small
numbers they have been excluded from the com-
parisons and statistical tests, which thus compare
European and North American services only.
Experimental services
More of the North American services had a
psychiatrist on the team, although psychiatrists 
on European teams were more likely to be inte-
grated members than those on North American
teams and had twice as much dedicated time.
Significantly more European than North 
American teams had OTs. More European teams
had psychologists, and more North American
teams had social workers (Table 21).
All the North American services had in-service
training, compared to 61% of the European
services, and the difference was highly significant.
The European services were larger, with a 
higher target number of patients. They also 
had a larger average caseload size: 18 compared 
to 14 for the North American services. The maxi-
mum and average contact frequencies for the
North American teams were around twice the
European contact frequencies, although only 
the latter was significant (Table 22).
Having a ‘home treatment function’, regularly
visiting patients at home and the proportion of
contacts made at home did not differ between 
the North American and European services. 
North American services operated the same
number of days a week, but significantly longer
hours than the European services: 11.4 hours
compared to 8.7 hours. More of the North
American services had responsibility for both
TABLE 19  Team operation (CMHT control services)
Characteristics RCTs Non-RCTs Total
max. n = 21 max. n = 6 max. n = 27
Home treatment function (%) 14 (70) 3 (50) 17 (65)
Regularly visit patients at home (%) 14 (70) 3 (50) 17 (65)
Mean proportion of visits made at home (SD) 38.6 (25.3) 16.7 (20.8) 35.2 (25.4)
Mean days per week (SD) 5.2 (0.7) 5.4 (0.9) 5.3 (0.7)
Mean hours per weekday (SD) 8.5 (1.9) 11.6 (7.0) 9.2 (3.7)
Responsibility for healthcare functions (%) 15 (75) 3 (50) 18 (69)
Responsibility for social care functions (%) 15 (79) 3 (60) 18 (75)
Responsibility for health and social care (%) 12 (63) 2 (40) 14 (58)
Crisis element to the team (%) 10 (50) 1 (20) 11 (44)
Multidisciplinary review at least weekly (%) 9 (47) 2 (40) 11 (46)
Protocol for meeting needs of carers (%) 3 (16) 1 (17) 4 (16)
TABLE 20  Location and response rate
Europe North America Other
Total studies 25 59 7
Authors responded 18 35 2Follow-up of authors
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health and social care and had a crisis element and
significantly more had weekly multidisciplinary
review. More than twice as many North American
services (41%) had a protocol for meeting carers’
needs (Table 23).
Control services
The following figures are only for services where
the control service was stated to be a CMHT: 
seven European, 20 North American and two
‘Other’ studies, both of which were Australian.
More European control services than North
American had a psychiatrist on the team and 
more had a psychiatric nurse, with more 
dedicated psychiatrist hours, although these
differences were not significant. Significantly 
more European services had a junior doctor 
on the team and significantly more had an 
OT. More North American services had social
workers on the team (77% compared to 57%)
(Table 24).
More European control services had in-service
training, and the European control services 
were again larger, with more patients and staff,
although these differences did not reach signifi-
cance. The North American services had larger
caseloads, but this result was not significant. The
North American services had a significantly higher
average contact frequency, with eight visits per
month compared to 1.5 for European control
services (Table 25).
All seven of the European control services which
were CMHTs and for which we had the infor-
mation had a ‘home treatment function’ and all
visited patients at home, compared to 53% and
47% of North American services respectively. 
Only ‘regularly visit[ing] patients at home’
TABLE 21  Team structure by location (experimental services)
Characteristics Europe North America Other p-value
Multidisciplinary teams (%) 19 (86) 31 (80) 4 (67) –
Psychiatrist on the team (%) 12 (67) 30 (88) 2 (100) 0.554
Junior doctor on the team (%) 7 (39) 7 (28) 1 (50) –
Psychiatric nurse on the team (%) 17 (94) 24 (83) 2 (100) –
OT on the team (%) 13 (72) 9 (32) 2 (100) 0.002
Social worker on the team (%) 11 (61) 26 (86) 2 (100) 0.097
Psychologist on the team (%) 7 (35) 7 (18) 3 (50) 0.209
Psychiatrist an integrated member of  10 (83) 21 (70) 1 (50) 0.464
team (% of services with a psychiatrist)
Mean hours of dedicated psychiatrist  34.6 (43.0) 18.9 (11.8) 20.0 (0) 0.234
time per week (SD)
TABLE 22  Training, caseloads and contacts by location (experimental services)
Characteristics Europe North America Other p-value
Specific qualifications in community 
working (%) 12 (67) 22 (73) 1 (50) –
In-service training (%) 11 (61) 33 (100) 2 (100) < 0.001
Mean number of staff on team (SD) 9.6 (6.6) 7.2 (3.2) 6.5 (0.7) 0.540
Mean target number of patients (SD) 117.2 (114.4) 82.3 (73.6) 55.0 (7.1) 0.314
Mean target individual caseload size (SD) 18.1 (11.2) 14.3 (7.7) 10.0 (–)
* 0.271
Mean maximum contact frequency  17.3 (11.9) 32.5 (32.8) 39.0 (22.6) 0.245
per month (SD)
Mean average contact frequency per  4.5 (4.7) 11.0 (12.8) 15.5 (10.6) 0.003
month (SD)
* One case onlyHealth Technology Assessment 2001; Vol. 5: No. 15
45
TABLE 23  Team operation by location (experimental services)
Characteristics Europe North America Other p-value
Home treatment function (%) 16 (94) 33 (97) 2 (100) –
Regularly visit patients at home (%) 17 (94) 32 (94) 2 (100) –
Mean proportion of visits made at  63.1 (22.3) 55.2 (26.6) 87.5 (10.6) 0.552
home (SD)
Mean days per week (SD) 5 (0.5) 5.6 (1.1) 6.5 (0.7) –
Mean hours per weekday (SD) 8.7 (1.5) 11.4 (5.4) 12.0 (2.8) 0.013
Responsibility for healthcare  15 (83) 30 (91) 2 (100) –
functions (%)
Responsibility for social care  16 (89) 32 (94) 2 (100) –
functions (%)
Responsibility for health and social  14 (78) 34 (87) 2 (100) 0.442
care functions (%)
Crisis element to the team (%) 9 (53) 22 (76) 22 (76) 0.124
Multidisciplinary review at least  13 (72) 33 (97) 33 (97) 0.022
weekly (%)
Protocol for meeting needs of carers (%) 3 (18) 13 (41) 13 (41) 0.143
TABLE 24  Team structure by location (control services)
Characteristics Europe North America Other p-value
Multidisciplinary team (%) 6 (86) 10 (83) 2 (100) –
Psychiatrist on the team (%) 7 (100) 11 (55) 2 (100) 0.226
Junior doctor on the team (%) 6 (86) 2 (13) 1 (50) 0.003
Psychiatric nurse on the team (%) 7 (100) 8 (57) 2 (100) 0.239
OT on the team (%) 6 (86) 3 (20) 2 (100) 0.017
Social worker on the team (%) 4 (57) 13 (77) 2 (100) 0.255
Psychiatrist an integrated member of  6 (86) 8 (67) 1 (50) 0.110
team (% of services with a psychiatrist)
Mean hours of dedicated psychiatrist  31.4 (32.0) 19.5 (25.3) 57.5 (31.8) 0.354
time per week (SD)
TABLE 25  Training, caseloads and contacts by location (control services)
Characteristics Europe North America Other p-value
Specific qualifications in community  4 (57) 9 (53) 1 (50) –
working (%)
In-service training (%) 5 (71) 6 (32) 1 (50) 0.205
Mean number of staff on team (SD) 9.7 (2.6) 6.4 (2.4) 29.0 (1.4) 0.033
Mean target number of patients (SD) 247.8 (199.1) 98.1 (60.3) 905.0 (63.6) 0.212
Mean target individual caseload  21.5 (15.5) 33.9 (26.3) 30.0 (0) 0.559
size (SD)
Mean maximum contact frequency  8.4 (7.5) 21.2 (22.9) 8.0 (2.8) 0.298
per month (SD)
Mean average contact frequency per  1.5 (0.4) 8.0 (10.7) 4.0 (–)
* 0.018
month (SD)
* One case onlyFollow-up of authors
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approached significance (p = 0.052). European
control services delivered almost half their contacts
at home, compared to just under 30% for North
American services. More European services took
responsibility for both health and social care and
more had weekly multidisciplinary review, but
fewer had a crisis element in the team (Table 26).
Service classification
We tested components identified through the
service characterisation questionnaire to see
whether they were associated with each other or
whether they clustered in ways that might point 
to a way of classifying the services.
There were no significant associations between 
the service characteristics ‘target individual case-
load size’, ‘average contact frequency’, ‘hours of
operation’ and ‘proportion of contacts at home’
(Table 27). Services with high proportions of 
home contacts were not more likely to have 
lower caseloads, for instance, or to be in more
frequent contact with patients.
Most of the experimental services for which 
we had information on both components 
(56 out of 58) had both a ‘home treatment
function’ and regularly visit[ed] patients at 
home. These components were thus almost
interchangeable, although two respondents said
that they had one and not the other (home treat-
ment function but did not regularly visit at home:
Jerrell – S. Carolina 1
83; or regularly visited at
home but did not have a home treatment function:
Wood – California
84). We tested ‘regularly visit[ing]
patients at home’ against the other service com-
ponents. As expected, those services that did
regularly visit patients at home had significantly
higher proportions of contact at home, with a
difference of 55 percentage points more than
those that did not regularly visit patients at home.
There was no significant difference in days of
TABLE 26  Team operation by location (control services)
Characteristics Europe North America Other p-value
Home treatment function (%) 7 (100) 9 (53) 1 (50) 0.121
Regularly visit patients at home (%) 7 (100) 8 (47) 2 (100) 0.052
Mean proportion of visits made at  48.8 (19.3) 29.5 (25.7) 45.0 (35.4) 0.185
home (SD)
Mean days per week (SD) 5.0 (0) 5.3 (0.8) 5.5 (0.7) –
Mean hours per weekday (SD) 8.0 (0) 9.5 (4.4) 12.0 (5.7) –
Responsibility for healthcare  7 (100) 9 (53) 2 (100) 0.146
functions (%)
Responsibility for social care  5 (71) 11 (73) 2 (100) –
functions (%)
Responsibility for health and social  5 (71) 7 (47) 2 (100) 0.381
care functions (%)
Crisis element to the team (%) 2 (29) 8 (50) 1 (50) 0.320
Multidisciplinary review at least  5 (71) 5 (33) 1 (50) 0.314
weekly (%)
Protocol for meeting needs of carers (%) 1 (14) 3 (19) 2 (100) –
TABLE 27  Correlation between service characteristics
Correlation coefficient
* Target individual  Average contact Hours of operation % of contacts
caseload size frequency at home
Target individual caseload size 1 –0.058 0.140 –0.134
Average contact frequency 1 0.237 0.058
Hours of operation 1 0.037
% of contacts at home 1
* None is significant: p > 0.13 in each caseHealth Technology Assessment 2001; Vol. 5: No. 15
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operation between services that regularly visited 
at home and those that did not (means were 
5.7 and 4.7 respectively) (Table 28).
Services that regularly visited at home had
significantly smaller individual caseloads (14.2)
than those that did not (33.3) (p = 0.004). Of 
the 70 services regularly visiting patients at home,
46 took responsibility for both health and social
care (87% of those for which we had data on 
both components) compared to one of the three
services that did regularly visit at home. This
difference failed to reach significance, however 
(p = 0.064). There were no significant associations
between regularly visiting patients at home and:
hours of operation of the team; maximum and
average contact frequencies; being a multi-
disciplinary team; having a psychiatrist on the
team; the psychiatrist being an integrated team
member; and the team having a crisis element
(Table 28).
The majority of the services (83%) had both 
health and social care functions. We tested the
associations between this and other components. 
It was a smaller majority than that for regularly
visiting at home, which suggests the results of 
these tests are likely to be more robust. We
expected the services with responsibility for 
both functions to be more likely to be multi-
disciplinary teams, and 93% of them were,
compared to 67% of services that did not take
responsibility for both functions. However, 
this difference just failed to reach significance 
(p = 0.067). Two-thirds of services with responsi-
bility for both functions said the psychiatrist 
was an integrated team member, as opposed 
to one-third of services that did not (p = 0.03).
Responsibility for both health and social care 
was not significantly associated with the com-
ponents: caseload size; proportion of contacts
made at home; maximum and average contact
frequencies; home treatment function; and the
team having a crisis element (Table 29).
This would seem to provide some evidence for a
group of service components – multidisciplinarity,
psychiatrist on the team as an integrated member,
small caseloads, regularly visiting patients at home
and taking responsibility for both health and social
care – linked by patterns of association, though 
not strongly cohesive (Figure 2). This group of
components could be seen as a subset of com-
ponents identified as belonging to ACT (page 51,
‘Service classification’). We examined whether
those studies in our review for which we had full
information and which had been reported as
having these service components were the same
studies that had identified themselves as being
studies of ACT, ICM or TCL.
TABLE 28  Associations between service components (regular home visits)
Regularly visit at home p-value
Yes No
n = 53
* n = 3
% of contacts at home (SD) 62 (24.2) 8  (7.6) 0.001
*
Mean days of operation (SD) 5.7  (0.96) 4.7  (0.58) 0.056
Mean caseload size (SD) 14.2  (8.0) 33.3  (11.5) 0.004
*
Responsible for health and social care (%) 46  (87) 1 (33) 0.064
* Data on the other components was not available for all 53 services, so valid percentages are given
TABLE 29  Associations between service components (responsibility for health and social care)
Responsibility for both  p-value
health and social care 
Yes No
n = 43
* n = 9
Multidisciplinary team (%) 37  (93) 6  (67) 0.067
Psychiatrist an integrated member of the team (%) 28 (65) 3 (33) 0.03
* Data on the other components was not available for all services, so valid percentages are givenFollow-up of authors
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This was not the case. When we defined ‘small
caseloads’ as being 15 or under (the smallest 
size mentioned by participants in the Delphi
exercise), we found that 12 experimental services
for which we had information qualified for
inclusion in our group. Ten of these (Drake – 
New Hampshire
85; Holloway – London
86; Jerrell –
San Jose
87; Jerrell – S. Carolina 2
57; Korr –
Pittsburgh
88; Lehman – Baltimore
59; McFarlane –
Maine
89; Muijen – London 1
90; Solomon –
Philadelphia 2
91; UK700
92) had named them-
selves varieties of ACT or ICM, but two had not:
one (Christensen – Svendborg
93) called itself
‘community psychiatric care’, the other 
‘intensive psychiatric community care’ 
(Rosenheck – Connecticut
61).
Conversely, 23 studies labelled as ACT/ICM, for
which we had information on service components
from the authors, did not appear in this group of
studies. This number was reduced on further
scrutiny, which revealed that:
•t here was insufficient information on five of the
studies (usually on team composition to assess
multidisciplinarity), although the authors had
responded to follow-up;
•t hree studies (Bond – Chicago 1
94; Ford –
London 1
95; Johnston – New South Wales
96)
were excluded from our group only because the
psychiatrists on their teams were not integrated
team members;
•n ine further studies could be included 
when caseload size was calculated from figures
given for the number of staff on the team 
and the target number of patients (Chandler 
– California 2
97; Herinckx – Oregon
21; Lafave 
– Ontario
98; Marx – Madison
27; Mowbray –
Michigan
99; PRiSM – London
46; Sands –
Philadelphia
100; Stein – Madison
11; 
Test – Wisconsin
101);
• five authors, accounting for six of the above
studies (Lafave – Ontario
98; Marx – Madison
27;
Mowbray – Michigan
99; Sands – Philadelphia
100;
Stein – Madison
11; Test – Wisconsin
101) said 
that the question about caseload size was
irrelevant as the team had shared caseloads.
Thus, although the staff to client ratio qualified
them for inclusion, their management of
caseloads was a different one.
This left us with a group of 21 studies that would
be included in our group of services with multi-
disciplinary teams, integrated psychiatrists, case-
loads smaller than 15, regularly visiting patients 
at home and taking responsibility for both 
health and social care, all but two of which had
labelled themselves a variety of ACT, ICM or TCL.
There were then nine studies for which we had 
Smaller
caseloads
Regularly
visiting at home
High % of
contacts at home
Psychiatrist
integrated in team
Responsible for
health and social care
Multidisciplinary
items
FIGURE 2 Associations between service components (––––, significant association; – – –, association approached significance)Health Technology Assessment 2001; Vol. 5: No. 15
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sufficient information, which gave themselves 
an ‘ACT/ICM/TCL’ label but did not ‘qualify’ 
for inclusion in our group. Moreover, had we
defined ‘small caseloads’ as ten or under (the
‘ideal’ caseload size
4), four more studies (Drake 
– New Hampshire
85; Jerrell – San Jose
87; Jerrell 
– S. Carolina 2
57; UK700
92) would have 
dropped out.
Sustainability
Services
Of the 55 studies whose authors responded to
follow-up, 24 of the services were ‘still identifiable’
(44%). Two authors said the team was not identi-
fiable but the practices were; one said the team 
was “sort of” identifiable; and three said the 
teams were still running at some but not all of 
the sites involved in the original study. All but 
one of these provided information about the
current services, so are included in the figures
below. Two authors were no longer connected 
with the service and could not comment. The
median year of publication was only 2 years
different for the services that were still running
compared with those that were not (1996 com-
pared to 1994), and this difference was not
significant. Ten of those services that were not 
still running had ended when or before the study
was published, three had run for up to 3 years 
after publication and three had run for 4 or 
5 years after publication.
Services were more likely to be in operation 
if the study had found a significant reduction 
in hospitalisation in their favour than if they 
had had non-significant hospitalisation results 
(p = 0.003). In all, 13 studies of the 29 still or 
‘sort of’ in operation (45%) had found significant
results in favour of the experimental service and
nine (31%) had non-significant results. Of those
which were no longer in operation (25), only two 
(8%) had significant findings in favour of the
experimental service, while 15 (63%) had non-
significant findings. The findings on which this
calculation is based are whatever hospitalisation
measure was reported in the study, days in 
hospital where available.
Service components
Of the 29 experimental services still in operation,
or in operation at some sites or identifiable in
practice, 15 had retained all the features the
authors identified in the follow-up questionnaire 
as having ‘made the service innovative’ at the 
time of the study. Authors of ten studies identified
features of the experimental services that they 
had since ‘found unhelpful and decided to drop’.
Three had abandoned their earlier emphasis on
small caseloads, and one on ‘intensive working’.
One had found offering a 24-hour service un-
helpful because clients did not make use of it. 
Two had abandoned ‘home treatment’, but one of
these emphasised that this was because of ‘insuffi-
cient personnel’ and was regrettable. They also
mentioned features not explicitly tested in this
review. One had “worked with families to break
pathological dependency relationships” but had
since ceased to do so. One had offered a time-
limited service (14 months); he now felt that there
should be no time limits on patients and that
discharge should be based on the patient being
“well stabilised and integrated”. Another had
abandoned the previous emphasis on ‘speed of
assessment’. One service had originally not had
responsibility for inpatient beds, but had taken 
this on. Finally, one service had not found
‘assertive outreach’ to be helpful.
Most of the services still identifiable had retained
most of the key components identified in the
service characterisation questionnaire. Most had
not changed their multidisciplinarity, with only 
one service ceasing to be multidisciplinary. No
services with a psychiatrist reported a change in
whether the psychiatrist was an integrated member,
but three services had gained hours of dedicated
psychiatrist time (Table 30). In one service, the 
staff were now qualified in community working
where they had not been before, but three services
had ceased to deliver in-service training. Staff 
and patient numbers had risen in eight and ten
services respectively, and fallen in three services
each. The average caseload size had risen in six
cases and fallen in two; where it had fallen, it was
only by two or three patients, but where it had
risen the difference ranged from one patient to
ten, with a mean rise of four patients. Five services
had decreased their maximum contact frequency
and one their average contact frequency. Fewer
had increased contact frequency (Table 31). 
Where the average contact frequency had
dropped, it was by five contacts per month, and
where it had increased it was only by two contacts
in each case. In the services where the maximum
contact frequency had decreased, the difference
ranged from two contacts a month to 30, with 
a mean difference of nine; in the case where 
it had increased, it was by 18 contacts a month.
Only one service reported no longer having a
home treatment function, and two had ceased 
to visit patients regularly at home, while one had
started to. While the majority of services reported
no change in the proportion of contacts made atFollow-up of authors
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home, six services made fewer home contacts
(ranging from 15 to 95 percentage points, with 
a mean of 33) and one made more (increasing 
by 40 percentage points). The days and hours of
operation had changed in only a few services and
where they had done so they had usually increased
(from 5- to 6- or 7-day opening, and by 1–3 hours 
a day). No services had changed their roles with
regard to healthcare and social care functions, 
but two had gained or dropped a crisis element 
in the team. No services had changed whether 
they had regular multidisciplinary review. Three
services had gained a protocol for meeting carer
needs (Table 32).
TABLE 31  Training, caseloads and contacts (sustainability)
Component Dropped (%) Gained (%) No change (%)
Specific qualifications in community working 0 0 1 (4) 22 (96)
In-service training 3 (13) 0 0 20 (87)
Number of staff on team 3 (14) 8 (38) 10 (48)
Target number of patients 3 (18) 10 (59) 4 (23)
Target individual caseload size 2 (15) 6 (46) 5 (39)
Maximum contact frequency per month 5 (28) 1 (6) 12 (66)
Average contact frequency per month 1 (7) 3 (21) 11 (72)
TABLE 32  Team operation (sustainability)
Component Dropped (%) Gained (%) No change (%)
Home treatment function 1 (4) 0 0 24 (96)
Regularly visit patients at home 2 (8) 1 (4) 22 (88)
Proportion of visits made at home 6 (32) 1 (5) 12 (63)
Days per week 1 (4) 3 (13) 20 (83)
Hours per weekday 0 0 3 (12) 22 (88)
Responsible for healthcare functions 0 0 0 0 23 (100)
Responsible for social care functions 0 0 0 0 24 (100)
Responsible for health and social care functions 0 0 0 0 23 (100)
Crisis element to the team 1 (4) 1 (4) 23 (92)
Multidisciplinary review at least weekly 0 0 0 0 21 (100)
Protocol for meeting needs of carers 0 0 3 (14) 19 (86)
TABLE 30  Team structure (sustainability)
Component Dropped (%) Gained (%) No change (%)
Multidisciplinary teams 1 (5) 0 0 19 (95)
Psychiatrist on the team 1 (5) 0 0 22 (95)
Junior doctor on the team 0 0 2 (1) 18 (99)
Psychiatric nurse on the team 1 (4) 0 0 22 (96)
OT on the team 0 0 1 (5) 21 (95)
Social worker on the team 1 (5) 1 (5) 20 (90)
Psychiatrist an integrated member of team  0 0 0 0 25 (100)
(proportion of services with a psychiatrist)
Hours of dedicated psychiatrist time per week 0 0 3 (19) 13 (81)Health Technology Assessment 2001; Vol. 5: No. 15
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Discussion
Response rate
The response rate from study authors was high
(60%). It was significantly higher for the authors 
of RCTs, of whom 77% responded, than for the
authors of non-randomised studies, of whom 
only 34% responded. This may have been because
RCTs are in general more demanding of people’s
time and resources, so that authors are more
involved and committed and consequently more
inclined to respond to requests for information.
Alternatively, the authors of non-randomised
studies may have doubted that their results 
would be included in a systematic review and 
so been reluctant to involve themselves in the
process of completing follow-up questionnaires.
Responses did, however, cover the full range 
of studies in terms of control service, number 
of participants, location and year of 
first publication.
Some authors admitted to knowing little about 
the services they had used as controls. Overall, 
we obtained some (though not complete) data 
on 54% of the control services, mostly through
follow-up. It is likely that little of this infor-
mation would have been available in the 
published papers.
Service utilisation and costing
Given the need for a comprehensive service 
profile in mental health research, it was encour-
aging that so many of the authors who responded
had collected service utilisation data on a range 
of services. This reported coverage, however, 
stands in contrast to the availability of evidence 
in practice. Relatively few of the study authors 
who had reported collecting the service use data
(12 out of 46) were able to provide us with it when
we requested it. Moreover, in many cases where
authors had stated that service use data had been
collected, the published papers did not report it.
This information would give a fuller picture of the
services, as well as allowing a substantial costing 
of all their constituent parts. It must be of some
concern that so many data are collected, but 
either not analysed, or analysed but not published.
This raises certain ethical issues, particularly the
question of whether policy and practice decisions
based on the results of these research studies 
are as well-informed as they could be.
Service components
Despite meeting our broad inclusion criteria, 
the services under study were fairly heterogeneous
in terms of the size of the service, caseload size,
contact frequency and other service components,
although largely homogeneous in terms of 
‘home treatment function’. Almost a fifth of the
experimental services were not multidisciplinary
teams, and more than a fifth did not have psychia-
trists on the team. This finding is contrary to 
the importance attached to psychiatrist input 
by the experts consulted in the Delphi exercise
(page 28, ‘Components rated “essential” and 
“very important”’), albeit that they were 
themselves psychiatrists.
There was no evidence that these various
components had become more common in
experimental or control services over time, other
than proportions of home contacts in control
services. Control services in later studies had
higher proportions of contacts made at home.
Impact of location on service
components
The North American experimental and control
teams were more likely than the European ones
to include social workers and to take responsibility
for social care as well as healthcare. They were 
less likely to include OTs and junior doctors. They
were open for longer hours than the European
services (9.5 hours per day compared to 8 hours)
and made contact with the patients more fre-
quently (8 contacts compared to 1.5 contacts per
patient per month). More of the European control
services had an explicit home treatment function,
but the number of studies for which this infor-
mation was available was small. For experimental
services, there was no difference between North
America and Europe in whether the team had 
a ‘home treatment function’.
Service classification
We had hoped to be able to develop a new
taxonomy of services on the basis of our findings.
We used a Delphi exercise to identify important
components of care rather than identifying the
components of each of the services and then
attempting to reclassify them (a top-down rather
than bottom-up approach). The bottom-up
approach was simply not possible, as the infor-
mation on service components is not reported
sufficiently systematically or in detail in the papers.
That substantial numbers of authors were able to
provide information on these components (such 
as contact frequency and caseload size) indicates
that these are pertinent questions. Where authors
did not respond to follow-up, however, it was fre-
quently impossible to obtain information from the
papers in a standard form. It is also notable that
even when authors had responded to follow-up, Follow-up of authors
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it was not always possible for them to provide
sufficient information for us to attempt a classifi-
cation. Retrospectively characterising services by
these components is therefore difficult. We would
suggest that studies routinely collect information
on service components,
102 and that for home treat-
ment studies the components we have identified 
be used prospectively in future.
It has thus not proved possible to present a new
classification system for the services covered by 
our term ‘home treatment’, since the few associ-
ations found between key service components 
did not present clear evidence for a particular
cluster of components. This is illustrative of the
reviewed area, in that service models within 
‘home treatment’ have not been defined 
or operationalised with sufficient clarity to 
permit such a classification. There was limited
evidence, however, for a group of services that 
were multidisciplinary, had psychiatrists as
integrated team members, had small caseloads,
visited patients at home regularly and took
responsibility for both health and social care. 
This cannot be seen as a cohesive group, how-
ever, as within this group each component 
was linked to some of the others but not all.
These service components – multidisciplinarity,
psychiatrist on the team as an integrated member,
small caseloads, regularly visiting patients at home
and taking responsibility for both health and social
care – might be seen as a subset of the components
associated with ACT as a service model. In fact, all
have been explicitly listed by McGrew and Bond,
3
Teague and colleagues
4 and Marshall and Lock-
wood
6 as components of ACT, except for small
caseloads (McGrew and Bond
3 and Teague and
colleagues
4 only), and taking responsibility for 
both health and social care (Teague and colleagues
4
only). It should be noted, however, that these com-
ponents are only a subset of those that have been
identified as part of ACT. Moreover, the eponymous
ACT component, ‘assertive outreach’, was not 
tested in this review because it did not appear in 
the Delphi exercise. The spirit of assertive outreach
might be argued to be captured in the ideas of small
caseloads and home visiting, in that these suggest 
a close knowledge of patients by clinicians. This is
debatable, however, and should not be assumed.
The component ‘psychiatrist as an integrated
member of the team’, moreover, is not specified 
in the ACT models. It could not be assumed to 
be synonymous with ‘having a psychiatrist on 
the team’, since only half the teams with psychia-
trists who responded to our survey said that the
psychiatrists were integrated team members. This
component was found to be associated with others
in the group, where simply having a psychiatrist 
on the team had not. This component filtered 
out three studies.
Our component ‘smaller caseloads’ (whether
defined as fewer than 10 or fewer than 15 patients)
was not given for six studies of ACT whose authors
said that the teams had shared responsibility for
patients, rather than individual caseloads. This
included the pioneering studies of ACT (Stein –
Madison
11; Marx – Madison
27). It is important to
bear in mind this original feature of ACT, which 
is not reflected in the preoccupation with small
(but implicitly individual) caseloads.
Our group of loosely associated service com-
ponents is thus not put forward here as an altern-
ative, simplified configuration of models of ACT.
In fact, this set of components that we had identi-
fied as loosely associated did not robustly identify
studies in our review that labelled themselves ACT
or ICM, even though it appeared to be a subset of
ACT components. It should be emphasised that 
we were not here applying an ACT scale, such as
the Dartmouth ACT scale,
4 to the studies in our
review that label themselves ACT, or variants of
that name. This would not be within the scope 
of this review. What we seem to have identified
tentatively is a group of services linked by this
group of components: most of the studies identify
themselves as based on ACT or ICM principles, 
but not all do, and the group excludes a large
number of studies that also identify themselves 
as being based on ACT or ICM.
It is clear that the ACT model comes closest to 
a distinct service configuration, although this
review provides some evidence of studies using 
the ACT label unjustifiably. This review, however,
looks at a wider range of services: those which aim
to ‘treat patients outside hospital as far as possible
and to stay in their usual place of residence’.
‘ACT’, even if it were defined clearly enough,
would only be a subsection of the services in this
review. Having attempted to test for clustering of
service components, we found both that the links
of association between the components were weak,
and that the group of studies identified was not a
clear subsection of ACT/ICM-labelled studies.
Sustainability of services and 
their components
Less than half of the services whose authors
responded to follow-up were still in operation. 
We had imagined that services from earlier studiesHealth Technology Assessment 2001; Vol. 5: No. 15
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were less likely to be still enduring, but this does
not seem to be the case, since there was no differ-
ence in the year of publication between those 
that were still running and those that were not.
Whether the study had found a significant reduc-
tion in hospitalisation (measured in various ways),
however, was significantly associated with whether
the experimental service was still in operation.
More than half of the services still in existence 
had dropped features that had been seen as
‘innovative’ at the time of the study, sometimes
because they were not sustainable in terms of
resources and sometimes because the services 
had evolved and they were no longer considered
useful. Three had abandoned their previous
emphasis on smaller caseloads, but the small
number of studies for which we have information
makes this difficult to generalise from. Where
services were still operating, most of the com-
ponents in our service characterisation question-
naire had not changed in most of the services,
suggesting that these components are largely
sustainable. Only a quarter of the services for
which we had information, however, were running
in approximately their original form: that is, had
not dropped features originally seen as making
that service innovative. Although nothing is 
known about the sustainability of the services
whose authors did not respond to the follow-up, 
it is probable that they are less likely to be still 
in operation. Overall, therefore, the sustainability
of home treatment services does not seem to have 
been very great.Health Technology Assessment 2001; Vol. 5: No. 15
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Introduction
This review has provided a comprehensive 
overview of studies of home treatment, in terms 
of both their study features and the components 
of the experimental and control services they
evaluate. The review has a further aim: to use 
the data on hospital days and costs obtainable 
from the papers and the authors themselves 
in a series of analyses. We aimed to test the
effectiveness of home treatment services over
inpatient care and over other community-based
services (a conventional meta-analysis based on
Cochrane methodology). The review is unusual 
in also testing the service components identified
through the Delphi exercise (page 34, ‘Use 
of Delphi-generated components in service
characterisation’) and collected through follow-
up (chapter 5) for association with the outcome
days in hospital. We hoped to ascertain whether
the following service features were more likely 
to reduce hospitalisation for their patients:
•m ultidisciplinary teams
• smaller caseloads
•h igher contact frequency
• more contacts made at home
•l onger hours of operation
•r esponsibility for both health and social care.
In the ‘Review of economic evaluations’ (chapter 3),
we present the results of a review of those studies
which themselves contain a specific economic
evaluation. Here, however, we use further data on
service utilisation (collected through follow-up of
authors) in order to attempt a more comprehensive
cost analysis.
It will be clear from the details already given that
the studies included in this review cover a wide
range of services. The control services studied
constitute a heterogeneous group, while some of
them would themselves qualify as ‘home treatment’
services according to our wide definition. These
factors make meaningful meta-analysis difficult 
and may call into question the validity of calcu-
lating the overall difference between experimental
and control data (the conventional meta-analysis).
These difficulties and their implications are
discussed below. Where we compared data from
different locations, and where we tested for
associations between service components and 
days in hospital, however, the analyses are more
robust. We present below two alternative analytical
strategies, along with the results of these analyses.
Methods
Analytical methods
Each study had been allocated into one of the
following groups:
Inpatient-control (Type I): individuals already in
hospital or presenting to hospital when selected;
control service was an initial period of inpatient
treatment for all patients, with patients being
discharged when appropriate (with the possibility
of readmission if necessary).
Community-control (Type II): individuals selected
either at the point of discharge or by other means;
control service was not inpatient treatment
(although patients might be admitted if 
deemed necessary).
Studies were only included in the analysis if 
data were available in the form of mean hospital
days. Where necessary the outcome variable 
mean hospital days per patient per month was
calculated from the information given. In order 
to analyse all studies with data on mean hospital
days, an outcome variable was used for which we
calculated a monthly figure for the entire period 
of the study (or the longest period for which we
had data). Where studies presented data for more
than one time-point, the interim data were used 
to calculate the average monthly mean across the
entire period. It was hypothesised that studies of
less than a year’s duration would give misleading
results, and for this reason they were excluded from
all the analyses, except where we specify otherwise.
High quality non-randomised studies were included
in the comparative analysis only (Strategy 1). As
well as having data on mean hospital days, they
were required to be prospective studies, with
matched controls or clinically comparable groups.
Within each group (inpatient-control studies 
or community-control studies), all studies were
Chapter 6
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analysed, regardless of the range of diagnostic
categories of the individuals within that study. 
The analysis was then repeated, omitting the
studies with predominately neurotic patients, 
to test the difference this made.
Data on mean hospital days was available for 
52 studies (71% of the RCTs (40 studies) and 
34% of the non-randomised studies (12 studies)):
57% of all the studies. A total of 34 studies 
(37%) reported findings on hospitalisation in
another form, such as the percentage of patients 
re-hospitalised during the study period or the 
mean number of admissions (page 10, ‘Outcome
variables’). This was more common with the 
non-randomised studies (20 studies or 57%) 
than the RCTs (14 studies or 25%, p = 0.007).
These findings could not be used in our analysis.
Four studies did not collect hospitalisation data 
at all (Table 11).
Statistical analyses were performed by HW using
SPSS version 9.
Studies with three treatment conditions
Where studies had three treatment conditions, 
it was not possible to include all three groups. 
The analysis requires that all the data points are
independent, and this is only satisfied when each
data point is taken from a separate study. It was
decided that combining groups where the authors
had not done so would be unjustifiable. Instead,
we chose either the second experimental group or
the control group as the control for the purposes
of our analysis. This decision was based entirely 
on the pragmatic grounds of which choice would
yield data for the maximum number of analyses,
blind to the results of the studies. This meant 
that when the control service was not a CMHT 
and the second experimental group was, we 
chose the latter to include in the analysis, as some
analyses were restricted to studies where the con-
trol service was a CMHT. We collected information
on service components for all three arms of these
studies where possible. We were thus able to use
data on components from the second experi-
mental arms where necessary (appendix 8).
Two analytical strategies were used, the
‘comparative analysis’ and the ‘experimental
services analysis’.
Strategy 1: comparative analysis 
(Figure 3)
This whole analysis was conducted with the 
RCTs alone, and then repeated including non-
randomised studies of sufficient methodological
rigour (prospective; matched controls or
comparable groups).
The primary outcome measure was difference 
in mean hospital days (per patient per month)
between patients in the experimental and control
services. The requirement in some studies that 
all control patients had at least an initial period 
of inpatient treatment as the control service was
thought likely to impact on this outcome. For 
this reason, inpatient-control and community-
control studies were analysed separately. We then
calculated the difference in this mean between the
experimental and control arms of each study. We
calculated the overall mean difference across the
different studies, weighting by 1/(1/n 1 + 1/n 2),
where n 1 and n 2 are the numbers of patients 
with hospital days in the control and experimental
arms of each study. The same weighting was used
in all the comparative analyses, unless specified
otherwise. This summary mean difference was
calculated for studies of all durations (including
those of less than a year) and subsequently
restricted to studies of at least a year’s duration
(both results reported). For the inpatient-control
studies, we calculated this mean for studies with
data on hospital days at one year only, since the
duration of follow-up could have a particularly
strong effect here. Study-specific standard
deviations were only available for about half 
of the data on mean hospital days. Without 
having them for all studies analysed, it was not
possible to put confidence intervals on the
weighted mean differences.
Fortunately, the subsequent analyses testing for
associations with service components, duration 
of the study and year of publication are not
affected by this lack of standard deviations. 
These analyses do not use the standard deviations
between patients within individual studies in
calculating significance.
To test whether or not the duration of the study
had an influence on this outcome measure, the
difference in mean hospital days was regressed 
on the duration of the study, including studies 
with a duration of less than a year, using the
weighting specified above. To test for the effect 
of the length of the study, this variable was tested
for its association with the outcome measure, and
for this test the studies of less than a year’s
duration were included.
We looked for an association between several
components of the services and the difference in
mean hospital days per month. The difference inHealth Technology Assessment 2001; Vol. 5: No. 15
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mean hospital days was plotted against the
difference between the experimental and 
control services in terms of caseload size, average
contact frequency per patient per month and 
proportion of contacts at home. In the latter 
case, all control services that were not CMHTs 
were taken to have no contacts at home, and 
the analysis was conducted with all studies with
available data. This was the only analysis with
sufficient data available for a formal statistical
analysis. Weighted regressions were used.
We further tested to see whether the difference 
in mean hospital days was affected by whether 
both the control and experimental service 
satisfied the following criteria, or whether only 
the experimental service satisfied it. The criteria
tested were hours of operation of the team (at 
least 10 hours per weekday compared with fewer
than 10 hours per weekday), whether the team
took responsibility for both health and social 
care, whether the authors described the team 
as having a ‘home treatment function’, and 
whether the team regularly visited patients at
home. Weighted unpaired t tests were used, 
or an unweighted Mann–Whitney U exact test
where the numbers were smaller. Nearly all 
the experimental and control services were
multidisciplinary (three or more disciplines) 
so this could not be tested.
All studies
Study design screened
Have mean hospital days for cases and controls
for duration of 1 year or more?
Have data on service components for
experimental and control services?
Prospective, with well-
matched groups
Non-RCTs RCTs
No
*
Yes
Community-control studies Inpatient-control studies
Yes Yes No No
Yes Yes No No
Comparative
analysis of overall
mean difference
Comparison
analysis of overall
mean difference
Comparative
regression analysis
Comparative
regression analysis
* Whole analysis repeated, including these non-RCTs the second time only
FIGURE 3 Comparative analysisData analysis
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These components could only be tested where we
had information on both the experimental and the
control services, in order to calculate the differ-
ence between them. They could not be tested 
for inpatient-control studies if they did not apply 
to inpatient treatment. Thus, caseload size, for
example, could not be tested. The exceptions 
were ‘proportion of contacts at home’, where 
the inpatient services and other services that were
not CMHTs could be scored as zero, and ‘home
treatment function’ and ‘regularly visiting patients
at home’, where they could be scored as ‘No’.
The location of the study (Europe or North
America) and the year of first publication of data
were also tested for their association with the dif-
ference in hospital days, using an unpaired t test
and a weighted regression analysis respectively.
Strategy 2: experimental services
analysis (Figure 4)
This analytical strategy aimed to avoid the
problems created by the wide range and poor
definition of control services, by omitting all
control service data from the analysis. Only
experimental service data were included in this
analysis in order to assess the relationship between
components of the experimental services and
mean hospital days per patient per month. All
studies were analysed together, whether they were
inpatient-control or community-control studies.
The outcome measure was mean days in hospital
per patient per month for patients in the experi-
mental arm of the trial. This was not a randomised
comparison. Its validity was based on the methodo-
logical rigour of the study data. For that reason, 
we included only RCTs in this analysis and did 
not repeat it including non-randomised studies.
The analyses were weighted by the number of
patients with hospital days in the experimental 
arm of the study.
We performed weighted regressions of the mean
hospital days per patient per month on each 
of the following: year of first data publication,
duration of follow-up of the study, caseload size,
average contact frequency per patient per month,
and the percentage of contacts which took place 
at home. We then adjusted for severity of illness 
of the patients in each of the studies as far as was
possible. To do this, we adjusted for whether or 
not the authors described the study as specifically 
All studies
Study design screened
Have mean hospital days for cases 
for duration of 1 year or more?
Have data on service components
for experimental services?
Non-RCTs RCTs
Excluded
No
Yes
No Yes
Experimental
service analysis
(regressions)
FIGURE 4 Experimental services analysisHealth Technology Assessment 2001; Vol. 5: No. 15
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a trial of high service users, and repeated the
regression analyses. The influence of location 
was also studied, to determine whether or not 
this influenced the mean hospital days, using a
weighted t test, and then a weighted analysis of
variance, adjusting for whether or not the study
focused on high service users.
Cost analysis
Data on service utilisation obtained from the
follow-up process (page 38, ‘Service utilisation
data’) were used to provide detailed costing of 
the studies in the analysis. The cost analysis aimed
to mirror the analysis of hospital days as far as pos-
sible: analysing inpatient-control studies separately
from community-control studies, and mirroring
both the comparative analysis and the experi-
mental services analysis (see above). It aimed to
cost the findings of the regression analyses used to
test for associations between service components,
wherever possible. These cost analyses were only
performed, however, when data were available for
more service utilisation than just days in hospital.
To provide a costing based on inpatient treatment
alone would not have added anything to the
analysis of days in hospital above.
Results
Details of studies put into the different analyses 
are given in appendix 9.
Comparative analysis: reduction in
hospital days
For this analysis, inpatient-control studies were
analysed separately from community-control
studies. The outcome was the difference in mean
hospital days per patient per month between the
experimental and control services, for the longest
available follow-up period. Analyses are restricted
to studies of at least a year in duration unless
otherwise specified.
Inpatient-control studies
Eight RCTs had usable data overall. The mean
difference between experimental and control
service outcomes when all eight were included,
using the longest available follow-up, was 6 days
per patient per month. For the reasons given
above, we could not measure the significance of
this finding. When four non-randomised studies
were included in the analysis, the difference 
found across studies of any duration was 3 days 
per patient per month: about half that found 
when only RCTs were analysed (Table 33).
Impact of non-psychotic studies
No inpatient-control studies contained
predominately neurotic patients.
Duration of follow-up
Because in these studies the control service was
inpatient treatment, we hypothesised that the
duration of follow-up would have a greater impact
here than with the other studies. For this reason,
we also calculated the mean difference for only
studies of a year’s duration, and the mean differ-
ence in this case was 4.9 days. Only one non-
randomised study had a follow-up duration of 
a year. Not surprisingly, this did not affect the
result, which decreased by only 0.1 days. We 
also tested the follow-up duration against the
difference in days in hospital for all studies 
(of any duration). This is presented in Figure 5.
Year of study
The difference in hospital days was also regressed
against the year of first data publication (Figure 6).
Community-control studies
We had usable data for 29 community-control
RCTs. The mean difference in hospital days
between experimental and control services for
these studies was much smaller: 0.5 days per
month. When we excluded studies of less than 
a year’s duration, the mean difference dropped
still further, to 0.2 days per month. Again, we
cannot measure the statistical significance of 
this finding, but it is clearly not significant
clinically (Table 34).
Three non-randomised studies were eligible for
inclusion in the analysis. Inevitably, since the
figures were very small, including them made 
little difference.
TABLE 33  Inpatient-control studies: difference in hospital days
Length of study n RCTs only
* n RCTs and non-RCTs
*
Any duration of study 8 6.01 (3.54) 12 3.31 (3.74)
1-year follow-up only 5 4.86 (4.30) 6 4.75 (4.04)
* Mean (SD) days per patient per monthData analysis
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Duration of study (years)
Difference in mean hospital days per patient per month between control  
and experimental services
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FIGURE 5 Inpatient-control studies: the difference in hospital days against the duration of the study
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FIGURE 6 Inpatient-control studies: the difference in hospital days against the year of first data publicationHealth Technology Assessment 2001; Vol. 5: No. 15
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Impact of non-psychotic studies
Two community-control RCTs (Burns – London
103;
Paykel – London
104) were predominately of
neurotic patients. Excluding them did not alter 
the mean difference (Table 34). Since our aim 
was to examine the effect of home treatment on
the treatment of all people with mental health
problems, we included them in all further analyses.
Duration of follow-up
Duration of follow-up was tested against days in
hospital (using the aggregate outcome variable 
for the longest available time-point) for every
community-control study, including those of less
than a year’s duration. The association was highly
statistically significant. It suggested that as the
duration of a study increases by a year, it finds a
difference in hospitalisation between experimental
and control services of 0.6 fewer days per patient
per month. The difference in the findings of a 
1-year study compared to a 3-year study would 
thus be just over 1 day (1.2) per patient per 
month. (Table 35.) The results including non-
randomised studies were very similar.
Year of study
The year of publication of data was not
significantly associated with difference in days 
in hospital. When three non-randomised studies
were added to the analysis of the year of publi-
cation against the outcome, the result was still 
not significant (Table 36).
Comparative analysis: service utilisation
data and costs
Although there were a number of apparent
differences between experimental and control
groups in relation to the usage made of individual
services, it was not possible to conduct formal
statistical tests, as with the data on hospital days.
Again, very few authors were able to send us
standard deviations in addition to means when
reporting service use levels, and standard devi-
ations were rarely reported in published papers.
We were only able to aggregate costs across (a 
few) service categories for a small subset of studies
because the patterns of data availability were so
very different. For example, although there were
40 RCTs for which we had inpatient usage data,
there were only 13 for which there was inpatient
and outpatient data. Other cost combinations 
were even rarer. This further service use data was
required for meaningful cost analysis. The second
most common type of service use data available 
was outpatient attendance, so we costed inpatient
and outpatient services for each analysis where
TABLE 34  Community-control studies: difference in hospital days
Length of study n RCTs only
* n RCTs and non-RCTs
*
Any duration of study 29 0.46 (1.13) 32 0.40 (1.23)
Only durations of 1 year or more 25 0.18 (0.80) 28 0.12 (0.94)
Only predominantly psychotic studies  23 0.19 (0.82) 26 0.13 (0.97)
with a duration of 1 year or more
* Mean (SD) days per patient per month
TABLE 35  Community-control studies: regression of difference in hospital days on duration of follow-up
Duration of follow-up (years) n Regression coefficient
* 95% CI p-value
RCTs 29 –0.612 –1.077 to –0.148 0.012
RCTs and non-RCTs 32 –0.580 –1.080 to 0.080 0.021
* Measures change in hospital days per month for each year of duration of follow-up
TABLE 36  Community-control studies: regression of difference in hospital days against year
Year of first publication (years) n Regression coefficient
* 95% CI p-value
RCTs 25 –0.026 –0.130 to 0.078 0.61
Non-RCTs 28 –0.031 –0.146 to 0.084 0.59
* Measures hospital days (per patient per month) for each year (date of study)Data analysis
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these data were available. We do not report the
differences between inpatient costs alone because
these would have exactly the same results as the
tests of inpatient days.
No inpatient-control studies (either RCTs or 
non-randomised studies) had available outpatient
data; 12 community-control RCTs had both in-
patient and outpatient data. The overall difference
in costs between the experimental and control
services was £41 per patient per month in favour 
of the experimental services (Table 37). As noted, 
it is not possible to measure the significance 
of this difference because of the lack of 
standard deviations.
Only one non-randomised community-control
study (PRiSM – London
46) provided us with
outpatient as well as inpatient data. This study 
was added to the 12 RCTs and the cost analysis
repeated. Its inclusion reduced the overall cost
difference finding by £7 per patient per month
(Table 38).
The costs for each type of service in each study 
for which we had the information are reported
individually in appendix 7.
Comparative analysis: location
For community-control studies, the results were
significantly different for European studies com-
pared with North American ones. North American
studies found an overall reduction of 0.8 days in
hospital in favour of the experimental services,
while the European studies found a difference 
of only 0.3 days in favour of the control services.
Neither finding, however, is very significant clin-
ically. When three non-randomised studies were
added, the result just failed to reach significance
(Table 39). There were insufficient inpatient-
control studies to test for differences in location.
Comparative analysis: service
components
To see if any service components were associated
with reducing days in hospital, the difference in
hospital days between the two services was tested
against the difference between the experimental
and control service in terms of the service com-
ponent (for instance, the difference in caseload
size or contact frequency) using weighted
regression analyses.
Inpatient-control studies
The components ‘caseload size’, ‘contact
frequency’, ‘multidisciplinarity’ and ‘hours 
of operation’ were not relevant to inpatient
treatment, so they were not tested for association
with the outcomes of the inpatient-control studies.
There were too few studies in this category to 
test the remaining service components for
association with the outcome, or to compare 
North American to European study findings.
Community-control studies
The components were tested using all 
community-control studies for which we had
sufficient information; that is, mean hospital days
TABLE 37  Community-control RCTs: inpatient and outpatient
mean monthly cost per patient
Weighted Experimental Control Difference
cost (n = 12)
Inpatient £524.93 £590.20 £65.27
Outpatient £79.97 £55.73 –£24.24
*
Total £604.90 £645.93 £41
* Difference favours controls
TABLE 38  Community-control RCTs and non-RCTs: inpatient
and outpatient mean monthly cost per patient
Weighted Experimental Control Difference
cost (n = 13)
Inpatient £509 £567 £58
Outpatient £76 £52 –£24
*
Total £585 £619 £34
* Difference favours controls
TABLE 39  Community-control studies: difference in hospital days by location
Type of study North America Mean difference  Europe Mean difference p-value
*
(n) (days) (n) (days)
RCTs 16 0.78 8 –0.30
† 0.01
RCTs and non-RCTs 18 0.57 9 –0.28
† 0.056
* Weighted unpaired t test
† Difference favours the control serviceHealth Technology Assessment 2001; Vol. 5: No. 15
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and information on the relevant components for
the experimental and control services.
The two service characteristics found to be
significantly associated with fewer days in hospital
were ‘regularly visiting patients at home’ and
‘taking responsibility for both health and social
care’. The former was only significant when non-
randomised studies were included. Studies in
which the experimental service regularly visited
patients at home, while the control service did not,
demonstrated a small difference of 0.6 days per
patient per month in favour of the experimental
service. By contrast, studies where both services
regularly visited patients at home (so that there 
was no difference in this variable) found a differ-
ence of only 0.03 days per patient per month in
favour of the control service. The difference
between the two results was significant. It should
be noted that no significance can be placed on 
the reduction in hospital days within each cate-
gory (Table 40). Multidisciplinarity was not tested
because the number of studies where one service
was not multidisciplinary was too small.
A significant association was found between the
difference in whether the services took responsi-
bility for both health and social care and the
difference in hospital days between the services
(Table 41). Studies where only the experimental
service took both roles found a mean difference 
of 1.3 days per patient per month in favour of the
experimental service, whereas studies where both
services took both roles found a mean difference
of 0.4 days – in favour of the control service. 
The numbers of studies here, however, are small.
Moreover, when one non-randomised study 
was added to the analysis, the finding ceased 
to be significant.
The other components tested were not found 
to be significantly associated with a reduction 
in hospitalisation (Tables 40 and 42). No non-
randomised studies had data on the percentage 
of contacts made at home. Average contact
frequency and caseload size against difference 
in hospital days are presented in Figures 7
and 8 respectively.
Costs
None of the regression analyses could be mirrored
by a corresponding cost analysis due to the scarcity
of service use data other than inpatient days. The
significant finding that ‘regularly visiting patients
at home’ was associated with a greater reduction 
in hospital days could be costed. The reduction in
hospital days found in studies where the experi-
mental service regularly visited patients at home
and the control service did not was 0.6 days per
month. Examining only long-run inpatient costs,
TABLE 40  Community-control studies: difference in hospital days by regularly visiting at home and home treatment function
Both services n Mean Experimental only n Mean p-value
*
difference difference
Regularly visit: RCTs 10 –0.03
† Regularly visit: RCTs 13 0.58 0.07
Regularly visit: RCTs and  11 –0.036
† Regularly visit: RCTs and  14 0.64 0.046
non-RCTs non-RCTs
Home treatment function: RCTs 8 0.05 Home treatment function: RCTs 10 0.60 0.47
Home treatment function: 9 0.03 Home treatment function: 11 0.68 0.36
RCTs and non-RCTs RCTs and non-RCTs
* Weighted unpaired t test for comparison of mean differences
† Favours control service
TABLE 41  Community-control studies
*: difference in hospital days by responsibility for health and social care
Both services n Mean Experimental only n Mean p-value
†
difference difference
RCTs 7 –0.35
‡ RCTs 3 1.31 0.02
RCTs and non-RCTs 7 –0.35
‡ RCTs and non-RCTs 4 0.95 0.07
* Only studies where the control service was a CMHT
† p-value for comparison of mean differences; unweighted Mann–Whitney U exact test (numbers are very small)
‡ Difference in favour of controlData analysis
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this represents a saving of £133 per patient per
month (1999 prices
80).
Experimental services analysis:
duration and year of study
Only the experimental service data were used in
this analysis, and for this reason all studies were
analysed together, regardless of whether the control
service was inpatient treatment or not (type). One
study (Rosenheck – Connecticut
61) was excluded
because its finding for days in hospital for patients
in the experimental arm was much greater than 
the other studies, so that it constituted an outlier.
This was because it was a study of a Veterans 
Affairs hospital, which does not have the usual
pressures to discharge patients.
Duration of study
The duration of the study was not significantly
associated with days in hospital in the experimental
condition, whether adjusted for high service use 
or not (Table 43).
Year of study
The year of first data publication was significantly
associated with outcome (p = 0.008), with earlier
studies achieving fewer days in hospital. The differ-
ence was only small, however: studies published 
10 years later had mean days in hospital which
were an average 0.9 days per patient per month
higher (Table 44). The studies used in this analysis
had publication dates ranging from 1973 to 
1999 (median 1994), but the majority (72%) 
Difference in average number of contacts per patient month
Difference in mean hospital days per patient per month between control  
and experimental services
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FIGURE 7 Community-control studies (CMHT controls): the difference in hospital days against the difference in the average number of
contacts per patient per month
TABLE 42  Community-control RCTs: regressions of difference in hospital days
n Regression coefficient
* 95% CI p-value
Difference in % of contacts ‘at home’  16 –0.008 –0.026 to 0.010 0.35
between experimental and 
control services
* Measures hospital days (per patient per month) for each percentage point of contacts made at homeHealth Technology Assessment 2001; Vol. 5: No. 15
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were from 1990 or later, making this finding 
less robust.
The analyses were repeated, adjusting for whether
or not each study was focused on high service 
users (based on studies’ inclusion criteria). It was
not possible to use baseline hospital days’ data
(mean hospital days per month in the period
before entering the study) for this adjustment
because insufficient data were available. When
adjusted, the association between year of the study
and outcome ceased to be significant (Table 44).
Experimental services analysis: location
In this experimental services analysis, the differ-
ence in mean hospital days by location of study
Difference in caseload size per keyworker
Difference in mean hospital days per patient per month between control  
and experimental services
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FIGURE 8 Community-control studies (CMHT controls): the difference in hospital days against the difference in caseload size per 
keyworker
TABLE 44  Regression of year of study against hospital days
Year of first data publication n Regression coefficient
* 95% CI p-value
Unadjusted results 30 –0.090 –0.156 to –0.025 0.008
Adjusted for high service use 30 –0.052 –0.106 to 0.001 0.055
* Measures hospital days (per patient per month) for each year (date)
TABLE 43  Regression of duration of follow-up against hospital days
Duration of follow-up (years) n Regression coefficient
* 95% CI p-value
Unadjusted 36 0.076 –0.368 to 0.519 0.73
Adjusted for high service use 36 0.076 –0.279 to 0.432 0.66
* Measures hospital days (per patient per month) for each year of duration of follow-upData analysis
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approached significance, but was only of the mag-
nitude of 0.2 days per month (Table 45). (These
differences became even smaller after adjusting 
for whether or not the study stated that it was
specifically for high users of services.)
Experimental services analysis: service
utilisation and costs
The experimental services analysis could not 
be mirrored in the cost analysis. There were no
inpatient-control studies with data usable in the 
cost analysis, so combining inpatient-control with
community-control studies would have been no
different from the cost analysis performed in the
comparative analysis (pages 61/2). There was insuffi-
cient service use data to mirror any of the regression
analyses (including those for components, below).
Experimental services analysis:
components
Of the service characteristics tested, only caseload
size was significantly associated with days in hosp-
ital. For caseload size, the direction of effect was
the opposite of that predicted – namely, that
smaller caseloads were associated with more days 
in hospital. The size of the effect, however, was
modest – an increase in caseload size of ten
patients, reducing hospitalisation by 0.7 days 
per patient per month. Moreover, all but three
experimental services in this analysis had a
caseload size of 22 or under, so the range 
was small (Table 46).
Three service characteristics, ‘home treatment
function’, ‘regularly visiting patients at home’ 
and ‘responsibility for both health and social care’
could not be tested because all the studies for
which we had usable data had answered ‘yes’ to
these questions (all but two for ‘health and social
care’). We also tested whether having a service
open for 10 hours or more per weekday (com-
pared to fewer than 10 hours) was associated with
fewer days in hospital. Data from 25 studies could
be used for this analysis, but the difference found
was negligible (0.08 days) and non-significant.
There was also no significant association between
multidisciplinarity and days in hospital (p = 0.66).
When the analysis was adjusted for ‘high service
use’, again only caseload size was significantly
associated with outcome (Table 47).
Discussion
Implications of meta-analysis
Great emphasis has been placed on meta-analysis
in recent years as a means of establishing definitive
TABLE 45  Hospital days by location
North America Europe p-value
*
(n = 19) (n = 9)
Mean days 1.57 1.75 0.064
* Analysis of variance, weighted by numbers in experimental
arm
TABLE 46  Associations between experimental RCT service characteristics and hospital days (unadjusted results)
n Regression coefficient
* 95% CI p-value
Caseload size 21 –0.071 –0.113 to –0.030 0.002
Average contact frequency (per month) 19 –0.025 –0.091 to 0.041 0.43
Percentage of contacts ‘at home’ 19 0.013 –0.005 to 0.031 0.14
* Measures hospital days (per patient per month) for each extra patient on the caseload, contact per month, and percentage point of
contacts at home (respectively)
TABLE 47  Associations between experimental RCT service characteristics and hospital days (adjusted for ‘high service use’)
n Regression coefficient
* 95% CI p-value
Caseload size 21 –0.050 –0.089 to –0.011 0.016
Average contact frequency (per month) 19 –0.018 –0.070 to 0.034 0.47
Percentage of contacts ‘at home’ 19 –0.005 –0.021 to 0.011 0.53
* Measures hospital days (per patient per month) for each extra patient on the caseload, contact per month, and percentage point of
contacts at home (respectively)Health Technology Assessment 2001; Vol. 5: No. 15
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answers about an area under review, so far as
current research allows. It presupposes a homo-
geneity of the services or interventions and of 
the patient groups studied which is unwarranted 
in the case of mental health services research
currently. Mental health interventions and 
services are notoriously, and necessarily, difficult 
to standardise. The benefits of pooling the results
of studies that purport to be considering the 
same kind of service or intervention is already
questionable for this reason. Services research is
further complicated by clinicians using a range 
of different specific interventions within any given
service configuration. These may be controlled 
for within individual studies that take place at 
a specific time and place where certain inter-
ventions are in vogue, but even this may not be
fully achieved. When comparing a number of
services in different studies, there can be no 
such confidence that the content of services 
as well as their configuration is identical.
Even in reviews where it is possible to define the
reviewed area more narrowly than in the present
study, the meta-analysis of data from large numbers
of studies is a questionable activity. The conclu-
sions that may be drawn from such meta-analyses
risk being misleading by implying certainty about
areas in which in fact no such certainty exists. 
At present it is widely believed that research to
date has already reached a verdict concerning 
the effects of home treatment that is generalisable 
to a wide range of services. Our findings do not
support such certainty with regard to hospital-
isation data and cost-effectiveness.
Our systematic search of the literature produced 
a pool of studies that were fairly heterogeneous in
terms of such service components as caseload size
and contact frequency, although identifiable as
‘home treatment services’. They were also hetero-
geneous in terms of their controls. As we had
anticipated, there was a range of control services,
some very poorly defined. Some were similar, at
least in label, to the experimental services in other
(usually earlier) studies. We analysed separately
those studies in which the control condition was 
at least an initial period of hospitalisation. This is
not always done in meta-analyses (see, for example,
Tyrer and colleagues
7), but our findings suggest 
it is justified when using days in hospital as an
outcome measure (see below). The community-
control group, however, comprised a range of
control services, as reported above.
The problems of analysing such a heterogeneous
group of studies were compounded by the 
limited availability of data. Only 57% of the studies
yielded data that were usable in our meta-analysis,
even with the intensive follow-up conducted. This
is typical for Cochrane Reviews in this area, and
severely limits generalisability. We chose to use a
particular outcome measure – days in hospital.
This is the most commonly collected hospital-
isation measure, but not all the studies had
collected it. We considered creating a proxy 
for hospitalisation from the range of different
hospital measures reported (percentage of 
patients hospitalised; admissions; number in
hospital at the end of the study period), which
would have included more studies. This would
have been a much cruder and less reliable
measure, however, with no clear scaling, 
and would have been difficult to interpret.
Very few standard deviations were available for
hospital days, either in the papers or directly from
the authors. This further limited the generalis-
ability of our findings because confidence intervals
could not be placed around the differences in
means found between experimental and control
services. Cochrane Reviews include in their meta-
analyses only outcome data for which standard
deviations are available. We did not follow this
policy, however, as this would have severely limited
the number of studies we could include. We have
included all studies for which data on hospital 
days were available, but with a serious caveat 
about the disadvantages of so doing.
It was not the aim of this review to perform
separate analyses of, say, studies of programmes
labelled ‘ACT’ versus those labelled ‘case
management’, or of those labelled ‘strengths 
case management’ versus those described as
outpatient treatment, since these labels are not
clearly defined. The great number of studies 
that simply use the labels ‘standard care’ or 
‘usual services’ for their control conditions 
would render this m/eaningless in many cases.
Recent Cochrane Reviews have already per-
formed analyses of some such areas, relying 
mainly on the labels given to services by authors.
Our intention was to find a way of reviewing the 
whole area of ‘home treatment’. We aimed to
consider the feasibility of assessing its effectiveness
and the extent to which it constitutes a distinct
service model (page 51, ‘Service classification’).
The evidence concerning its effectiveness is at
present not sufficient to answer the original
research questions.
With the community-control studies (the majority
of the studies in the review), the inadequacy of Data analysis
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the evidence base is largely due to the fact that
many studies use as their control conditions
services that would themselves meet our criteria 
for ‘home treatment’, and which may also have
been studied as experimental conditions, or that
are simply not clearly defined. In pooling their
results in our conventional meta-analysis, we were
aware that all we could test was what difference
studies had found between ‘home treatment’
services and the ‘existing’ services to which they
had compared them. This militates against drawing
any conclusions from the conventional meta-
analysis of the community-control studies, which
should be regarded instead as an intellectual
exercise and is discussed as such below.
The meta-analysis of the inpatient-control studies
was not affected by these difficulties to the same
degree, as we knew that all the control services 
in the studies involved at least an initial period 
of inpatient treatment. It was limited, however, 
by the small number of such studies with appro-
priate available data. This may have been because
inpatient-control studies were earlier studies 
on average, making follow-up of authors 
more difficult.
It is thus not possible for us to offer a robust 
meta-analysis of the studies in this review along
conventional lines (pooling all their results for the
outcome of reduction in hospitalisation). Indeed,
questions could be raised about the value of meta-
analysis in this area. The results we present are
illustrative of the difficulties of the task and the
inadequacy of the evidence base, and as such
constitute an important finding. However, this
review also offers an analysis of the study findings
against service components and other variables
(location of the study, year of publication and
duration of follow-up). The attempt to determine
whether such components as caseload size, contact
frequency and home visiting were associated with 
a reduction in hospitalisation is unprecedented.
None of these analyses (of components or of
variables such as duration, year and location) are
hampered by the lack of standard deviations, so
that we have been able to place significance values
on the associations found. The regressions using
duration, year and location of study are limited by
the range of service models used. However, the
analyses of components are not limited by
heterogeneity of studies. We were able to pose
more focused research questions, based on the
Delphi exercise, and use data reliably collected
from the authors. In considering the community-
control studies, we included only those for which
the components were relevant to the control
services (usually where they were CMHTs) and for
which we had information on the control service
components. The conclusions that can be drawn
from this exercise, however, are limited: again,
probably due to insufficient available data.
Days in hospital (conventional 
meta-analysis)
The difference in mean hospital days in favour 
of the experimental over the control services
found by community-control studies was only a 
tiny proportion of that found by inpatient-control
studies: 0.2 days per patient per month compared
to 4.9. This confirms our hypothesis that studies
where the control service involved an initial 
period of inpatient treatment would show greater
differences in hospitalisation. This may have 
been exacerbated by the fact that the inpatient-
control studies were significantly earlier than the
community-control studies, so more likely to be
conducted at a time when inpatient treatment 
was the norm and patients were less likely to be
discharged quickly. Differences between locations
are discussed on page 69.
Duration of follow-up
We had hypothesised that the duration of 
follow-up would have a greater impact on days 
in hospital when the control service was inpatient
treatment (that is, with a guaranteed initial 
period in hospital). There were too few studies 
of this type, however, to test this hypothesis in 
a regression analysis of duration of follow-up
against reduction in hospitalisation. When two
studies of less than a year’s duration and one of 
2 years’ duration were omitted from the analysis,
the overall difference dropped by 2 days per
patient per month.
The association between duration of study and
days in hospital across community-control studies
was highly significant. Studies with a longer
duration of follow-up found smaller reductions 
in days in hospital (a difference of 0.6 fewer days
per further year of follow-up). This might imply
that the effect of the experimental service is
diluted over time. Possibly, initial staff commit-
ment to maintaining patients in the community
fades. Alternatively, the difficulties of collecting
data reliably over longer periods may lead to
greater proportions of missing data, introducing
random bias. This finding should be treated with
caution because it used a range of heterogeneous
studies. In the experimental services analysis,
which used only experimental arm data, no
significant association was found with the 
duration of follow-up.Health Technology Assessment 2001; Vol. 5: No. 15
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Changes over time
In the comparative analysis, no significant
association was found between the year of the
study and reduction in hospitalisation, perhaps 
due to dividing up the studies depending on
whether or not the control service was an initial
period of inpatient treatment, and thus having
insufficient numbers. In the experimental services
analysis, however, experimental group patients
were found to spend fewer days in hospital in
earlier studies, as we had expected. The differ-
ence was only small, however: 0.9 days per patient
per month for each 10 years later that the study
was published. This finding should also be treated
with caution because it used a range of hetero-
geneous studies. Moreover, the majority of studies
for which we had usable data included studies
from the 1990s, although some were published 
as early as 1973.
We do not therefore have robust evidence to
confirm the hypothesis that later studies find
smaller reductions in hospitalisation. The hypoth-
esis that improving control services may account
for smaller reductions in hospitalisation in later
studies can also not be confirmed or refuted
through this analysis. The analysis that found an
association between year of publication and days 
in hospital (the experimental services analysis) 
was not only not robust, but had used only days 
in hospital in the experimental arm as its outcome
measure, rather than the difference between the
experimental and control arms.
Location
There was some suggestion that North American
studies demonstrated greater reductions in
hospitalisation than European ones, using their
experimental services, but the evidence was not
conclusive. In the comparative analysis, it was 
not possible to test the difference by location for
inpatient-control studies due to small numbers 
of studies with available appropriate data. For
community-control studies the difference was
statistically significant, but clinically small: only
about a day fewer in hospital per patient per
month. This may reflect a greater disparity be-
tween the experimental and control services in
North America compared with Europe. This
finding should be treated with caution, however, 
as it may be confounded by the range of services
included and the fact that services used as the
experimental condition in some studies are 
used as the control condition in others. When 
we analysed all studies with available data, using
only experimental condition data (the experi-
mental services analysis), we found no significant
difference in days in hospital between North
American and European studies.
Service components
In the comparative analysis, no inpatient-control
studies could be used to test for associations
between service components and days in hospital
due to the small numbers of studies with appro-
priate available data. The only components 
found to be significantly associated with reduced
hospitalisation for community-control studies in
this analysis were ‘regularly visiting patients at
home’ and ‘responsibility for both health and
social care’.
Studies where only the experimental service 
took responsibility for both health and social 
care found a reduction of 1.6 more hospital 
days than studies where both services had those
roles. This difference ceased to be statistically
significant, however, when non-randomised 
studies were added. On the other hand, ‘regularly
visiting at home’ was only significant when non-
randomised study data were included, which 
may call the result into question. The difference 
in mean hospital days found by studies where 
only the experimental service regularly visited 
at home compared with where both services 
did, was about 0.6 fewer days per patient per
month. Moreover, this service component is 
an unquantified one. The continuous measure
associated with it, ‘proportion of contacts de-
livered at home’, was not significantly associated
with the difference in days in hospital. Thus, 
while the hypothesis received confirmation, the
difference is not very meaning-ful for service
planning. ‘Regularly visiting patients at home’
could not be tested in the experimental services
analysis because all the experimental services 
with available data said that they did regularly 
visit their patients at home.
There were insufficient data available for analysis
of the difference in caseload size against the mean
difference in hospital days between the experi-
mental and control services. In the experimental
services analysis, paradoxically, lower caseloads
were actually associated with slightly increased 
days in hospital for experimental patients,
although the magnitude of the difference was
small (0.7 more days per patient per month for
every ten patients removed from the caseload).
Despite the small magnitude of this difference, 
this is a strikingly counter-intuitive finding. Most
intensive community services have assumed that
smaller caseloads lead to reduced inpatient care.
Indeed, it was this conclusion from Stein and Data analysis
70
Test’s landmark study (Stein – Madison
11) that
fuelled much of the service and research activity.
Two explanations are possible. Smaller caseloads
may enable clinicians to detect relapse more
quickly, resulting in increased hospital use,
14
or to maintain contact with patients who might
otherwise be lost to contact. Alternatively, it may 
be that services with smaller caseloads serve 
more severely ill people. This would not have 
been controlled for in this analysis, since it was
based on experimental data alone rather than 
on randomised comparisons. We did make an
attempt to adjust for ‘high service use’. There
were, however, insufficient data on hospital use
prior to the study, so we were obliged to construct
a proxy for high service use, incorporating a 
range of inclusion criteria from the studies. 
Studies that did not specify high service use 
as an inclusion criterion might have included 
patients whose hospital use was equal to those 
in the ‘high service use’ studies. Our attempt to
adjust for services with smaller caseloads having
more ill people in them was therefore limited. 
It made no difference to the result: caseload size
was still negatively associated with hospital days.
Overall, we do not have sufficient evidence to 
draw conclusions about the effect of working 
with smaller caseloads.
The lack of evidence for lower caseloads may be
seen as supporting the Delphi participants’ view
that caseloads of less than 15 were not particularly
important in successfully treating patients out 
of hospital (page 33, ‘Caseload size’). Their view 
that caseloads of fewer than 25 were important 
is not tested in this review because most of the
experimental services for which we had infor-
mation had caseloads of fewer than 25.
Patient groups
Our findings are based primarily on studies where
the majority of the patients suffered from psychotic
illness. These findings should be extrapolated to
services focused on neurotic patients only with
caution. The few studies predominately of neurotic
patients were included in the analysis to reflect our
brief of reviewing studies of patients with ‘mental
health problems’ rather than psychotic illness.
Excluding them would have been problematic in
any case, given that the studies predominately of
psychotic patients sometimes included neurotic and
other patient groups. The heterogeneity of patients,
even in those studies where the majority suffered
from psychotic illness, may be a weakness of the
studies, which, where they lack stratified samples,
may fail to detect significant impacts of services on
specific subgroups of patients, limiting the reliable
extrapolation of findings to these patients.
Impact of non-randomised studies
It was not a primary aim of this review to test the
robustness of non-randomised studies in compari-
son to RCTs. In the event, the small number of
prospective non-randomised studies with well-
matched patient groups made this impossible. 
We had relatively few non-randomised studies 
with appropriate data to add to the analyses. In-
evitably, their inclusion usually had little impact 
on the results. Where they did affect the results,
however, it was often, though not always, in lessen-
ing their significance or reducing the magnitude 
of the finding. This is the opposite of what might
be expected, since concerns are often raised that
non-randomised studies may be more likely to
detect bigger or significant differences. However,
the numbers of non-randomised studies in these
analyses were too small to draw any firm
conclusions about their impact.Health Technology Assessment 2001; Vol. 5: No. 15
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T
his review provides an overview of the range 
of studies of ‘home treatment’ services and
assesses the current state of research into their
effectiveness. Through a process of intensive
follow-up, we supplemented the information
available in the papers (published and un-
published) and retrospectively identified key
service components, generated using a Delphi
exercise. Through this process we also aimed 
to ascertain the sustainability of the services and
their key components. We consider the main 
focus of this review to be these elements – review
of the state of research, and characterisation and
sustainability of the services – rather than the
limited meta-analysis that was possible.
This review uses Cochrane methodology as its
starting point, but builds on it in several ways. 
First, we chose not to include in our meta-analyses
only studies for which we had standard deviations
for the data on mean hospital days. This would
have severely compromised the generalisability 
of the findings. It was our policy instead to include
all studies for which we had data on mean hospital
days, but to contextualise our findings in an
understanding of the limitations of such a meta-
analysis in this area. These limitations have been
made clear, along with the implications of this for
our findings. Secondly, we included high-quality
non-randomised studies in our analyses, although
always analysing the RCT findings separately too.
The implications of this are discussed below. This
review is also unprecedented in its attempt to test
service components for their association with days
in hospital. The conclusions that can be drawn
from this, however, are limited.
Review of the state of research
We chose to review a broad area, ‘home treatment’
(defined as ‘services that enable the patient to 
be treated outside hospital as far as possible and 
to remain in their usual place of residence’), in
response to the movement of mental healthcare
from the hospital to the community over the 
last three decades and the urgent need to provide
an evidence base for further community mental
health service provision. We found 91 studies,
including non-randomised ones, conducted 
over a 30-year period. This is quite a large number
for mental health services research. On the other
hand, given that these studies need to provide the
evidence base for crucial policy decisions, it might
be seen as a relatively small number. Moreover, it
might be expected that it would be possible to
provide evidence for the effectiveness of home
treatment from the findings of 91 studies, 
however heterogeneous. This is not the case.
Our finding that inpatient-control studies found 
a difference of nearly 5 days in hospital per 
patient per month in favour of home treatment 
(at 1 year) was open to question due to the
difficulties of meta-analysis. Despite (or perhaps
owing to) the huge influence of the pioneering
studies moving mental healthcare into the
community, there were relatively few studies
comparing home treatment to inpatient treat-
ment with appropriate available data for use in 
this analysis, so the finding was not based on 
many studies. Moreover, no statistical significance
could be calculated owing to the lack of standard
deviations. Nevertheless, if this finding is valid, its
magnitude is extremely significant clinically. Its
implications, however, are circular: it demonstrates
that home treatment services result in patients
spending less time in hospital than services that 
(at least initially) treat them in hospital.
For studies comparing a home treatment service
to another (commonly the ‘usual’) community
service, the heterogeneity of the control services
used, the wide range of outcome measures, 
even for hospitalisation alone, and the limited
availability of data, may all confound the attempt
to ascertain effectiveness. The difference found
between experimental and control services was
close to zero.
While many individual studies may be of a high
quality, the lack of uniformity of outcome measures
(even for hospitalisation alone) militates against
meta-analysis of their results in order to ascertain
their generalisability. Many studies, moreover, had
small sample sizes, giving them inadequate power
to detect statistically significant outcome differ-
ences. Moreover, the ‘Review of economic evalu-
ations’ (chapter 3) found that when authors them-
selves conducted tests of differences between
Chapter 7
Conclusions and recommendations Conclusions and recommendations
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control and experimental groups, the tests were
not always appropriate.
Costs
This review attempted to evaluate the cost-
effectiveness of home treatment by two comple-
mentary means: a review of economic evaluations
(chapter 3) and the inclusion of service utilisation
data in the larger analysis (chapter 6).
The review of economic evaluations undertook 
an evaluation of the subgroup of studies in this
review that had published cost analyses. It was
notable that only 22 of the 91 studies were found
to have cost analyses adequate by the criteria used.
It found the evidence in favour of home treatment
in general to be largely inconclusive, due both to
the heterogeneity of the included studies and to
problems in study design such as sample size,
protocol adherence, duration of follow-up, and
difficulties with the choice of CEA in the majority
of the studies.
Even when attempting to draw conclusions
regarding the cost-effectiveness of a more specific
service model such as ACT (the model in most 
of the studies for which there were cost analyses),
drawing conclusions is hampered by inter-study
variations in: location (including urban/rural);
selection criteria; controls; service models;
outcome measures; follow-up periods; and quality
of analysis. Conclusions about the wider focus of
this review, ‘home treatment’, are still more
difficult to draw.
The analysis of service utilisation data attempted 
in chapter 6 aimed to complement the review of
economic evaluations with a different approach. 
It aimed to combine service utilisation data, 
where available, from the full range of studies 
in order to mirror the meta-analyses (both 
more and less conventional) undertaken for the
hospitalisation outcome. This process was severely
hampered, however, by the lack of data available in
the papers and from the authors. The conclusions
that can be drawn from it are minimal as, again
due to the lack of standard deviations available, 
the statistical significance of the only analyses 
that were possible cannot be measured.
Other outcomes
In this review we have not analysed outcomes other
than days in hospital. We acknowledge that using
hospitalisation as a proxy for clinical outcome 
is problematic but, for reasons given previously
(page 3), it was the most feasible option. The
studies also collected data on a wide range of
clinical, social and other outcomes, but (as with
hospitalisation outcomes) used a variety of forms
and scales. Extrapolating from these results would
be difficult.
Patient groups
The remit for this review was a widely defined
patient group: people with ‘mental health
problems’. Despite the breadth of the search
strategy, we found far more studies focusing 
on patients with severe mental illness and with
psychotic illness: the vast majority of the studies
(87 out of 91) were made up predominately of
people with psychotic disorders. This was inevi-
table, given the loading of the research base 
at the ‘severe’ end of the spectrum of mental
illness. The findings of our analysis should be
extrapolated to patients with neurotic illness 
only with caution. Similarly, only a few studies
tested home treatment services for other 
narrower patient groups such as homeless 
mentally ill people or people with severe 
mental illness and substance misuse. Within 
the subgroup of studies that had an economic
evaluation, there was evidence in favour of 
ACT for homeless mentally ill people, but 
this was based on only two studies.
Carers
Only one of the economic evaluations reviewed
included costs for relatives and carers, perhaps 
due to difficulties in measuring the effects of
treatment on carer well-being and in valuing time-
savings. We did not analyse carer-related outcomes
for the whole pool of studies, but it is possible 
to comment on carer support on the basis of 
this review.
The role of carers and relatives was identified 
as important in the Delphi exercise. This may
reflect the growing awareness of their needs of
which ‘The National Service Framework for 
mental health’
79 gives evidence. The National
Service Framework recommends that carers of 
the severely mentally ill be seen by keyworkers
every year for an assessment of their caring,
physical and mental health needs and have their
own care plan. It is less clear, however, how carers
are to be identified and exactly what their careHealth Technology Assessment 2001; Vol. 5: No. 15
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plans are to involve. This may be mirrored in the
findings of the Delphi exercise, which rated
‘support for carers’ and ‘attention to the needs of
informal carers’ as very important, but identified
few specific ideas for supporting them and rated
these ideas only as ‘important’, rather than ‘very
important’ or ‘essential’ (page 34, ‘Carers’).
Results from the UK700 trial suggest that even
intensive services rarely see carers as often as 
the National Service Framework stipulates.
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Although we did not analyse carer contact across
the studies in our review, we can comment on the
proportion of the services that had a ‘protocol for
meeting the needs of carers’. Only 24% of the
authors who responded to our follow-up said that
their experimental service had such a protocol
during the period under study. Of the control
services whose authors had the information, only
7% had a protocol. More of the experimental ser-
vices still in operation (as at February 2000) had 
a carer protocol, but still only a minority (35%).
Moreover, we cannot comment on the specificity 
of such protocols in detailing the support to be
offered to the carers. Our review did not survey
current ‘home treatment’ services, and it is not
clear how representative the 29 services still in
operation are of current practice. Nevertheless, 
it seems likely that most services do not have a
formal protocol for meeting carer needs.
Non-randomised studies
The possibility that RCTs may not necessarily 
be generalisable to the ‘real world’ of service
provision has been discussed earlier (page 2). 
It may be that this problem could be addressed 
by high-quality non-randomised (observational)
studies. This review, however, highlights some of
the problems involved in seeking evidence from
such studies. The diffi-culties associated with
searching for non-randomised studies have 
been discussed above. We found far fewer non-
randomised studies than RCTs (35 compared to
56), and only one of these included an economic
evaluation. The non-randomised studies found 
also included retrospective studies and studies 
of groups that were not similar at baseline,
reducing the number appropriate for analysis. 
This imbalance was then compounded by the
relatively poor response rate of non-randomised
study authors to our follow-up survey (only a third
responded). Including the few non-randomised
studies in our analyses had little impact on the
findings and gives rise to no definite conclusions.
The issue of the reliability of non-randomised
study findings warrants further investigation. 
It should also be noted that alternative solutions
have been proposed, such as ‘pragmatic’ RCTs.
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Location
There were some differences between North
American and European studies with respect to
team composition. North American services
operated significantly longer hours and made
contact with their patients more often. Neither 
of these features was itself associated with a
difference in days in hospital, however. It is
unlikely that these differences between the two
locations account for the significant difference
found in hospitalisation, the magnitude of which
was only 1 day per patient per month.
The two groups tested were dominated by US 
and UK studies, with few studies from Canada 
or elsewhere in Europe. Of the 22 economic
evaluations, all but one (Fenton – Montreal
56) 
were from these two countries. There were very 
few studies from outside North America and
Europe, and for this reason their results could 
not be used in either our descriptive or our 
meta-analyses to test the effect of location. The
meagre number of studies from other areas may
have been due to an English language bias in 
our methodology. Nevertheless, it is a cause for
concern that so little is known about home
treatment services outside of the USA and UK.
Service components and
classification
There was no evidence for the service components
changing over time, in either the experimental 
or the control services, with the exception of the
percentage of contacts at home, which had in-
creased for control services over time. It was not
possible to provide a new taxonomy of services on
the basis of our retrospective characterisation of
services in terms of these components. We would
recommend, however, that they be used
prospectively in future.
‘Home treatment service’ is defined broadly 
as the inclusion criterion for this review. On the
strength of the Delphi, however, we also looked 
at service components that imply a more focused
definition of home treatment, namely ‘explicit
home treatment function’, ‘regularly visit[ing]
patients at home’ and ‘percentage of contacts
made at home’. Having a ‘home treatmentConclusions and recommendations
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function’ and ‘regularly visit[ing] patients at
home’ turned out to be virtually synonymous 
and to be loosely associated with being a multi-
disciplinary team, having psychiatrists as integrated
team members, having smaller caseloads and
taking responsibility for both health and social
care. These components thus comprise a more
tightly defined ‘home treatment’ service.
Among leading UK psychiatrists, opinion on 
the merits of ‘home treatment’ according to 
the narrower definition was mixed (page 35). 
Our analysis, however, found that services that
regularly visited patients at home achieved
significantly greater reductions in days in hospital
than services that did not (when we considered
community-control studies alone). There was 
also some evidence that taking responsibility for
both health and social care was associated with
reduced hospitalisation. However, there was no
evidence that multidisciplinarity, having a ‘home
treatment function’, smaller caseloads, or greater
proportions of contacts delivered at home were
individually associated with reduced hospital-
isation. While there is some evidence for a 
distinct model of home treatment comprised 
of these components, the evidence base for 
its effectiveness is clearly inadequate.
Sustainability of home 
treatment services
Only a quarter of the services whose authors
responded to follow-up – likely to represent less
than a quarter overall – were still enduring in
approximately their original form, without having
dropped their ‘innovative’ features.
Only half of the responding authors reported 
that the services were still running at all. For those
services, the components identified through follow-
up had largely not changed in most cases. Where
services endured, therefore, they are likely to have
retained the components identified through our
Delphi exercise as central to community-based
care. This may be because our components had
been generated from an exercise (the Delphi)
ascertaining what psychiatrists currently consider
to be important to community-based services. 
By contrast, the services were less likely to have
retained specific individual features that marked
them out as innovative at the time of inception.
Overall, such innovative features seem short-lived.
Many of them were no longer perceived as useful,
however, so that the changes were seen as being
part of service evolution.
Nevertheless, the sustainability of home treatment
services as a whole does not seem to have been
high. The fact that finding a significant reduction
in hospitalisation was significantly associated with
still being operational suggests that studies having
non-significant results may lead to disbanding of
the experimental service. This trend, however,
might also be due to the innovative nature of the
experimental services studied. We did not ascertain
how long each service had been operational before
the study began, but this would be a useful area 
for future research. Moreover, many of the services
tested in earlier studies were used as controls later
on, when they had become standard practice. 
We did not collect components for the control
services currently, anticipating insurmountable
difficulties with the changing nature of ‘standard
care’, although it would have been interesting to
do so. We did find, however, that control services 
in more recent studies were more likely to make
higher proportions of contacts with patients in
their homes. There is thus some evidence to
suggest that some components originally found 
in innovative services gradually become 
standard practice.
Cochrane reviews
The present review complements the work of 
four existing Cochrane reviews: ACT (Marshall 
and Lockwood
6), Case Management (Marshall and
colleagues
5), CMHTs (Tyrer and colleagues
7) and
Crisis Intervention (Joy and colleagues
8). Here we 
briefly outline the differences between our
approach and findings and theirs.
Assertive community treatment
6
This review included studies of services labelled
ACT, assertive Case Management, PACT or as
based on the Madison, TCL, ACT or Stein and 
Test models. It divided up the analysis on the 
basis of whether the control service was ‘standard
care’, ‘hospital-based rehabilitation’ or ‘case
management’. The separate treatment of hospital-
based rehabilitation matches ours of inpatient-
control studies. The further division of controls
into ‘standard’ care and Case Management, how-
ever, contrasts with our analysis. We avoided using
labels given to services as the basis for subanalysis
and this is in contrast with the inclusion criteria
used in this ACT review for both experimental
services and non-hospital controls. The ACT review
thus looks at a subset of the studies in our home
treatment review, selected by different means. For
these studies, they found ACT reduced days in
hospital. For other outcomes, they reported aHealth Technology Assessment 2001; Vol. 5: No. 15
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range of measures collected and a great deal of
data that were of insufficient quality for analysis.
ACT was superior on a few measures (such as
employment and accommodation status), but for
most clinical and social outcomes there were either
insufficient high-quality data or no significant
differences were found. Despite this, the authors
conclude that ACT is “clinically effective” and
should become the service of preference over 
Case Management. While ACT was cheaper than
the alternatives in terms of hospital costs, Case
Management was actually cheaper in terms of 
total costs. The overall cost-effectiveness of the 
two is by no means clear from this analysis.
While the present authors would endorse the
recommendation of the ACT review that a clear
distinction be made between ACT and other
community-based service models, this is not
robustly achieved by the ACT review. Contrary to
received wisdom, ACT has not been clearly and
robustly defined; the ACT review has not tested
only studies of ‘the whole model’ for this reason,
and because the labels applied to the studied
services are simply taken on trust.
Case management
5
Again using the labels given by authors to the
services, this reviews 11 studies comparing ‘case’ 
or ‘care management’ to ‘standard care’, excluding
ACT and ‘home-based care’ (by a different defin-
ition to that used here). It found some evidence
that patients in Case Management were more likely
to remain in contact with psychiatric services, and
found that they were twice as likely to be admitted
to hospital. Since these two features may well be
related, the analysis of duration of hospital stay is
potentially more useful. Only six studies, however,
had appropriate data. Four of these suggested 
that length of stay was longer for Case Manage-
ment patients, but the authors admit that they
cannot reach definitive conclusions on this subject
without recourse to individual patient data. For
clinical and social outcomes, there were again no
significant differences, or insufficient data. The
data on costs were also inconclusive. It suggested
that Case Management increases healthcare costs
but slightly reduces total costs.
Community mental health teams
7
Studies of CMHT care, defined to exclude ACT
and Case Management, were reviewed, and only
five studies were included. Data on hospitalisation
were inconclusive: while duration of admission was
less for experimental patients in each study, distri-
bution of the data was unclear; for admissions, the
data were significantly heterogeneous due to one
study (Hoult – Sydney) – perhaps a result of
analysing inpatient-control and community-control
studies together. Data suggested that more CMHT
patients than controls were satisfied with care 
and stayed in the studies, but there were no clear
differences for clinical and social outcomes, 
which were recorded using different scales or
could not be analysed due to lack of standard
deviations. Interpretation of the cost data was
problematised by skewed data, although there 
was a suggestion that the total care costs were
lower for CMHT patients.
Crisis intervention
8
This review defined ‘crisis intervention’ as “any
crisis-oriented treatment … by staff with a specific
remit ... in and beyond ‘office hours’”. In practice,
this was always combined with a home care pack-
age, so that the review’s findings cannot be attrib-
uted to crisis intervention alone. Only five studies
were included, including one (Pasamanick –
Ohio
18) considered to have flawed randomisation
in the present review. The criterion that services
must operate out-of-hours was problematic. Three
studies were described as having on-call staff 
24 hours a day, but the remaining two had only
answering machines referring patients to the
hospital emergency clinic or the police. Our
detailed follow-up of authors, however, revealed 
a different picture. Only one of these three con-
firmed that they had operated 24 hours a day; 
one said they had operated 14 hours on weekdays,
although it was a 7-day service with a ‘specific 
crisis element’; the third said it did not have a
‘specific crisis element’ and operated 7 days a
week, but for 15 hours per weekday. While all 
thus operated ‘out of hours’, they cannot be 
said to be ‘24-hour’ services, as claimed.
This information was not available to the Cochrane
reviewers. It demonstrates, however, the disparity
between service details reported (and summarised)
in published papers and the reality of actual
practice during the studies. This and the fact that
two of the five services did not in effect operate
‘out of hours’ at all (as the Cochrane authors
admit) throws the conclusions of the review into
some doubt.
The reviewers reported a wealth of non-validated
outcome scales. They did not compare admissions
because the studies were all inpatient-control and
the controls therefore had an index admission. In
comparing repeat admissions there was a ‘slightly
significant’ difference, but significant hetero-
geneity. No differences were found in global state
or mental state, but the experimental patients Conclusions and recommendations
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were more satisfied overall and less family ‘burden’
was reported. The reporting of cost data was
problematic and no definite conclusions could be
drawn from it, although the experimental care
packages seemed to be cheaper.
In summary, the present review is intended 
in part to complement these four Cochrane
reviews by analysing the data in a different way 
and avoiding the problems created by division 
of the field into narrower service models on the
basis of poor definitions. Our intensive follow-up
yielded information that not only provided a way
of comparing all the studies in this field, but also
directly contradicted the categorisation and
description of services in one of the existing
reviews. Scrutiny of the Cochrane reviews also
reveals the same problems with heterogeneity of
outcome measures, poor quality data and absence
of standard deviations as we report here. Both are
illustrative of this field of mental health research.
For this reason, the Cochrane reviewers, despite
analysing narrower subject areas, were able to find
only a few statistically significant results, based on
fewer studies. While their findings have been
formative of mental health service planning and
continue to provide useful information, the
present review should be seen as complementary 
to them in providing an alternative approach, as
well as underlining the lack of clarity which has so
far been achieved in home treatment research.
Recommendations
Research recommendations
• coordinated research strategy, nationally driven
• economics evaluations to be included in studies,
reporting health and social service utilisation
• service components to be collected and
reported for both experimental and 
control services
• studies to be designed with adequate 
statistical power
• multicentre studies
• studies to be designed with longer duration 
of follow-up
• comparable measures to be used, to facilitate
meta-analysis
•i nstrument for measuring mental health-related
quality of life should be developed
•s ubanalysis for different patient groups to 
be performed
• study protocols should be adhered to
•i ndependent researchers to conduct studies
• no further studies of home treatment compared
to inpatient admission
• no further localised replications of more highly
powered studies.
Recommendations for commissioners
There is not yet a strong evidence base in the area
of home treatment for mental health problems,
particularly in the UK. This highlights the need 
for further research into home treatment. The
inadequacy of the evidence base affects economic
conclusions as well as clinical ones.
Scope of future research: economic studies
We would recommend that future studies include
economic evaluations that are comprehensive in
their approach to care, reporting utilisation of both
health and social care services, as well as the input
of other agencies and user and carer costs. Further
research should also be directed towards the devel-
opment of an instrument that can be broadly
applied to measure improvements in mental health-
related quality of life. Techniques such as conjoint
analysis should then be used to generate a system 
of valuations applicable to changes in health status
measured by this instrument. The appropriateness
of using long-run marginal cost estimates should be
more closely examined in future economic studies 
in order to value any reduction in inpatient stay
appropriately. Further research should be directed
into the appropriate valuation of reduced con-
gestion within the inpatient system. We would also
encourage further work on appropriate analytical
techniques for economic data.
Study design
It is clear that the days of funding small, localised
studies of existing service models (replicating more
highly powered existing studies) should now be
over, except for the purposes of audit. They remain
valid, however, for innovative services. In severe
mental illness in particular, mental health
evaluations must be sufficiently powered to take
account of the positive skew on inpatient and cost
outcomes. Multisite studies may be a solution to
this problem. Resources should be directed
towards studies that convincingly demonstrate
adequate statistical power; we would recommend
that prospective power calculations become the
norm, allowing for relatively high attrition rates.
Studies should also be designed with a longer
duration of follow-up in order to evaluate longer-
term effectiveness robustly, and with comparable
measures and methodologies.
In order to test the effectiveness of home treat-
ment for different patient groups, more studies
should be conducted into specific diagnostic
groups, or a priori subanalyses performed.Health Technology Assessment 2001; Vol. 5: No. 15
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Most studies of home treatment are reported by
the clinicians who run the services. Our review
attempted to control for the enthusiasm of the
experimental team by analysing all experimental
services against each other (experimental services
analysis). Nevertheless, it would be appropriate 
for independent research experts, rather than 
the providing clinicians, to test mental health
services in future.
The National Service Framework recommends 
that there be more government direction of
research in the NHS. The findings of the present
review would seem to support this view. At present,
small pieces of research may add little to the
overall picture. A nationally driven coordinated
research strategy is advisable, allowing both for
prioritisation of subject and for overall standards
for methodological rigour.
Home treatment services achieved fewer days in
hospital than services involving at least an initial
period of inpatient treatment (inpatient-control
studies). Although such studies were likely to be
earlier, there were some recent examples. We recom-
mend that studies of home treatment compared with
admission are no longer initiated, at least where
hospitalisation is used as an outcome measure.
Service components
In the short-term, defining service components 
will allow for more meaningful prospective com-
parison between services and studies. Studies
should routinely collect information on service
components. We would suggest that the com-
ponents used in this review (as identified in 
the Delphi exercise) be recorded prospectively.
This approach should replace that of analysing
services according to their label (both in in-
dividual evaluations and in reviews), which up 
to now has necessarily been the only option. In 
the longer-term, the description of certain key
components of care offered by a service should
offer the possibility of a new taxonomy of services 
around which future research may be based.
It is recommended that control services in studies
also be clearly defined. In reviews, studies using
inpatient treatment as the control should be
analysed separately from those using other services.
Adherence to the service protocol should also 
be measured.
Implications for clinicians
This review does not give rise to many implications
for clinicians. The evidence suggests, however, 
that visiting patients at home regularly and taking
responsibility for both health and social care may
each reduce hospitalisation for severely mentally 
ill patients. These findings should be extrapolated
to all patients with mental health problems only
with caution. These components were loosely
associated with having multidisciplinary teams,
psychiatrists as integrated team members and 
small caseloads, but this was not a cohesive group
of components. We cannot provide evidence that
the other components are individually associated 
with reduced hospitalisation.
Other recommendations for clinicians cannot 
be made on the basis of the evidence from this
review. Comparing home treatment services to
admission, unsurprisingly, showed that the former
were superior in reducing hospital days. When
comparing home treatment to other community-
based services, no evidence can be provided on
their overall effectiveness.
Expert psychiatrists’ opinions ascertained in the
Delphi exercise supported flexible working hours
across 7 days rather than 24-hour services, and
caseloads under 25 rather than under 15. This 
was supported by our analysis, which found no
evidence supporting lower caseloads (within a
limited range) and no correlation between hours
of operation and hospitalisation. The Delphi 
panel considered home visiting to be essential,
which was supported by our findings, but was not 
strongly in favour of teams specifically dedicated 
to home treatment or crisis care. They recognised
skill-mix on teams as essential, with psychiatrists
‘integrated’ in multidisciplinary teams, along 
with good management and organisation.
Implications for consumers
This review does not give rise to many implications
for consumers of mental health services due to the
lack of a strong evidence base. It seems, however,
that home treatment services that visit patients at
home regularly and those that take responsibility
for both health and social care are more effective
in reducing days spent in hospital.
Our Delphi exercise showed that expert psychia-
trists in this field thought that visiting a patient in
his/her home or home environment was essential
for the patient’s care, and that teams should attend
to social needs such as housing and finance as well
as to clinical ones. They also considered support
for relatives and carers to be important. The
evidence of our review, however, is that only a 
small proportion of home treatment services
currently have an established protocol for
addressing carers’ needs.Health Technology Assessment 2001; Vol. 5: No. 15
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Cochrane Schizophrenia Group
The CSG’s terms for psychotic illness are as follows:
[(((TARDIV* near DYSKINE*) or (AKATHISI*) 
or (ACATHISI*) or (NEUROLEPTIC* and
(MALIGNANT near2 SYNDROME)) or
(NEUROLEPTIC* and MOVEMENT and
DISORDER*) or (PARKINSONI*) or
(NEUROLEPTIC-INDUC*)) not (PARKINSON’S
near1 (DISEASE in TI))) or (‘DYSKINESIA-DRUG-
INDUCED’ / all subheadings) or (‘AKATHISIA-
DRUG-INDUCED’ / all subheadings) or
(‘NEUROLEPTIC-MALIGNANT-SYNDROME’ / 
all subheadings) or ((explode ‘SCHIZOPHRENIA’
/ all subheadings) or (explode ‘PARANOID-
DISORDERS’ / all subheadings) or (SCHIZO*) 
or (HEBEPHRENI*) or (OLIGOPHRENI*) 
or (PSYCHOTIC*) or (PSYCHOSIS) or
(PSYCHOSES) or (((CHRONIC* or SEVER*)
near2 MENTAL*) near2 (ILL* or DISORDER*)))].
Database-specific search strategies
CINAHL
CINAHL (1982–10.99) was searched using the
CSG’s terms for RCTs combined with the term for
mental health problems and the term for home
treatment, plus:
[or explode ‘Community-Assessment’ / all topical
subheadings / all age subheadings or explode
‘Community-Health-Nursing’ / all topical
subheadings / all age subheadings or explode
‘Rehabilitation-Community-Based’ / all topical
subheadings / all age subheadings or explode
‘Community-Networks’ / all topical subheadings 
/ all age subheadings or explode ‘Community-
Health-Centers’ / all topical subheadings / all 
age subheadings or explode ‘Community-Health-
Services’ / all topical subheadings / all age
subheadings or explode ‘Community-Living’ / all
topical subheadings / all subheadings or explode
‘Community-Mental-Health-Nursing’ / all topical
subheadings/ all age subheadings or explode
‘Community-Programs’ / all topical subheadings 
/ all age subheadings or explode ‘Community-
Reintegration’ / all topical subheadings / all age
subheadings or explode ‘Community-Service’ / 
all topical subheadings / all age subheadings or
explode ‘Community-Special-Programs-(Saba-
HHCC)’ / all topical subheadings / all age
subheadings or explode ‘Community-Trials’ / 
all topical subheadings / all age subheadings or
explode ‘Home-Rehabilitation’ / all topical
subheadings / all age subheadings or explode
‘Psychiatric-Home-Care’ / all topical subheadings 
/ all age subheadings or explode ‘Home-Health-
Care’ / all topical subheadings / all age
subheadings or explode ‘Home-Health-Agencies’ 
/ all topical subheadings / all age subheadings 
or ‘Home-Nursing’ / all topical subheadings / 
all age subheadings or explode ‘Home-Nursing-
Professional’ / all topical subheadings / all age
subheadings or explode ‘Home-Occupational-
Therapy’ / all topical subheadings / all age
subheadings or explode ‘Home-Rehabilitation’ 
/ all topical subheadings / all age subheadings 
or explode ‘Home-Visits’ / all topical subheadings
/ all age subheadings or explode ‘Crisis-
Intervention’ / all topical subheadings / all 
age subheadings or explode ‘Crisis-Intervention-
(Iowa-NIC)’ / all topical subheadings / all age
subheadings or explode ‘Crisis-Management-
(Iowa-NIC)-(Non-Cinahl)’ / all topical
subheadings / all age subheadings or explode
‘Mobile-Health-Units’ / all topical subheadings /
all age subheadings].
Cochrane Schizophrenia Group
Register
The Cochrane Schizophrenia Group Register
(–9.99) was searched using the term for home
treatment.
EMBASE
EMBASE (1980–10.99) was searched using the
CSG’s terms for RCTs combined with the term for
mental health problems and the term for home
treatment, plus:
[or explode ‘ community-care’ / all subheadings 
or explode ‘health-center’ / all subheadings or
explode ‘community-mental-health’ / all
subheadings or explode ‘community-mental-
health-center’ / all subheadings or explode
‘mental-health-service’ / all subheadings or
explode ‘social-psychiatry’ / all subheadings or
explode ‘home-care’ / all subheadings or explode
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‘crisis-intervention’ / all subheadings or explode
‘preventive-health-service’ / all subheadings].
MEDLINE
MEDLINE (1966–12.99) was searched using the
CSG’s terms for RCTs combined with the term for
mental health problems and the term for home
treatment, plus:
[or ‘Community-Mental-Health-Services / all
subheadings or explode ‘Community-Psychiatry’ 
/ all subheadings or explode ‘Home-Care-Services’
/ all subheadings or explode ‘Crisis Intervention’
/ all subheadings or ‘Mobile-Health-Units’ / 
all subheadings].
PsycLIT
PsycLIT (1887–9.99) was searched using the 
CSG’s terms for RCTs combined with the term for
mental health problems and the term for home
treatment, plus:
[or explode ‘Community-Mental-Health-
Centers’ / all subheadings or ‘Community-
Mental-Health-Services / all subheadings 
or explode ‘Community-Psychiatry’ / all
subheadings or explode ‘Home-Care-Services’ 
/ all subheadings or explode ‘Crisis-Intervention’ 
/ all subheadings or ‘Mobile-Health-Units’ 
/ all subheadings].Health Technology Assessment 2001; Vol. 5: No. 15
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T
he following studies were found in the
systematic literature search but were excluded
from the review because they did not meet our
inclusion critieria.
In the annotations below, home treatment is
defined as “a service that enables the patient to be
treated out of hospital as far as possible and to stay
in their usual place of residence” (excluding, for
example, day, foster and residential care), and a
comparative study is defined as one that compares
two services (excluding, for example, within-
subject comparisons).
Armstrong HE, Cox GB, Short BA, Allmon DJ. A
comparative evaluation of two day treatment programs.
Psychosoc Rehabil J 1991;14(4):53–67.
Reason for exclusion: not a home treatment study 
(day care).
Beard JH, Pitt RB, Fisher SH, Goertzel V. Evaluating 
the effectiveness of a psychiatric rehabilitation program.
Am J Orthopsychiatry 1963;33:701–12.
Reason for exclusion: not a home treatment study 
(day care).
Bedell J, Ward JC. An intensive community-based
treatment alternative to state hospitalization. Hosp
Community Psychiatry 1989;40:533–5.
Reason for exclusion: not a home treatment study
(residential).
Bell M, Lysaker P. Levels of expectation for work activity
in schizophrenia: clinical and rehabilitation outcomes.
Psychiatr Rehabil J 1996;19(3):71–6.
Reason for exclusion: not a home treatment study.
Bond GR. An economic analysis of psychosocial
rehabilitation. Hosp Community Psychiatry 1984;35:356–62.
Reason for exclusion: not a home treatment study 
(day care).
Bond GR, Witheridge TF, Setze PJ, Dincin J. Preventing
rehospitalization of clients in a psychosocial rehabili-
tation agency. Hosp Community Psychiatry 1985;36:993–5.
Reason for exclusion: not a comparative study.
Bond GR, Dincin J. Accelerating entry into transitional
employment in a psychosocial rehabilitation agency.
Rehabil Psychol 1986;31:143–55.
Reason for exclusion: not a home treatment study.
Bond GR, Witheridge TF, Wasmer D, Dincin J, McRae
SA, Mayes J, et al. A comparison of two crisis housing
alternatives to psychiatric hospitalization. Hosp
Community Psychiatry 1989;40:177–83.
Reason for exclusion: not a home treatment study.
Boomsma J, Dassen T, Dingemans C, van den Heuvel W.
Nursing interventions in crisis-oriented and long-term
psychiatric home care. Scand J Caring Sci 1999;13:41–8.
Reason for exclusion: not a home treatment study; 
not a comparative study.
Borland A, McRae J, Lycan C. Outcomes of five years of
continuous intensive case management. Hosp Community
Psychiatry 1989;40:369–76.
Reason for exclusion: not a comparative study.
Bowers L. Trends in the psychosocial problems of those
with serious and enduring mental illness under the Care
Programme Approach: a three and a half year follow up.
Psychiatr Care 1998;5:6–11.
Reason for exclusion: not a comparative study.
Brekke J, Test MA. An empirical analysis of services
delivered in a model community support program.
Psychosoc Rehabil J 1987;10(4):51–61.
Reason for exclusion: not a comparative study.
Brooker C, Molyneux P, Deverill M, Repper J. Evaluating
clinical outcome and staff morale in a rehabilitation
team for people with serious mental health problems. 
J Adv Nurs 1999;29:44–51.
Reason for exclusion: not a comparative study.
Brown G, Bone M, Dalison B. Schizophrenia and social
care: a comparative follow-up study of 339 schizophrenic
patients. Maudsley Monograph. London: Oxford
University Press; 1966.
Reason for exclusion: not a comparative study.
Buchkremer G, Klingberg S, Holle R, Schulze MH,
Hornung WP. Psychoeducational psychotherapy for
schizophrenic patients and their key relatives or care-
givers: results of a 2-year follow-up. Acta Psychiatr Scand
1997;96:483–91.
Reason for exclusion: not a home treatment study.
Bybee D, Mowbray CT, Cohen E. Short versus longer
term effectiveness of an outreach program for the
homeless mentally ill. Am J Community Psychol
1994;22:181–209.
Reason for exclusion: not a comparative study.
Caffey EMJ, Galbrecht CR, Klett CJ. Brief hospitalizaion
and aftercare in the treatment of schizophrenia. 
Arch Gen Psychiatry 1971;24:81–6.
Reason for exclusion: not a home treatment study.
Caton CL, Wyatt RJ, Grunberg J, Felix A. An evaluation
of a mental health program for homeless men. Am J
Psychiatry 1990;147:286–9.
Reason for exclusion: community housing; not a
comparative study.
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Claghorn JL, Kinross-Wright J. Reduction in
hospitalization of schizophrenics. Am J Psychiatry
1971;28:344–7.
Reason for exclusion: not a home treatment study.
Coelho RJ, Kelley PS, Deatsman-Kelley C. An
experimental investigation of an innovative community
treatment model for persons with a dual diagnosis
(DD/MI). J Rehabil 1993;59:37–42.
Reason for exclusion: dual diagnosis of mental
retardation and mental illness.
Coffey M. Provision of out-of-hours support to a forensic
population: strategies and research potential. J Psychiatr
Ment Health Nurs 1998;5:367–75.
Reason for exclusion: not a comparative study.
Conway AS, Melzer D, Hale AS. The outcome of
targeting community mental health services: evidence
from the West Lambeth schizophrenia cohort. BMJ
1994;308:627–30.
Reason for exclusion: not a comparative study.
Cotroneo M, Outlaw FH, King J, Brince J. Advanced
practice psychiatric–mental health nursing in a
community-based nurse-managed primary care program.
J Psychosoc Nurs Ment Health Serv 1997;35:18–25.
Reason for exclusion: not a comparative study.
Creed F, Anthony P, Godbert K, Huxley P. Treatment of
severe psychiatric illness in a day hospital. Br J Psychiatry
1989;154:341–7.
Reason for exclusion: not a home treatment study 
(day care).
Crosby C. Health Services Research Unit (HSRU)
University College of North Wales: evaluation of the
strategy for mental health services in North Wales. 
J Ment Health 1993;2:85–8.
Reason for exclusion: not a comparative study.
Cuffel BJ. Violent and destructive behaviour among 
the severely mentally ill in rural areas: evidence from
Arkansas’ community mental health system. Community
Ment Health J 1994;30:495–504.
Reason for exclusion: not a comparative study.
Davidson L, Tebes JK, Rakfeldt J, Sledge WH. Differ-
ences in social environment between inpatient and day
hospital–crisis respite settings. Psychiatr Serv
1996;47:714–20.
Reason for exclusion: not a home treatment study 
(day care/crisis respite).
De Cangas JPC. Le ‘case management’ affirmatif: une
evaluation complete d’un programme du genre en
milieu hospitalier. [Assertive case management: a
comprehensive evaluation of a hospital based case
management programme.] Sante Ment Que
1994;19:75–92.
Reason for exclusion: not a home treatment study 
(‘case management’ programme is hospital-based).
Deci PA, Santos AB, Hiott DW, Schoenwald S, Dias JK.
Dissemination of assertive community treatment
programs. Psychiatr Serv 1995;46:676–8.
Reason for exclusion: not a comparative study.
De Haan L, Linszen DH, Gorsira R. Early intervention,
social functioning and psychotic relapse of patients with
recent-onset schizophrenic disorders. Int Clin
Psychopharmacol 1998;13 Suppl 1:S63–6.
Reason for exclusion: not a comparative study.
Dharwandkar M. Effectiveness of an assertive outreach
community treatment program. Aust N Z J Psychiatry
1994;28:244–9.
Reason for exclusion: not a comparative study.
Dick PH, Sweeney ML, Crombie IK. Controlled
comparison of day-patient and out-patient treatment 
for persistent anxiety and depression. Br J Psychiatry
1991;158:24–7.
Reason for exclusion: not a home treatment study 
(day care).
Dickey B, Cannon NL, McGuire TG, Gudeman JE. 
The Quarterway House: a two-year cost study of an
experimental residential program. Hosp Community
Psychiatry 1986;37:1136–43.
Reason for exclusion: not a home treatment study
(residential care + psychosocial programme).
Dickey B, Gonzalez O, Latimer E, Powers K, Schutt R,
Goldfinger S. Use of mental health services by formerly
homeless adults residing in group and independent
housing. Psychiatr Serv 1996;47:152–8.
Reason for exclusion: not a home treatment study.
Dickey B, Latimer E, Powers K, Gonzalez O, 
Goldfinger SM. Housing costs for adults who are
mentally ill and formerly homeless. J Mental Health 
Adm 1997;24:291–305.
Reason for exclusion: not a home treatment study.
Donlon PT, Rada RT, Knight SW. A therapeutic aftercare
setting for “refractory” chronic schizophrenic patients.
Am J Psychiatry 1973;130:682–4.
Reason for exclusion: not a home treatment study.
Drake RE, Becker DR, Biesanz JC, Torrey WC, 
McHugo GJ, Wyzik PF. Rehabilitative day treatment 
vs. supported employment: I. Vocational outcomes.
Community Ment Health J 1994;30:519–32.
Reason for exclusion: not a home treatment study 
(day care versus supported employment).
Durbin J, Goering P, Wasylenki D, Roth J. Meeting the
challenge: field evaluations of community support
programs. Psychosoc Rehabil J 1995;19(1):19–26.
Reason for exclusion: not a comparative study.
Durbin J, Goering P, Wasylenki D, Roth J. Who gets how
much of what: a description of intensive case manage-
ment. Psychiatr Rehabil J 1997;20(3):49–56.
Reason for exclusion: not a comparative study.
Durell J, Lechtenberg B, Corse S, Frances RJ. Intensive
case management of persons with severe mental illness
who abuse substances. Hosp Community Psychiatry
1993;44:415–16.
Reason for exclusion: not a comparative study.Health Technology Assessment 2001; Vol. 5: No. 15
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Durst R, Teitelbaum A, Bar-El Y, Shlafman M, Ginath Y.
Evaluation of compulsory ambulatory treatment in
Israel. Psychiatr Serv 1999;50:698–700.
Reason for exclusion: not a comparative study.
Endicott J, Cohen J, Nee J, Fleiss JL, Herz MI. Brief vs
standard hospitalization: for whom? Arch Gen Psychiatry
1979;36:706–12.
Reason for exclusion: not a home treatment study.
Falloon IH, Boyd JL, McGill CW. Family management in
the prevention of morbidity of schizophrenia. Clinical
outcome of a two-year longitudinal study. Arch Gen
Psychiatry 1985;42:887–96.
Reason for exclusion: not a home treatment study.
Fenton WS, Mosher LR, Herrell JM, Blyler CR.
Randomized trial of general hospital and residential
alternative care for patients with severe and persistent
mental illness. Am J Psychiatry 1998;155:516–22.
Reason for exclusion: not a home treatment study
(residential).
Field G, Yegge L. A client outcome study of a community
support demonstration project. Psychosoc Rehabil J
1982;6(2):15–22.
Reason for exclusion: not a comparative study.
Fitzgerald P, Kulkarni J. Home-oriented management
programme for people with early psychosis. Br J
Psychiatry Suppl 1998;172(33):39–44.
Reason for exclusion: not a comparative study.
Freeman D, Garety P, Fowler D, Kuipers E, Dunn G,
Bebbington P, et al. The London–East Anglia
randomized controlled trial of cognitive-behaviour
therapy for psychosis IV: Self-esteem and persecutory
delusions. Br J Clin Psychol 1998;37:415–30.
Reason for exclusion: not a home treatment study.
Freeman H, Cheadle AJ, Korer JR. A method for
monitoring the treatment of schizophrenics in the
community. Br J Psychiatry 1979;134:412–16.
Reason for exclusion: not a home treatment study.
Gill KJ, Pratt CW, Librera L. The effects of consumer vs.
staff administration on the measurement of consumer
satisfaction with psychiatric rehabilitation. Psychiatr
Rehabil J 1998;21(4):365–70.
Reason for exclusion: not a home treatment study.
Glick ID, Fleming L, DeChillo N. A controlled study 
of transitional day care for non-chronically-ill patients.
Am J Psychiatry 1986;143:1551–6.
Reason for exclusion: not a home treatment study 
(day care).
Goldman HH, Morrissey J, Ridgely S. Evaluating the
Robert Wood Johnson Foundation Program on chronic
mental illness. Milbank Q 1994;71:37–47.
Reason for exclusion: not a home treatment study.
Gudeman JE, Dickey B, Rood L, Hellman S, 
Grinspoon L. Alternative to the back ward: the quarter-
way house. Hosp Community Psychiatry 1981;32:330–4.
Reason for exclusion: not a home treatment study
(residential).
Guy W, Gross M, Hogarty GE, Dennis H. A controlled
evaluation of day hospital effectiveness. Arch Gen
Psychiatry 1969;20:329–38.
Reason for exclusion: not a home treatment study 
(day care).
Heitger B, Saameli W. Wirksamkeit einer psychiatrischen
Tagesklinikbehandlung. Eine empirische Untersuchung
aus den Psychiatrischen Diensten des Regionalspitals
Thun. [Effectiveness of treatment in a psychiatric day
hospital.] Schweiz Arch Neurol Psychiatr 1995;146:33–8.
Reason for exclusion: not a home treatment study 
(day care).
Hemming M, Yellowlees P. An evaluation study of clinical
case management using clinical case management
standards. J Ment Health 1997;6:589–98.
Reason for exclusion: not a comparative study.
Herz MI, Endicott J, Spitzer RL, Mesnikoff A. Day versus
inpatient hospitalization: a controlled study. Am J
Psychiatry 1971;127(10):107–18.
Reason for exclusion: not home treatment (day care).
Herz MI, Endicott J, Gibbon M. Brief hospitalization:
two-year follow-up. Arch Gen Psychiatry 1979;36:701–5.
Reason for exclusion: not a home treatment study.
Hogarty GE, Goldberg SC. Drug and sociotherapy in the
aftercare of schizophrenic patients. One-year relapse
rates. Arch Gen Psychiatry 1973;28:54–64.
Reason for exclusion: not a home treatment study.
Hogarty GE, Kornblith SJ, Greenwald D, DiBarry AL,
Cooley S, Ulrich RF, et al. Three-year trials of personal
therapy among schizophrenic patients living with or
independent of family, I: description of study and effects
on relapse rates. Am J Psychiatry 1997;154:1504–13.
Reason for exclusion: not a home treatment study.
Hu T, Jerrell JM. Cost-effectiveness of alternative
approaches in treating severely mentally ill in California.
Schizophr Bull 1991;17:461–7.
Reason for exclusion: review.
Hu X, Xiong W, Fei L, Wang R. Comprehensive family
treatment for schizophrenic patients: a prospective,
randomised, single-blind control trial of 63 patients.
Chinese Ment Health J 1994;8:210–15.
Reason for exclusion: trial type not clear: ‘2-year follow-
up study’; family-based treatment vs standard care;
Chinese – translation not possible.
Husted J, Wentler SA, Bursell A. The effectiveness of
community support programs for persistently mentally ill
in rural areas. Community Ment Health J 1994;30:595–600.
Reason for exclusion: not a comparative study.
Jones R, Goldberg D, Hughes B. A comparison of two
different services treating schizophrenia: a cost–benefit
approach. Psychol Med 1980;10:493–505.
Reason for exclusion: not a home treatment study 
(two hospital services).Appendix 4
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Khefner KW, van-der-Kheiden V, Klug I. The assessment
of a community-based care system for mental patients.
Zh Nevropatol Psikhiatr Im S S Korsakova 1985;85:116–21.
Reason for exclusion: not a comparative study.
Kluiter H, Giel R, Nienhuis FJ, Ruphan M, Wiersma D.
Predicting feasibility of day treatment for unselected
patients referred for inpatient psychiatric treatment:
results of a randomized trial. Am J Psychiatry
1992;149:1199–205.
Reason for exclusion: not a home treatment study 
(day care).
Krupinski J, Lippmann L. Multi-disciplinary or non-
disciplinary: evaluation of staff functioning in a
community mental health centre. Aust N Z J Psychiatry
1984;18:172–8.
Reason for exclusion: not a comparative study.
Kuldau JM, Dirks SJ. Controlled evaluation of a hospital-
originated community transitional system. Arch Gen
Psychiatry 1977;34:1331–40.
Reason for exclusion: not a home treatment study.
Kwakwa J. Alternatives to hospital-based mental health
care. Nurs Times 1995;91:38–9.
Reason for exclusion: not a comparative study.
Lamb HR, Goertzel V. Discharged mental patients – 
are they really in the community? Arch Gen Psychiatry
1971;24:29–34.
Reason for exclusion: not a home treatment study
(residential and day care).
Lamb HR. The new state mental hospitals in the
community. Psychiatr Serv 1997;48:1307–10.
Reason for exclusion: not a home treatment study
(residential); not a comparative study.
Leff HS, Lieberman M, Mulkern V, Raab B. Outcome
trends for severely mentally ill persons in capitated and
case managed mental health programs. Adm Policy Ment
Health 1996;24:3–23.
Reason for exclusion: not a home treatment study.
Leff J, Trieman M, Gooch C. Team for the assessment 
of psychiatric services (TAPS) project 33: prospective
follow-up study of patients discharged from two
psychiatric hospitals. Am J Psychiatry 1996;153:1318–24.
Reason for exclusion: not a home treatment study
(residential); not a comparative study.
Levenson AJ. Acute schizophrenia: an efficacious
outpatient treatment approach as an alternative to 
full-time hospitalization. Dis Nerv Sys 1977;38:242–5.
Reason for exclusion: not a home treatment study.
Linn MW, Caffey-EM J, Klett CJ, Hogarty G. Hospital vs
community (foster) care for psychiatric patients. Arch
Gen Psychiatry 1977;34:78–83.
Reason for exclusion: not a home treatment study
(foster care).
Linn MW, Caffey EM, Klett CJ. Day treatment and
psychotropic drugs in the aftercare of schizophrenic
patients. A veterans administration cooperative study.
Arch Gen Psychiatry 1979;36:1055–66.
Reason for exclusion: not a home treatment study 
(day care).
Linn MW, Klett CJ, Caffey J. Foster home characteristics
and psychiatric patient outcome: the wisdom of Gheel
confirmed. Arch Gen Psychiatry 1980;37:129–32.
Reason for exclusion: not a home treatment study
(foster care).
Linn MW, Gurel L, Williford WO, Overall J, Gurland B,
Laughlin P, Barchiesi A. Nursing home care as an
alternative to psychiatric hospitalization. A Veterans
Administration cooperative study. Arch Gen Psychiatry
1985;42:544–51.
Reason for exclusion: not a home treatment study.
Luo K, Yu D. Enterprise-based sheltered workshops in
Nanjing. A new model for the community rehabilitation
of mentally ill workers. Br J Psychiatry Suppl 1994;
165 Suppl 24:89–95.
Reason for exclusion: not a home treatment study.
Matthews SM, Roper MT, Mosher LR, Menn AZ. A non
neuroleptic treatment for schizophrenia: analysis of the
two year postdischarge risk of relapse. Schizophr Bull
1979;5:322–33.
Reason for exclusion: not a home treatment study
(residential).
McClary S, Lubin B, Evans C, Watt B. Evaluation of a
community treatment program for young adult
schizophrenics. J Clin Psychol 1989;45:806–8.
Reason for exclusion: not a comparative study.
McRae J, Higgins M, Lycan C, Sherman W. What
happens to patients after five years of intensive case
management stops? Hosp Community Psychiatry
1990;41:175–83.
Reason for exclusion: not a comparative study.
Meisler N, Blankertz L, Santos AB, McKay C. Impact of
assertive community treatment on homeless persons 
with co-occurring severe psychiatric and substance use
disorders. Community Ment Health J 1997;33:113–22.
Reason for exclusion: not a comparative study.
Michaux MH, Chelat MR, Foster SA, Pruin RJ. Day and
full-time psychiatric treatment: a controlled comparison.
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Measures of hospitalisation
The tables below list all the studies in this review.
Where studies use mean days in hospital as their
hospitalisation measure, the significance of their
findings is not reported here because they are
included in our meta-analysis (see chapter 6,
‘Results’). The exception to this is when no data
were available, in which case the significance of 
the finding is reported in Tables 50 and 51.
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TABLE 50  RCTs: hospitalisation measures
Study Hospitalisation measures available Significance
1 Aberg-Wistedt – Stockholm Emergency room visits Yes (favours experimental service)
Reduction in hospital days (within-group) NS
2 Bond – Chicago 1 Days in hospital
3 Bond – Indiana 1 Days in hospital
4 Burns – London Days in hospital
5 Bush – Atlanta Days in hospital
6 Chandler – California 1 Days in hospital
7 Chandler – California 2 Days in hospital
8C urtis – New York Days in hospital
9 Drake – New Hampshire Days in hospital NS
*
10 Essock – New York Days in hospital
11 Fenton – Montreal Days in hospital Yes (favours experimental service)
12 Ford – London 1 Days in hospital
13 Franklin – Texas Days in hospital Yes (favours control service)
*
14 Gater – Manchester None available
15 Godley – Illinois Days in hospital
16 Gournay – Middlesex None available
17 Hauenstein – Virginia None available
18 Herinckx – Oregon None available
19 Holloway – London Days in hospital
20 Hoult – Sydney Days in hospital
21 Ivarsson – Gothenburg [In progress]
22 Jerrell – San Jose Days in hospital
23 Jerrell – S. Carolina 1 Days in hospital
24 Jerrell – S. Carolina 2 Days in hospital
25 Johnston – New South Wales Days in hospital
26 Korr – Pittsburg Days in hospital
27 Lafave – Ontario Days in hospital
28 Lehman – Baltimore Days in hospital
29 Lehman – Maryland Days in hospital
30 Macias – Utah 1 Number of patients hospitalised  Yes (within-group only)
(within-group)
31 Marshall – Oxford Days in hospital
32 Marx – Madison Days in hospital
33 McDonel – Indiana ‘Hospital use’ NS
*
34 McFarlane – Maine Rate of re-hospitalisation NS
35 Merson – London Days in hospital
36 Modrcin – Kansas None available
* Figures not reported
NS, not significant
continuedHealth Technology Assessment 2001; Vol. 5: No. 15
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TABLE 50 contd  RCTs: hospitalisation measures
Study Hospitalisation measures available Significance
37 Morse – St Louis 1 None available
38 Morse – St Louis 2 % of individuals receiving hospital contacts  [Significant decrease over time]
(within-group)
39 Muijen – London 1 Days in hospital
40 Muijen – London 2 Days in hospital
41 Paykel – London Days in hospital
42 Quinlivan – California Days in hospital
43 Rosenheck – Connecticut Days in hospital
44 Rosenthal – New York None available
45 Salkever – Baltimore  Days in hospital
46 Sellwood – Manchester Days in hospital
47 Solomon – Philadelphia 1 Days in hospital
48 Solomon – Philadelphia 2 None available
49 Stein – Madison Days in hospital
50 Test – Wisconsin Days in hospital
51 Tyrer – London 1 Days in hospital
52 Tyrer – London 2 Days in hospital
53 UK700 Days in hospital
54 Vaccaro – LA None available
55 Wolff – New Jersey % of patients receiving 1+ units of NS
inpatient treatment: between groups
56 Wood – California Days in hospital
NS, not significantAppendix 5
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TABLE 51  Non-randomised studies: hospitalisation measures
Study Hospitalisation measures available Significance
1 Barker – Kentucky Readmissions Yes (favours experimental service)
2B igelow – Victoria % of possible community days spent  Yes (favours experimental service)
in hospital
3 Bond – Indiana 2 Days in hospital
4 Bond – Indiana 3 Days in hospital
5 Buhrich – New South Wales Rate and duration of admission Yes (favours experimental service)
6 Champney – Ohio None available
7 Christensen – Svendborg Days in hospital
8 Coates – Vancouver % of individuals admitted NS
Duration of initial admissions NS
Readmissions NS
9 Cutler – Oregon Hospitalisations Yes (favours experimental service)
10 Dean – Birmingham 1 Days in hospital
11 Dean – Birmingham 2 Days in hospital
12 Drake – Washington None available
13 Felton – New York Days in hospital
14 Ford – London 2 None available
15 Goering – Ontario Total readmissions and recidivism rate NS
Length of stay NS
16 Grad – Chichester Days in hospital
17 Hornstra – Missouri Days in hospital
18 Macias – Utah 2 None available
19 McGorry – Victoria None available
20 McGurrin – Philadelphia Units of inpatient care Fewer used by experimental  
group (significance not reported)
21 Melzer – London Number of patients in hospital at follow-up [odds ratio]
22 Mowbray – Michigan Days in hospital
23 Pai – Bangalore Readmissions
24 Pasamanick – Ohio Days in hospital
25 PRiSM – London Days in hospital
26 Rössler – Mannheim Total length of key hospitalisation NS
Length of 2nd hospitalisation (if applicable) NS
Probability of still being in hospital 
5 weeks after admission
27 Sands – Philadelphia Days in hospital
28 Santiago – Arizona None available
29 Slavinsky – Connecticut  Percentage re-hospitalised NS
30 Stanard – Georgia Hospital days NS
*
31 Tyrer – London 3 Number of admissions Not clear
32 Vincent – New York Readmissions Not clear
33 Weinman – Philadelphia Readmissions Yes (favours experimental service)
34 Wood – Dunedin Number of individuals with no admissions Yes (favours experimental service)
35 Zhang – Shanghai Readmissions NS
* Figures not given: authors report no difference between groups
NS, not significantHealth Technology Assessment 2001; Vol. 5: No. 15
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Systematic review of home treatment for mental health problems
Study: ___________________________________________________________________________________
Name of respondent: ______________________________________________________________________
Tel: _________________________________________
Please answer the following questions:
Is the team or service evaluated in the above study still identifiable? Yes / No
(If it is, please complete the 3rd [final] column in the ‘Service characterisation 
questionnaire’ table as well as the 1st column)
If the service is no longer running, could you tell us in what year it ceased to operate?
Was the control service a community mental health team? Yes/ No
(If yes, please also complete the 2nd column in the ‘Service characterisation questionnaire’ table)
If not, please describe the control service briefly here:
Please list around six features of the experimental service at the time of the study that made it
innovative in your area:
Which of the characteristics of the service as described in your study or above do you still find useful
and carry out now?
Were there any that you found unhelpful and decided to drop?
Appendix 6
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Home treatment review
Service characterisation questionnaire
Please answer each question, if possible, for the  Experimental Control  Experimental
Experimental service at the time of the study [column 1],  service during service service
the Control service at the time of the study (if it was a team)  the study during the today
[column 2] and the Experimental service today (if it still  period study 
exists) [column 3] period
1W ere the following part of the team?
Postgraduate qualified psychiatrist Yes / No Yes / No Yes / No
Junior doctor Yes / No Yes / No Yes / No
Psychiatric nurse Yes / No Yes / No Yes / No
OT Yes / No Yes / No Yes / No
Social worker Yes / No Yes / No Yes / No
Other (please state) Yes / No Yes / No Yes / No
2D id any of the staff have specific qualifications in  Yes / No Yes / No Yes / No
community working?
3W as there in-service training especially geared at  Yes / No Yes / No Yes / No
community-based care?
4 How many staff (approximately) were in the team?
5 What was the target number of patients on the 
team’s books?
6 What was the target individual caseload size?
7I f there was a psychiatrist on the team, was s/he  Yes / No Yes / No Yes / No
an integrated member?
8 How many hours of psychiatrist time were  h h h
designated per week? (1/2 day = 3.5 hours)
9D id the team have a home treatment function? Yes / No Yes / No Yes / No
10 Did team members regularly visit patients at home? Yes / No Yes / No Yes / No
11 If so, approximately what proportion of patient 
contacts took place at home? (%) % % %
12 How many days a week did the team operate? days days days
13 How many hours did the team operate on weekdays? h h h
14 Did the team take responsibility for healthcare  Yes / No Yes / No Yes / No
functions (e.g. medication)?
15 Did the team take responsibility for social care  Yes / No Yes / No Yes / No
functions (e.g. housing, benefits)?
16 Did the team have a specific crisis element? Yes / No Yes / No Yes / No
17 What was the maximum contact frequency per 
patient per month?
18 What was the average contact frequency per patient 
per month?
19 Did the team have multidisciplinary review of   Yes / No Yes / No Yes / No
patients at least once weekly?
20 Did the team have a protocol for meeting the needs  Yes / No Yes / No Yes / No
of carers?Health Technology Assessment 2001; Vol. 5: No. 15
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Data information: UK studies
Below is a list of services that people with severe mental health problems might typically come into contact
with. Please tick all relevant boxes if data on frequency of contact and/or average contacts were collected
in your study.
Did you collect medication dosage? Yes / No
Data information: USA
Below is a list of services that people with severe mental health problems might typically come into contact
with. Please tick all relevant boxes if data on frequency of contact and/or average contacts were collected
in your study.
Did you collect medication dosage? Yes / No
Type of service Tick only if contact frequency and/or 
average contacts were collected
Inpatient attendances
Outpatient attendances
Residential care/rehabilitation
Day care/occupational rehabilitation
Employment patterns
Emergency services
Community psychiatric nurse
Local authority social worker
Contact to issue medication
Prison
Police cell
Type of service Tick only if contact frequency and/or 
average contacts were collected
Inpatient attendances private
Inpatient attendances Medicaid
Outpatient attendances private
Outpatient attendances Medicaid
Residential care/rehabilitation
Day activities/occupational rehabilitation
Employment patterns
Emergency room attendances
Mental health worker
Social worker
Contacts to deliver medication
Jail
Overnight in police jailAppendix 6
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Data information:Australia
Below is a list of services that people with severe mental health problems might typically come into contact
with. Please tick all relevant boxes if data on frequency of contact and/or average contacts were collected
in your study.
Did you collect medication dosage? Yes / No
Data information: Canada
Below is a list of services that people with severe mental health problems might typically come into contact
with. Please tick all relevant boxes if data on frequency of contact and/or average contacts were collected
in your study.
Did you collect medication dosage? Yes / No
Type of service Tick only if contact frequency and/or 
average contacts were collected
Inpatient attendances public
Inpatient attendances private
Outpatient attendances public
Outpatient attendances private
Residential support/rehabilitation
Day activities/occupational rehabilitation
Employment status
Emergency room attendances
Community-based staff/mental health worker
Social worker
Contacts to deliver medication
Jail
Overnight in police jail
Type of service Tick only if contact frequency and/or 
average contacts were collected
Inpatient stays
Outpatient visits
Supervised residences
Day activities/day centres
Employment patterns
Emergency room visits
Mental health worker
Social worker
Contacts to deliver medication
Prison/jail
Overnight in police jailHealth Technology Assessment 2001; Vol. 5: No. 15
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Appendix 8
Studies with three treatment conditions
Only studies for which we had appropriate data are listed here.
TABLE 59  Randomised controlled trials
Study Conditions Data used in our analyses
Curtis – New York Assertive outreach; CM; standard care Assertive outreach; CM
Gournay – Middlesex CPN; waiting list for CPN; GP CPN; GP
Jerrell – S. Carolina 1 ACT vs behavioural skills vs 12-step ACT; 12-step
Jerrell – S. Carolina 2 PACT; hybrid CM; broker CM PACT; broker CM
Marx – Madison Total in-community treatment; research unit; Total in-community treatment; inpatients
inpatients
Quinlivan – California ICM; standard CM; usual services ICM; standard CM
Salkever – Baltimore PACT at CMHC; PACT at another location; PACT (both combined); standard care
*
standard care
Wood – California ICM; standard CM – each with and without  ICM; standard CM
†
housing certificate
* Data from the two experimental conditions is combined in the authors’ own analysis
† Author provided data for groups combined (ICM with and without housing certificate, and CM with and without housing certificate)
TABLE 60  Non-randomised studies
Study Conditions Data used in our analyses
Bond – Indiana 2 ACT; reference groups; CMHC ACT; reference groups
Felton – New York ICM with peer specialist; ICM with non-peer  ICM with non-peer assistant; standard CM
assistant; standard CM
Pasamanick – Ohio Drug home care; placebo home care; inpatient Drug home care; inpatientHealth Technology Assessment 2001; Vol. 5: No. 15
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T
he information given below relates to the
tables and four figures in chapter 6, ‘Results’,
and is not intended to stand alone.
Table 33:a ny duration
RCTs
Fenton – Montreal; Hoult – Sydney; Lafave – Ontario;
Marx – Madison; Merson – London; Muijen –
London 1; Rosenheck – Connecticut; Stein – Madison
Non-RCTs
Dean – Birmingham 2; Grad – Chichester;
Mowbray – Michigan; Pasamanick – Ohio
Table 33: 1-year follow-up only
RCTs
As above, dropping Merson – London; Marx –
Madison; Rosenheck – Connecticut
Non-RCTs
Dean – Birmingham 2 only
Figure 5
RCTs
Fenton – Montreal; Hoult – Sydney; Lafave –
Ontario; Marx – Madison; Muijen – London 1;
Muijen – London 2; Rosenheck – Connecticut;
Stein – Madison
Non-RCTs
Dean – Birmingham 2; Grad – Chichester;
Mowbray – Michigan; Pasamanick – Ohio
Figure 6
As in Figure 5
Table 34:a ny duration
RCTs
Bond – Chicago 1; Bond – Indiana 1; Burns –
London; Bush – Atlanta; Chandler – California 1;
Chandler – California 2; Curtis – New York; 
Drake – New Hampshire; Essock – New York; 
Ford – London 1; Godly – Illinois; Holloway –
London; Jerrell – San Jose; Jerrell – S. Carolina 1;
Jerrell – S. Carolina 2; Johnston – New South
Wales; Lehman – Baltimore; Marshall – Oxford;
Muijen – London 2; Paykel – London; Quinlivan –
California; Salkever – Baltimore; Sellwood –
Manchester; Solomon – Philadelphia 1; Test –
Wisconsin; Tyrer – London 1; Tyrer – London 2;
UK700; Wood – California
Non-RCTs
Bond – Indiana 2; Felton – New York; PRiSM –
London
Table 34:1  y ear or more
RCTs
As in ‘Table 34: any duration’, dropping Bond –
Indiana 1; Sellwood – Manchester; Test –
Wisconsin; Tyrer – London 2
Non-RCTs
As in ‘Table 34: any duration’ (none dropped)
Table 34: only predominately
neurotic studies
RCTs
As in ‘Table 34: 1 year of more’, dropping Burns –
London; Paykel – London
Non-RCTs
None dropped
Table 35
RCTs
All RCTs used in ‘Table 34: any duration’
Non-RCTs
All non-RCTs used in ‘Table 34: any duration’
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Table 36
RCTs
All RCTs used in ‘Table 34: 1 year or more’
Non-RCTs
All non-RCTs used in ‘Table 34: 1 year or more’
Table 37
RCTs
Burns – London; Ford – London 1; Jerrell – San
Jose; Jerrel – S. Carolina 1; Jerrell – S. Carolina 2;
Johnston – New South Wales; Lehman – Baltimore;
Muijen – London 2; Paykel – London; Quinlivan –
California; Solomon – Philadelphia 1; UK700
Table 38
Non-RCT
Added: PRiSM – London
Table 39
RCTs
All RCTs used in ‘Table 34: 1 year or more’,
dropping Hoult – Sydney
Non-RCTs
All non-RCTs used ‘Table 34: 1 year or more’
Table 40:r egularly visiting at
home
RCTs
Both regularly visit
Burns – London; Drake – New Hampshire;
Holloway – London; Johnston – New South Wales;
Muijen – London 2; Quinlivan – California;
Solomon – Philadelphia 1; Tyrer – London 1;
UK700; Wood – California
Only experimental service regularly visits
Bond – Chicago 1; Bush – Atlanta; Chandler –
California 1; Chandler – California 2; Curtis – New
York; Ford – London 1; Godley – Illinois; Jerrell –
San Jose; Jerrell – S. Carolina 2; Lehman –
Baltimore; Marshall – Oxford; Paykel – London;
Salkever – Baltimore
Non-RCTs
Both regularly visit
PRiSM – London
Only experimental service visits
Dean – Birmingham 2
Table 40: home treatment
function
RCTs
Both services have home treatment function
Burns – London; Drake – New Hampshire;
Holloway – London; Johnston – New South Wales;
Muijen – London 2; Quinlivan – California;
Solomon – Philadelphia 1; UK700
Experimental service only
Bond – Chicago 1; Chandler – California 1;
Chandler – California 2; Ford – London 1; 
Jerrell – San Jose; Jerrell – S. Carolina 1; Jerrell – 
S. Carolina 2; Lehman – Baltimore; Paykel –
London; Tyrer – London 1
Non-RCTs
Both services have home treatment function
PRiSM
Experimental service only
Bond – Indiana 2
Table 41
RCTs
Both services take responsibility for health and
social care
Burns – London; Drake – New Hampshire;
Holloway – London; Johnston – New South Wales;
Muijen – London 2; UK700; Wood – California
Experimental service only
Jerrell – S. Carolina 2; Quinlivan – California;
Solomon – Philadelphia 1
Non-RCTs
Both services take responsibility for health and
social care
None added
Experimental service only
PRiSM
Table 42
RCTs
Bond – Chicago 1; Burns – London; Chandler –
California 1; Chandler – California 2; Drake – 
New Hampshire; Ford – London 1; Jerrell – Health Technology Assessment 2001; Vol. 5: No. 15
129
San Jose; Jerrell – S. Carolina 1; Jerrell – 
S. Carolina 2; Johnston – New South Wales;
Lehman – Baltimore; Paykel – London; 
Quinlivan – California; Tyrer – London 1; 
UK700; Wood – California
Non-RCTs
None added
Figure 7
RCTs
Drake – New Hampshire; Essock – New York;
Jerrell – S. Carolina 2; Johnston – New South
Wales; Quinlivan – California; Solomon –
Philadelphia 1; UK700; Wood – California
Non-RCTs
Felton – New York
Figure 8
RCTs
Burns – London; Drake – New Hampshire; 
Jerrell – S. Carolina 2; Johnston – New South
Wales; Muijen – London 2; Quinlivan – California;
UK700; Wood – California
Non-RCTs
PRiSM
Table 43
29 RCTs as in Table 34 (any duration) omitting
Rosenheck – Connecticut, and eight studies in
Table 33 (any duration)
Table 44
25 RCTs as in Table 34 (1 year only) and five RCTs
in Table 33 (1 year only)
Table 45
As in Table 44
Table 46
Caseload size
Bond – Chicago 1; Curtis – New York; Drake – 
New Hampshire; Essock – New York; Ford –
London 1; Godley – Illinois; Holloway – London;
Jerrell – San Jose; Jerrell – S. Carolina 1; Jerrell – 
S. Carolina 2; Johnston – New South Wales;
Lehman – Baltimore; Marshall – Oxford; 
Muijen – London 1; Muijen – London 2; Paykel –
London; Quinlivan – California; Salkever –
Baltimore; Solomon – Phildelphia 1; UK700; 
Wood – California
Average contact frequency
Bond – Chicago 1; Burns – London; Chandler –
California 1; Drake – New Hampshire; Ford –
London 1; Hoult – Sydney; Jerrell – San Jose;
Jerrell – S. Carolina 1; Jerrell – S. Carolina 2;
Johnston – New South Wales; Lehman – 
Baltimore; Muijen – London 2; Paykel – London;
Quinlivan – California; Solomon – Philadelphia 1;
Stein – Madison; Tyrer – London 1; UK700; 
Wood – California
Percentage of contacts at home
Bond – Chicago 1; Burns – London; Chandler –
California 1; Chandler – California 2; Drake – 
New Hampshire; Ford – London 1; Hoult –
Sydney; Jerrell – San Jose; Jerrell – S. Carolina 1;
Jerrell – S. Carolina 2; Johnston – New South
Wales; Lafave – Ontario; Lehman – Baltimore;
Paykel – London; Quinlivan – California; 
Stein – Madison; Tyrer – London 1; UK700; 
Wood – California
Table 47
As in Table 46Health Technology Assessment 2001; Vol. 5: No. 15
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The HTA Programme and the authors would like to know 
your views about this report.
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your comments. If you prefer, you can send your comments 
to the address below, telling us whether you would like 
us to transfer them to the website.
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